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A B S T R A C T
Background
Colorectal cancer is the third most commonly diagnosed cancer worldwide. A diagnosis of colorectal cancer and subsequent treatment can
adversely aJect an individuals physical and mental health. Benefits of physical activity interventions in alleviating treatment side eJects
have been demonstrated in other cancer populations. Given that regular physical activity can decrease the risk of colorectal cancer, and
cardiovascular fitness is a strong predictor of all-cause and cancer mortality risk, physical activity interventions may have a role to play in
the colorectal cancer control continuum. Evidence of the eJicacy of physical activity interventions in this population remains unclear.
Objectives
To assess the eJectiveness and safety of physical activity interventions on the disease-related physical and mental health of individuals
diagnosed with non-advanced colorectal cancer, staged as T1-4 N0-2 M0, treated surgically or with neoadjuvant or adjuvant therapy (i.e.
chemotherapy, radiotherapy or chemoradiotherapy), or both.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 6), along with OVID MEDLINE, six other databases and
four trial registries with no language or date restrictions. We screened reference lists of relevant publications and handsearched meeting
abstracts and conference proceedings of relevant organisations for additional relevant studies. All searches were completed between 6
June and 14 June 2019.
Selection criteria
We included randomised control trials (RCTs) and cluster-RCTs comparing physical activity interventions, to usual care or no physical
activity intervention in adults with non-advanced colorectal cancer.
Data collection and analysis
Two review authors independently selected studies, performed the data extraction, assessed the risk of bias and rated the quality of the
studies using GRADE criteria. We pooled data for meta-analyses by length of follow-up, reported as mean diJerences (MDs) or standardised
mean diJerences (SMDs) using random-eJects wherever possible, or the fixed-eJect model, where appropriate. If a meta-analysis was not
possible, we synthesised studies narratively.
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Main results
We identified 16 RCTs, involving 992 participants; 524 were allocated to a physical activity intervention group and 468 to a usual care
control group. The mean age of participants ranged between 51 and 69 years. Ten studies included participants who had finished active
treatment, two studies included participants who were receiving active treatment, two studies included both those receiving and finished
active treatment. It was unclear whether participants were receiving or finished treatment in two studies. Type, setting and duration of
physical activity intervention varied between trials. Three studies opted for supervised interventions, five for home-based self-directed
interventions and seven studies opted for a combination of supervised and self-directed programmes. One study did not report the
intervention setting. The most common intervention duration was 12 weeks (7 studies). Type of physical activity included walking, cycling,
resistance exercise, yoga and core stabilisation exercise.
Most of the uncertainty in judging study bias came from a lack of clarity around allocation concealment and blinding of outcome assessors.
Blinding of participants and personnel was not possible. The quality of the evidence ranged from very low to moderate overall. We did
not pool physical function results at immediate-term follow-up due to considerable variation in results and inconsistency of direction of
eJect. We are uncertain whether physical activity interventions improve physical function compared with usual care. We found no evidence
of eJect of physical activity interventions compared to usual care on disease-related mental health (anxiety: SMD -0.11, 95% confidence
interval (CI) -0.40 to 0.18; 4 studies, 198 participants; I2 = 0%; and depression: SMD -0.21, 95% CI -0.50 to 0.08; 4 studies, 198 participants; I2
= 0%; moderate-quality evidence) at short- or medium-term follow-up. Seven studies reported on adverse events. We did not pool adverse
events due to inconsistency in reporting and measurement. We found no evidence of serious adverse events in the intervention or usual
care groups. Minor adverse events, such as neck, back and muscle pain were most commonly reported. No studies reported on overall
survival or recurrence-free survival and no studies assessed outcomes at long-term follow-up
We found evidence of positive eJects of physical activity interventions on the aerobic fitness component of physical fitness (SMD 0.82,
95% CI 0.34 to 1.29; 7 studies, 295; I2 = 68%; low-quality evidence), cancer-related fatigue (MD 2.16, 95% CI 0.18 to 4.15; 6 studies, 230
participants; I2 = 18%; low-quality evidence) and health-related quality of life (SMD 0.36, 95% CI 0.10 to 0.62; 6 studies, 230 participants; I2
= 0%; moderate-quality evidence) at immediate-term follow-up. These positive eJects were also observed at short-term follow-up but not
medium-term follow-up. Only three studies reported medium-term follow-up for cancer-related fatigue and health-related quality of life.
Authors' conclusions
The findings of this review should be interpreted with caution due to the low number of studies included and the quality of the evidence.
We are uncertain whether physical activity interventions improve physical function. Physical activity interventions may have no eJect
on disease-related mental health. Physical activity interventions may be beneficial for aerobic fitness, cancer-related fatigue and health-
related quality of life up to six months follow-up. Where reported, adverse events were generally minor. Adequately powered RCTs of high
methodological quality with longer-term follow-up are required to assess the eJect of physical activity interventions on the disease-related
physical and mental health and on survival of people with non-advanced colorectal cancer. Adverse events should be adequately reported.
P L A I N   L A N G U A G E   S U M M A R Y
Physical activity interventions for the physical and mental health of people during and a4er treatment for bowel cancer
Background
Bowel cancer is the third most common cancer diagnosed worldwide. Being diagnosed and receiving treatment for bowel cancer can have
a negative impact on a person's physical and mental health. Side eJects include reduced fitness levels and increased tiredness. People
are also at risk of their cancer returning aMer treatment and this can cause fear and worry. Research on physical activity programmes in
other cancer populations has shown benefits in reducing side eJects of treatment. Given that people who are active have a lower chance
of developing bowel cancer, physical activity may be beneficial for those with a bowel cancer diagnosis, but the research is not yet clear.
Review question
This review was undertaken to find out whether physical activity programmes are beneficial for the physical and mental health of people
with bowel cancer and whether they are safe.
Key results
We found 16 studies that included 992 participants, our evidence is current to June 2019. Participants were randomly assigned to receive
a physical activity programme or usual care (no physical activity programme). In the included studies, we are unsure whether physical
activity programmes improve physical function and we found no eJect of physical activity programmes compared to usual care on disease-
related mental health. No serious adverse events occurred in the eight studies that looked at adverse events. There was inconsistency
in reporting and measurement of adverse events. We do not know whether physical activity improves survival at any time point as no
studies looked at this. The included studies suggest physical activity programmes may increase aerobic fitness, health-related quality
of life (general well-being) and reduce fatigue (tiredness) in the short term. We are unsure of the long-term eJects of physical activity
interventions on physical function, disease-related mental health, adverse events, physical fitness, fatigue (tiredness), weight, health-
related quality of life (general well-being) and physical activity levels because no studies assessed this.
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Quality of the evidence
We rated the quality of the evidence from very low to moderate mainly because of the small number of studies and low number of
participants, as well as study limitations.
Conclusion
The findings of this review should be interpreted with caution due to the low number of studies included and the quality of the
evidence. This review shows the need for future high quality research with longer-term follow-up to assess the eJects of physical activity
interventions on the physical and mental health of people with bowel cancer, especially in relation to safety and survival.
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S U M M A R Y   O F   F I N D I N G S
 
Summary of findings 1.   Physical activity compared with usual care in adults with non-advanced colorectal cancer
Physical activity compared with usual care in adults with non-advanced colorectal cancer
Population: adults with non-advanced colorectal cancer treated surgically or with neoadjuvant or adjuvant therapy, or both
Settings: all but one study undertaken in high-income countries. Included home-based self-directed and supervised physical activity programmes
Intervention: aerobic or resistance training, flexibility or balance training or a combination of these, lasting at least 4 weeks
Comparison: control intervention (usual care or no physical activity intervention)
Illustrative comparative risks* (95% CI)
Assumed risk Corresponding risk
Outcomes





















We did not pool results due to considerable variability and inconsisten-
cy in direction of effect. Two studies observed no difference between
the physical activity and usual care group for physical function at imme-
diate-term follow-up. Two other studies reported significant improve-






We are uncertain whether physi-







12 weeks to 6 months
(short term)
The mean postintervention
HADS for depression ranged
across control groups from 2.14
to 4.72
The mean postintervention depres-
sion in the intervention group was







Scores estimated using SMD -0.21
(-0.50 to 0.08)g
No evidence of difference in de-
pression in the physical activity








HADS for anxiety ranged across
control groups from 2 to 3
The mean postintervention anxiety
in the intervention groups was 0.40







Scores estimated using SMD -0.11
(-0.40 to 0.18)g
No evidence of difference in anxi-
ety in the physical activity group































































































































































































enrolment in the study
and death of the per-
son from any cause)
Follow-up: 12 months
See comment See comment Not es-
timable
    The included studies did not re-




date of enrolment in
the study and the date
when colorectal can-




See comment See comment Not es-
timable
    The included studies did not re-
port on recurrence-free survival
Adverse events
Follow-up: range 8
weeks to 11 months
4 studies reported no adverse events, 3 other studies reported no se-
rious adverse events with 7 participants experiencing minor adverse
events in one study, 101 minor adverse events being reported in anoth-
er study and 39 and 36 minor adverse events being reported in the inter-
vention and control groups, respectively in another study. 1 study did
not differentiate between serious and minor adverse events and report-













Follow-up: up to 12
weeks (immediate
term)
The mean postintervention 6-
minute walk test score ranged
across control groups from
293.7 to 588.9
The mean postintervention physical
fitness in the intervention group was






Scores estimated using a SMD
0.82 (0.34 to 1.29)f
Evidence suggests an improve-
ment in aerobic fitness in the
physical activity group compared





























































































































































































and FACT-F (scale 0-52:
higher score indicates
lower fatigue)





ranged across control groups
from 37.1 to 44
The mean postintervention can-
cer-related fatigue score in the inter-
vention groups was





Evidence suggests an improve-
ment in cancer-related fatigue in
the physical activity group com-
pared with the usual care group
Health-related quali-




better quality of life)




FACT-C scores ranged across
control groups from 99.1 to
110.8
The mean postintervention HRQoL in
the intervention group was 6.64 (1.8






Scores estimated using SMD 0.36
(0.10 to 0.62)h
MID 5 to 8 points
Evidence suggests an improve-
ment in HRQoL in the physical ac-
tivity group compared with the
usual care group
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
CES-D: Centre for Epidemiological Studies Depression Scale; CI: confidence interval; FACIT-F: Functional Assessment of Chronic Illness Therapy-Fatigue; FACT-C: Function-
al Assessment of Cancer Therapy-Colorectal; FACT-F: Functional Assessment of Cancer Therapy-Fatigue; FACT-G: Functional Assessment of Cancer Therapy-General; HADS:
Hospital Anxiety and Depression Scale; HRQoL: health-related quality of life; MID : Minmal important difference, MD: mean difference: RCT: randomised controlled trial; SD:
standard deviation; SMD: standardised mean difference (used when studies assess the same outcome but measure it in a variety of ways).
GRADE Working Group grades of evidence
High quality: further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: we are very uncertain about the estimate.
aDowngraded one level due to indirectness (applicability of results to those undergoing active treatment).
bDowngraded one level due to imprecision (small sample size).
cDowngraded one levels due to inconsistency in reporting and measuring and numbers of adverse events reported.
dDowngraded one level due to indirectness (reporting adverse events and not reporting whether these are 'related' or 'unrelated' to the intervention).
eDowngraded one level due to risk of bias (lack of allocation concealment and blinding of outcome assessor).
fAnalysed with SMD and back estimated to MD to enable interpretation. SD for performing the calculation was obtained from study by Lee 2017.
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B A C K G R O U N D
Description of the condition
Colorectal cancer is the third most commonly diagnosed cancer
and the second leading cause of cancer death worldwide,
accounting for an estimated 881,000 deaths in 2018 (GLOBOCAN
2018). Incidence and mortality rates vary globally, with higher
incidence and lower mortality rates in higher-income countries
(Arnold 2017; GLOBOCAN 2018; Stewart 2014). In general, incidence
is higher in men than women and is strongly linked with age, with
highest incidence among people aged 65 to 74 years (Howlader
2016). Incidence is currently stabilising in high-income countries,
however a two-fold cumulative increase in incidence is expected
by 2025, due to increasing incidence in low- to middle-income
countries. With development, comes the adoption of more inactive
lifestyles and unhealthy dietary habits; established risk factors for
colorectal cancer (Stewart 2014). This is expected to increase the
global burden of colorectal cancer, which may be compounded
by a lack of health service resources in low- and middle-income
countries to deal with the escalation in incidence (Stewart 2014).
Five-year survival from colon and rectal cancer has reached 60%
or more in 22 countries worldwide (Allemani 2015). Between 1989
and 2011, colorectal cancer mortality rates decreased by more
than 25% and 30% in men and women, respectively in high-
income countries in Northern and Western Europe, but increased
in most Eastern European countries (Ouakrim 2015). Similar trends
are evident globally, with decreasing mortality rates in high-
income countries, including Australia, Canada (Coleman 2011), the
USA (Ryerson 2016), and Japan (Arnold 2017), and contrasting
increasing mortality rates in low- and middle-income regions,
such as Latin America and the Phillipines (Arnold 2017). These
disparities are not easily explained and are likely due to diJerences
in access to diagnostic and treatment services (Haggar 2009),
with advancements in treatment and early detection contributing
to decreasing mortality in high-income countries (Coleman 2011;
Stewart 2014).
Although treatments are advancing, anti-cancer therapies are
associated with a range of adverse physiological and psychological
side eJects, which aJect morbidity and mortality (Devin 2016a).
Surgical resection is the primary treatment modality for stage I-III
(T1-4 N0-2 M0) colorectal cancer, with systemic chemotherapy or
radiotherapy (more oMen in rectal cancer), or both, given either in
the adjuvant or neoadjuvant setting in stage III and high risk stage II
patients (El-Shami 2015; Labianca 2010). Major abdominal surgery
alone has been associated with declines in physical function
(Schroeder 1991), and fatigue (Christensen 1982). Cancer-related
fatigue aJects between 60% to 96% of people with cancer during
and following chemotherapy, radiotherapy or surgery (Cramp 2012;
Thomas 2014; Wagner 2004). It is a distressing symptom defined
as a sense of "physical tiredness or exhaustion related to cancer
or cancer treatment" (NCCN 2016), which can interfere with one's
ability to carry out daily activities (Curt 2000), and negatively aJect
mood and quality of life (Stone 2008). Cancer-related fatigue is
present in some colorectal cancer survivors at four years following
diagnosis (Schneider 2007). Physical inactivity has been identified
as both a risk factor for (Bower 2014), and a consequence of (Lynch
2010) cancer-related fatigue.
Declines in cardiorespiratory fitness can occur following treatment
for colorectal cancer (Devin 2016a; West 2014a). Lower levels of
cardiorespiratory fitness are linked with higher rates of cancer-
specific morbidity and mortality (Peel 2009; Schmid 2015), and
can predict morbidity aMer colonic and rectal surgery (West 2014b;
West 2014c). Furthermore, people with colorectal cancer may be
susceptible to sarcopenic obesity (obesity with depleted muscle
mass), which is associated with poorer functional status and poorer
survival rates (Prado 2008; Wang 2017). These adverse eJects,
alone or in combination can impact adversely on a patient's
quality of life and subsequent physical activity levels (Cramer
2014a). Colorectal cancer survivors are also at an increased risk of
developing second colorectal cancers (Green 2002; Markle 2010),
non-colorectal cancers (Birgisson 2005), and other comorbidities
(Denlinger 2011).
Concerns surrounding recurrence are common, aJecting over half
of cancer patients at one year following diagnosis (Baker 2005).
Even at five years following surgery for colorectal cancer, survivors
have concerns surrounding recurrence (Custers 2016). A significant
minority of colorectal cancer patients and longer-term survivors
of colorectal cancer (2 or more years postdiagnosis) experience
clinically meaningful levels of psychological distress, including
symptoms of anxiety and depression or reduced mental well-
being (Mosher 2016). Colorectal cancer survivors report high quality
of life at five years or longer postdiagnosis, but have higher
rates of depression than age-matched populations (Ramsey 2002).
Psychological outcomes vary greatly in this population, poorer
psychological outcomes have been linked with the presence of
existing comorbidities (Lynch 2008; Ramsey 2002), worse general
health (Yost 2008), and lower socioeconomic status (Ramsey 2002).
Levels of anxiety and depression are reported to be higher in people
who undergo surgery with adjuvant chemotherapy or radiotherapy
compared with surgery alone (Pereira 2012).
Description of the intervention
Physical activity interventions were the focus of this review.
Physical activity is defined as any bodily movement produced by
contraction of skeletal muscle that results in energy expenditure
above resting energy expenditure (ACSM 2009; Caspersen 1985). For
the purpose of this review the term 'physical activity interventions'
included 'exercise interventions'. Exercise is a subset of physical
activity that is planned, structured and repetitive, done to improve
or maintain one, or more of the components of physical fitness
(ACSM 2009; Caspersen 1985). Physical activity interventions may
be less structured than exercise interventions and oMen focus on
promoting the integration of activities into daily life (e.g. gardening,
walking or active travel). Physical activity interventions may be
self-directed or supervised by a healthcare professional. They can
involve aerobic or resistance training, flexibility or balance training,
or a combination of these, can take place in any setting and can
be individual or group based, or both. No restrictions were made
regarding frequency, intensity, time or type of physical activity
intervention included. Interventions were included if they lasted a
minimum of four weeks, this was to exclude studies on the acute
eJects of physical activity.
Physical activity interventions are not currently delivered as
part of standard practice during or following treatment for
colorectal cancer. Early postoperative mobilisation is, however,
strongly recommended, as part of the Enhanced Recovery
AMer Surgery (ERAS) guidelines following colorectal surgery,
encouraging patients to be out of bed for two hours on the day of
surgery and six hours per day, thereaMer until discharge (Lassen
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2009). The American College of Sports Medicine (Schmitz 2010), the
American Cancer Society (Rock 2012), and the British Association
of Sport and Exercise Science (BASES 2011) guidelines confirm
that exercise can be safely performed during and following cancer
treatment in the general cancer population. Specific guidance
statements on physical activity interventions during and following
treatment for colorectal cancer have not yet been published,
due to lack of evidence on adverse eJects and lack of safety
data (Schmitz 2010). Side eJects of treatments (cancer-related
fatigue, peripheral neuropathy, immune suppression, digestion
issues, bowel dysfunction (including faecal incontinence) and
urinary incontinence) may increase the risk of adverse events
during physical activity. These side eJects may represent barriers
to physical activity participation (Denlinger 2009; Denlinger 2011;
Rock 2012; Schmitz 2010). Indeed, chronic diarrhoea is a side
eJect that has been associated with limitations in activity and
negative body image (Schneider 2007). The presence of a stoma
is also associated with diminished body image (Hong 2014).
These side eJects have been highlighted as factors to consider
when prescribing physical activity. Existing comorbidities (most
commonly cardiovascular disease, musculoskeletal problems and
lung or breathing problems), particularly in older people with
colorectal cancer have been highlighted as other factors requiring
consideration, to reduce the risk of injury and adverse events
(Denlinger 2009; Rock 2012; Schmitz 2010).
How the intervention might work
Physical activity has been proposed as non-pharmacologic
intervention to attenuate the negative physiologic and psychologic
eJects of treatment in people with cancer (Courneya 2007; Schmitz
2005). There is a growing body of evidence from Cochrane and non-
Cochrane systematic reviews demonstrating the positive impact
of physical activity both during and following cancer treatment
(Galvao 2005; Knols 2005; Schmitz 2005; Speck 2010). Exercise
training improves cardiorespiratory fitness and muscle strength
(Schmitz 2005; Speck 2010), overall health-related quality of life
(HRQoL) (Knols 2005; Mishra 2012a; Mishra 2012b), and cancer-
related fatigue in the general cancer population during and
following cancer treatment (Cramp 2012; Furmaniak 2016; Speck
2010), and physical functioning during treatment (Mishra 2012a).
Through improved cardiorespiratory fitness and muscle strength,
physical activity may help address the physical deconditioning
associated with cancer treatments (Schmitz 2005; Speck 2010), and
help manage cancer-related fatigue (Al-Majid 2009; Cramp 2012).
Physical activity may also help the emotional and mental aspects
of cancer-related fatigue (Al-Majid 2009; Cramp 2012). Benefits of
exercise interventions on psychological well-being (Knols 2005),
anxiety and depression show positive trends but the evidence is not
consistent (Cramp 2012; Furmaniak 2016; Mishra 2012a).
Cardiorespiratory fitness has been highlighted as an independent
predictor of cancer mortality risk. Higher cardiorespiratory fitness
is associated with a significant reduction in total cancer mortality
(Schmid 2015), and colorectal cancer mortality (Peel 2009). Peel
and colleagues report that men with at least a moderate fitness
level had a 42% lower risk of colorectal mortality compared with
men with a low cardiorespiratory fitness level. Evidence from
observational studies suggest that physical activity is associated
with overall and disease-free survival (Haydon 2006; Meyerhardt
2006; Meyerhardt 2009), in both colon and rectal cancer patients.
There is consistent evidence linking physical activity to reduced
colon cancer risk (Leitzmann 2015; Wolin 2009). A meta-analysis of
52 studies found an inverse association between physical activity
and colon cancer, with an overall relative risk reduction of 24%
(Wolin 2009). This is consistent with findings of an earlier meta-
analysis of 19 cohort studies, which demonstrated a lower risk of
colon cancer of 22% and 29% in physically active men and women,
respectively (Samad 2005). Conversely, there appears to be no
consistent association between physical activity and rectal cancer
risk (Robsahm 2013).
The exact biological mechanisms for the observed benefit of
physical activity for the prevention and secondary prevention of
colorectal cancer are not fully understood. Various mechanisms
have been proposed. Physical activity may reduce carcinogen
exposure in the mucosa through decreased gastrointestinal transit
time (Quadrilatero 2003; Slattery 2003), may alter prostaglandin
levels (prostaglandins are unsaturated, free fatty acids that aJect
colonic function) (Quadrilatero 2003), and may alter the insulin-
like growth factor (IGF) pathway (Denlinger 2011; Fairey 2003).
In people with colorectal cancer, moderate-intensity exercise has
resulted in reduced levels of urinary markers of oxidative damage
(Allgayer 2008), and decreased interleukin-1 receptor agonist
(Allgayer 2004a), which may enhance immune function. Oxidative
DNA damage is thought to be involved in tumour formation
and may be associated with malignant transition and recurrence
(Allgayer 2008). IGF-1 is important for cellular proliferation and
survival (Hursting 2010), higher levels of which may be associated
with increased risk of colorectal cancer (Giovannucci 2000), but this
association remains elusive. Decreases in IGF and increases in IGF-
binding proteins have been observed following exercise training
in breast cancer survivors, which may be clinically relevant for the
colorectal cancer population (Fairey 2003)
Physical activity may therefore be potentially eJective in improving
overall and recurrence-free survival. Indeed, given that regular
physical activity can decrease the risk of colon cancer and has
improved cardiorespiratory fitness, muscle strength, HRQoL and
cancer-related fatigue in other cancer populations, it may be of
clinical relevance for the colorectal cancer control continuum.
Why it is important to do this review
Colorectal cancer is a major public health problem. With the
projected increasing incidence of colorectal cancer in low-
and middle-income regions, increasing mortality rates in low-
and middle-income countries and 3.5 million colorectal cancer
survivors worldwide (Stewart 2014), there is a need to develop
eJective interventions that aid physical and psychological
recovery, help alleviate treatment side eJects and increase overall
and recurrence-free survival. The Lancet Oncology commission has
prioritised the reduction in morbidity and mortality associated with
cancer, with a focus on "less toxic", "cost-eJective" interventions
(Sullivan 2011). There is, therefore, a need for a greater
understanding of the eJects of physical activity interventions on
the disease-related physical and mental health of individuals with
colorectal cancer, for policy, practice and for consumers.
To date, there are currently two published, non-Cochrane
systematic reviews on exercise interventions for people with
colorectal cancer (Cramer 2014b; van Rooijen 2018). In the review
by Cramer 2014b no recommendations regarding exercise as
a routine intervention for people with colorectal cancer were
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made due to insuJicient evidence and lack of safety data. The
review undertaken by Cramer and colleagues was limited to
individuals who had completed treatment. The second review
by van Rooijen and colleagues was undertaken in participants
undergoing treatment, and highlighted the limited evidence of
exercise training during treatment for colorectal cancer. Six out of
seven studies included mixed-cancer populations, three of these
studies were not RCTs. This review is restricted to RCTs only
and includes individuals who are receiving adjuvant therapy in
addition to those who have finished treatment; no previous review
has included such a population. This review will update current
evidence and include emerging evidence in relation to physical
activity interventions for individuals with colorectal cancer and so
identify current evidence gaps.
O B J E C T I V E S
To assess the eJectiveness and safety of physical activity
interventions on the disease-related physical and mental health of
individuals diagnosed with non-advanced colorectal cancer, staged
as T1-4 N0-2 M0, treated surgically or with neoadjuvant or adjuvant
therapy (i.e. chemotherapy, radiotherapy or chemoradiotherapy),
or both.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered randomised control trials (RCTs) and cluster-RCTs
comparing physical activity interventions to usual care or no
physical activity intervention for inclusion in this review.
Types of participants
We included studies that evaluated the eJect of physical
activity interventions, on adults (aged 18 years or over),
regardless of gender, diagnosed with non-advanced colorectal
cancer, staged as T1-4, N0-2, M0, treated surgically or with
neoadjuvant or adjuvant therapy (i.e. chemotherapy, radiotherapy,
chemoradiotherapy), or both. We included studies that examined
physical activity interventions delivered during adjuvant therapy,
following adjuvant therapy or following surgery alone. We excluded
studies that included participants with other cancer types (unless
outcomes for colorectal cancer were reported separately), and
studies that included participants who were more than five years
postdiagnosis.
Types of interventions
We compared physical activity interventions separately to no
physical activity intervention or to usual care. Participants in
both the control and intervention arms received the same usual
care. Physical activity sessions could take place in any setting,
be supervised, self-directed or both, could be individual or group
based, or a combination of both. Physical activity modalities
could include aerobic or resistance training, flexibility and balance
training or a combination of these. No restrictions were made
regarding frequency, intensity, time or type of exercise or physical
activity intervention. We only included studies with interventions
that lasted a minimum of four weeks in duration, to exclude
studies on the acute eJects of physical activity. We excluded
studies with a prehabilitation component. We included studies
that provided health education materials or seminars only if the
physical activity intervention was the main intervention in the
study. We recorded specific details on the intervention according to
the FITT-VP (frequency intensity, time, type, volume, progression)
principle (ACSM 2014). We classified physical activity intensity as
mild, moderate or vigorous based on the rate of perceived exertion,
heart rate or metabolic equivalents report (ACSM 2014), and used
the author's classification of mild, moderate, or vigorous when a
quantitative measure was unavailable.
Types of outcome measures
We extracted information for the primary and secondary outcomes
at all available time points. We sought to analyse overall survival
and recurrence-free survival at 12 months, three years and five
years. We analysed the other primary and secondary outcomes
according to the length of follow-up: up to 12 weeks aMer baseline
(immediate); more than 12 weeks but less than or equal to six
months aMer baseline (short term); more than six months but less
or equal to 12 months aMer baseline (medium term) and more than
12 months aMer baseline (long term).
Primary outcomes
1. Physical function (e.g. Karnofsky Performance Status Scale;
Eastern Cooperative Oncology Group Scale; timed chair rise test;
timed 'Up & Go' test) or other valid instruments
2. Disease-related mental health (e.g. Hospital Anxiety and
Depression Scale (HADS); Beck Depression Index (BDI))
3. Adverse events (participants experiencing at least 1 adverse
event, e.g. injury, death, adverse events resulting in
discontinuation of the intervention)
Secondary outcomes
1. Overall survival (time interval between enrolment in the study
and death of the person from any cause)
2. Recurrence-free survival (time interval between date of
enrolment in the study and the date when colorectal cancer
recurs or another cancer occurs during the follow-up)
3. Physical fitness (e.g. cardiorespiratory endurance (6-minute
walk test; 10-metre shuttle walk test; V02 peak or muscle
strength (dynamometry; 1 repetition maximum; 5 repetition
maximum) or another valid instrument
4. Cancer-related fatigue (e.g. Functional Assessment of Chronic
Illness Therapy-Fatigue (FACIT-F); Schwartz Cancer Fatigue
Scale (SCFS); Brief Fatigue Inventory (BFI); Piper Fatigue Scale
(PFS))
5. Anthropometric measurements (e.g. weight, body mass
index (BMI), body composition, waist measurement, skin-fold
measurement)
6. HRQoL (e.g. European Organization for Research and Treatment
of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-
C30); Medical Outcomes Study Short Form-36 General Health
Survey (SF-36); Functional Assessment of Cancer Therapy–
Colorectal scale (FACT-C))
7. Levels of physical activity (e.g. physical activity questionnaires
(International Physical Activity Questionnaire (IPAQ), Global
Physical Activity Questionnaire (GPAQ) or objective measures of
physical activity using pedometers or accelerometers)
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Search methods for identification of studies
Electronic searches
We searched the following electronic databases between 6 June
2019 and 14 June 2019 up to the latest issue, with no language or
date restrictions to identify relevant RCTs and cluster-RCTs for this
review.
1. The Cochrane Central Register of Controlled Trials (CENTRAL, in
the Cochrane Library) (Appendix 1) (inception to present)
2. Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-
Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R)
(1946 to Present) (Appendix 2)
3. Ovid Embase (1974 to present) (Appendix 3)
4. CINAHL (in EBSCOhost 1982 to present)
5. Web of Science (1970 to present)
6. PsycINFO (1806 to present)
7. Open Grey (formerly SIGLE) (1980 to present)
8. PEDro (1999 to present)
The searches were conducted by Cochrane Colorectal Cancer's
Information Specialist and a review author (MAT).
Searching other resources
We searched clinical trials registries separately on 6 June 2019 for
ongoing studies and study protocols of:
1. Clinical.trials.gov (www.clinicaltrials.gov);
2. the World Health Organization International Clinical Trials
Registry Platform (WHO ICTRP) (apps.who.int/trialsearch/);
3. the EU Clinical Trials Register (www.clinicaltrialsregister.eu/);
and
4. CenterWatch (www.centerwatch.com).
We screened reference lists of all included studies and any relevant
systematic reviews identified. We handsearched conference and
meeting abstracts of relevant organisations including:
1. American Society of Clinical Oncology (ASCO);
2. European Society for Medical Oncology (ESMO);
3. American College of Sports Medicine (ACSM);
4. BIT's Annual World Cancer Congress;
5. European Multidisciplinary Colorectal Cancer Congress
(EMCCC);
6. European Federation for Colorectal Cancer (EFR); and
7. European Cancer Congress (ECC).
We contacted individuals or organisations for information on
unpublished or ongoing studies.
Data collection and analysis
Selection of studies
We imported all records retrieved from the searches into EndNote
and removed duplicates (Endnote 2016). We exported these records
to covidence for screening (Covidence 2018). Two review authors
(MMG and MAT) independently examined the studies identified
in the literature search and screened all studies based on their
titles and abstracts, excluding studies that obviously did not meet
the eligibility criteria. We did not exclude studies solely on the
basis of reporting outcome data. We obtained the full texts of
potentially eligible studies and the two review authors (MMG and
MAT) independently examined the studies. In covidence, authors
coded the studies as 'include', 'exclude' or 'uncertain' based on
the outlined criteria. We resolved any disagreements through
discussion, where necessary involving a third review author (CC or
MMC), and kept a record of decisions made. We recorded reasons
for exclusion of full text articles.
Data extraction and management
Two review authors (MMG and MAT) independently extracted data
from the studies that met the inclusion criteria. We recorded
extracted data on an excel spreadsheet, predeveloped for this
purpose. MMG and MAT piloted the data extraction form in a
random sample of three studies to ensure it captured the required
information. We revised the form as required. We resolved any
disagreements through discussion, and where necessary referred
to a third review author (CC or MMC). Extracted data were entered
into the Cochrane soMware Review Manager 5 (RevMan 5) (Review
Manager 2014) for analyses. We extracted the following data.
1. Study details; author and year of publication, country of origin,
aim, design, funding source, method of randomisation, method
of recruitment, trial inclusion and exclusion criteria, duration of
participation, conflicts of interest/ethical concerns, risk of bias
assessment.
2. Participant details; total number randomised, age, gender,
comorbidities, other relevant sociodemographics, cancer stage,
type of cancer treatment, ethnicity, time since diagnosis, time
beyond active treatment, baseline imbalances.
3. Intervention details; exercise type, intensity, frequency, volume,
setting, duration of intervention, supervised or self-directed,
details of control/comparison intervention, withdrawals and
exclusion and co-interventions.
4. Outcomes; primary and secondary relevant to this review,
including adverse events, follow-up time points, measurement
tools used for outcomes.
Assessment of risk of bias in included studies
Two review authors (MMG and MAT) independently assessed each
included study for risk of bias using the Cochrane 'Risk of bias'
tool (Cochrane Handbook for Systematic Reviews of Interventions,
Chapter 8.5.d, Higgins 2011a; Higgins 2017; Appendix 4). We
assessed random sequence generation, allocation concealment,
blinding of personnel and outcome assessment, completeness of
outcome data, selective outcome reporting, and any other sources
of bias, and judged the risk of bias as 'high', 'low' or 'unclear'.
We resolved any disagreements through discussion and where
necessary, through involving a third review author (CC or MMC).
For each study, we detailed the risk of bias in table form alongside
a statement of justification for our judgement. We summarised
results in both a 'Risk of bias' summary figure and 'Risk of bias'
graph. When interpreting treatment eJects, we took into account
the risk of bias for studies that contribute to that outcome.
Measures of treatment e?ect
For continuous outcomes (physical function, disease-related
mental health, physical fitness, cancer-related fatigue,
anthropometric measurements, levels of physical activity and
HRQoL) we determined the mean diJerences (MDs) or standardised
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mean diJerences (SMDs) (in cases where diJerent instruments
were used to measure the selected outcome), in the intervention
group compared with the control with 95% confidence intervals
(CIs). We extracted data for final scores and change from baseline
scores, if available.
In this version of the review, no outcomes were reported as
time-to-event and we were unable to report adverse events as a
dichotomous outcome. In future versions of this review for time-
to-event outcomes (overall survival and recurrence-free survival)
we will extract hazard ratios (HRs) with standard errors, assuming
that the HR is constant over time to compare the risk of death
or recurrence of cancer in the treatment group with that in the
control group. Where HRs are not presented, we will estimate them
from reported data (e.g. Kaplan-Meier curves, logrank observed
minus expected events and the logrank variance) using methods
described by Tierney and colleagues (Tierney 2007). For adverse
events, we will calculate the risk ratio (RR) at individual study level
by dividing the risk of an event in the intervention group by the risk
of the event in the control group. We will define RRs greater than
1.0 as favouring the control group (i.e. fewer adverse events in the
control group) and RRs less than 1.0 as favouring the intervention
group (Deeks 2017).
Unit of analysis issues
For parallel-group, individually randomised trials, the colorectal
cancer participant was the unit of analysis in each study. No cluster-
RCTs met our inclusion criteria.
For studies reporting multiple follow-up time points, we conducted
separate meta-analyses to reflect immediate-, short-, medium- and
long-term periods of follow-up. For immediate-term follow-up we
extracted data closest to the 12-week follow-up time point. For
short- and medium-term follow-up, we extracted data closest to the
six- and 12-month follow-up time point. For long-term follow-up,
we extracted the longest time interval.
For studies with multiple arms, we included only relevant
intervention arms. We combined all relevant intervention arms into
a single group and combined all relevant control arms into a single
group, creating a single, pair-wise comparison.
For future versions of this review, we will extract data from cluster-
RCTs when they report appropriate analyses, adjusting for the
sample size in each cluster. Where control of clustering has not
been performed we will attempt to correct for the intervention
eJects of cluster-RCTs by reducing the size of each study to its
'eJective sample size', which is the number of the original sample
size divided by the 'design eJect'. We will calculate the design
eJect as 1 + (M-1)* ICC, where M is the average cluster size and
ICC is the intracluster correlation coeJicient as described in the
Cochrane Handbook for Systematic reviews of interventions, section
16.3.4 (Higgins 2011b). We will use an estimate of the ICC derived
from the study (if possible), from a similar study or from a study
of a similar population. If we use ICCs from other sources, we
will report this and conduct sensitivity analyses to investigate the
eJect of variation in the ICC. If we identify both cluster-randomised
trials and individually-randomised trials, we plan to synthesise the
relevant information. We will consider it reasonable to combine the
results from both if there is little heterogeneity between the study
designs and the interaction between the eJect of intervention and
the choice of randomisation unit is considered unlikely.
Dealing with missing data
We attempted to contact authors of the included studies to
request missing data on outcomes, participants and summary data
via email. We documented reasons for missing data (missing at
random or missing not at random) and how they were addressed.
We assessed the extent to which studies analysed data according
to the intention-to-treat principle. We assessed the level of missing
data for included studies by comparing the number of participants
included in the final analysis with the proportion of all participants
in each study available in Characteristics of included studies. In
future versions of this review, for studies at high risk of attrition
bias, we will attempt to perform both the best-case and worst-case
sensitivity analyses to assess the impact of missing data on the
estimates of eJect.
Assessment of heterogeneity
We evaluated clinical heterogeneity by examining diversity
in participant characteristics, physical activity intervention
characteristics, colorectal cancer treatment and outcomes among
studies. We evaluated methodological heterogeneity by examining
diversity in study designs and risk of bias. We did not pool
methodologically heterogeneous studies. We visually inspected
forest plots and used the Chi2 test to assess statistical heterogeneity
(with P < 0.1). We used the I2 statistic to assess the percentage of
variation across studies that is due to heterogeneity and not due
to chance (Higgins 2003). We tentatively regarded heterogeneity
as 'low' if I2 is less than 49%, 'moderate', if I2 is between
50% and 75% and 'high' if I2 is more than 75% (Deeks 2017).
We investigated potential sources of statistical heterogeneity by
reassessing diversity in characteristics of studies (participant,
intervention, treatment and outcomes) and by means of sensitivity
analysis.
Assessment of reporting biases
We attempted to control for time-lag bias, location bias, citation
bias and language bias by using a comprehensive search strategy
without language or date restriction, that included searching for
unpublished studies and searching trials registers. We controlled
for multiple publication bias by identifying duplicate publications
of the same study and grouping these together, listing them as
one study. For studies published aMer 1 July 2005, we screened the
Clinical Trials Register at the WHO ICTRP for the study protocols
(apps.who.int/trialsearch) to evaluate whether selective reporting
of outcomes was present (outcome reporting bias).
No analysis in this version of the review included more than 10
studies. For future versions of this review, if there are at least 10
studies included in a meta-analysis, we will visually inspect funnel
plots for asymmetry to investigate potential publication bias or
small-study eJects following the recommendations in Chapter 10
of the Cochrane Handbook for Systematic Reviews of Interventions
for any statistical testing of funnel plot asymmetry (Sterne 2017).
Data synthesis
We pooled results from comparable groups of studies using
both fixed-eJect and random-eJects models, when appropriate.
Whenever possible, we used a random-eJects model with inverse
variance weighting for meta-analyses (DerSimonian 1986), due to
the nature of physical activity as a highly varied intervention.
We used a fixed-eJect model when there were few studies or if
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the studies were small with few events. Where appropriate, we
conducted a sensitivity analysis to investigate the eJect of the
choice of model (fixed-eJect or random-eJects) on the pooled
estimate. MMG and CC conducted statistical analysis using RevMan
5 (Review Manager 2014). We considered a two-sided P value of less
than 0.05 as statistically significant. In cases where measurement
tools for outcomes had the opposite direction of eJect, we
multiplied mean scores of a selected measurement by minus one to
ensure all scales had the same direction of eJect as discussed in the
Cochrane Handbook for Systematic Reviews of Interventions section,
9.2.3.2 (Deeks 2017). Where data aggregation was not possible due
to heterogeneity, we provided a narrative synthesis of study results.
We summarised the findings of the systematic review alongside an
assessment of the quality of evidence for each individual outcome
using the GRADE approach (GRADE Working Group 2004).
Subgroup analysis and investigation of heterogeneity
No subgroup analyses were conducted in this version of the review
due to insuJicient data or inclusion of a range of treatment stages,
treatment types, participant ages, gender in each individual study,
or both. In future versions of this review where there are suJicient
data, we will perform subgroup analyses of the eJect of the
intervention according to:
1. exercise and physical activity intervention characteristics (using
frequency, intensity, time, type, volume progression (FITT-VP )
to calculate metabolic equivalents/hours per week);
2. participant characteristics (gender, age - over 65 years or under
65 years);
3. cancer stage (T1-2, N0, M0), (T3-4, N0, M0), (T1-4, N1-2, M0);
4. cancer type (colon or rectal);
5. treatment stage (during or post-treatment);
6. treatment type (laparoscopic or open surgery, neoadjuvant
therapy or no neoadjuvant therapy);
7. time since diagnosis (zero to one year, two to three years, four
to five years).
Sensitivity analysis
We undertook sensitivity analyses to assess the robustness of
results. We reanalysed data aMer excluding studies with high risk
of bias, those that had co-interventions (when appropriate) and
studies that had not performed an intention-to-treat analysis.
We conducted a sensitivity analysis to investigate heterogeneous
results with the identification and removal of heterogeneous
studies. We conducted a sensitivity analysis to investigate the eJect
of the choice of model (fixed-eJect or random-eJects) on the
pooled estimate. In future versions of this review, for studies at
high risk of attrition bias, we will conduct a best-case/worst-case
sensitivity analysis to assess the impact of missing data on the
estimates of eJect. If there are any assumptions for ICC value used
in cluster-RCTs, we will perform a sensitivity analysis.
Summary of findings
We assessed the overall quality of evidence of the main review
outcomes using the GRADE approach in 'Summary of findings 1
(GRADE Working Group 2004). The 'Summary of findings' table
highlights the overall quality of the body of evidence for the main
review outcomes, using the GRADE criteria (study limitations (i.e.
risk of bias), consistency of eJect, indirectness, imprecision and
publication bias). We used GRADEpro GDT 2015 soMware to prepare
the 'Summary of findings' table. We will also present the results
from the prespecified Sensitivity analysis and Subgroup analysis
and investigation of heterogeneity when appropriate in 'Summary
of findings' tables.
R E S U L T S
Description of studies
Results of the search
See: Characteristics of included studies; Characteristics of
excluded studies; Characteristics of studies awaiting classification;
Characteristics of ongoing studies
We conducted the comprehensive database search between 6 June
2019 and 14 June 2019 and found 5061 records. We identified
1092 additional records upon searching clinical trial registries and
handsearching references lists, conference and meeting abstracts.
AMer removing duplicates, 3837 potential records remained. We
excluded a total of 3640 records based on the title and abstract and
retrieved 197 records for more detailed evaluation (Figure 1).
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Figure 1.   PRISMA flow diagram.
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Figure 1.   (Continued)
 
From these, we excluded 99 studies (127 records) as they did
not meet the inclusion criteria (see 'Characteristics of excluded
studies') and 16 studies (40 records) were appropriate for inclusion
in the current review. In addition, nine studies are ongoing and 15
studies (21 records) are awaiting classification; we did not include
these studies in the analysis presented below, but will consider
them in future updates of this review. We completed all searches by
14 June 2019. Figure 1 illustrates the process of the literature search
and study selection for the review based on the PRISMA template
(Moher 2009).
Included studies
We included 16 studies in this review (14 journal articles and
2 dissertations) (Bourke 2011; Brown 2017; Cantarero-Villanueva
2016; Courneya 2003; Courneya 2016; Cramer 2016; Hubbard
2016; Kim 2018; Lee 2017; Lewis 2016; McDermott 2017; Nuri
2016; Pinto 2013; Van Blarigan 2019; Van Vulpen 2016; Waart
2017). We used the main publication as the study reference. We
reviewed and included information on study characteristics and
outcome related data from an additional 28 publications that were
secondary publications of seven of these 16 studies. We contacted
11 study authors for additional information (Bourke 2011; Brown
2017; Cantarero-Villanueva 2016; Courneya 2003; Cramer 2016;
Lee 2017; Lewis 2016; McDermott 2017; Nuri 2016; Van Vulpen
2016; Waart 2017), eight of these authors replied to information
requests (Bourke 2011; Courneya 2003; Cramer 2016; Lewis 2016;
McDermott 2017; Nuri 2016; Van Vulpen 2016; Waart 2017). For
study characteristics and outcomes, see the Characteristics of
included studies table.
Study characteristics
All 16 included studies were randomised controlled trials (RCTs).
No cluster-RCTs met our inclusion criteria. All studies except for
two randomised participants to either a physical activity or usual
care arm (Brown 2017; Waart 2017). These two studies included an
additional study arm, that included variations in exercise volume
in Brown 2017 and exercise intensity in Waart 2017. Three studies
included co-interventions (Bourke 2011; Courneya 2016; Hubbard
2016), involving healthy eating seminars and a dietary information
pack (Bourke 2011), health education materials for the usual care
group (Courneya 2016), and weekly education sessions on topics,
including physical activity, diet stress management and cardiac
specific issues (Hubbard 2016). In all, investigators allocated 992
participants (mean 62, range 18 to 273) to a physical activity
intervention group (n = 524, mean 33, range 9 to 136) or a control
group (n = 468, mean 29, range 9 to 137).
Participants
Participants enrolled in the studies had a diagnosis of colon
or colorectal cancer, six studies included only participants with
colon cancer (Bourke 2011; Brown 2017; Cantarero-Villanueva 2016;
Courneya 2016; Van Vulpen 2016; Waart 2017), whilst the remaining
10 studies included participants with colorectal cancer (Courneya
2003; Cramer 2016; Hubbard 2016; Kim 2018; Lee 2017; Lewis
2016; McDermott 2017; Nuri 2016; Pinto 2013; Van Blarigan 2019).
Four studies reported the percentage of rectal cancer participants
included (Kim 2018; McDermott 2017; Pinto 2013; Van Blarigan
2019). No studies with exclusively rectal cancer participants met
our inclusion criteria. The majority of studies included participants
with stage I-III colorectal cancer, however Courneya 2016, Lee
2017 and Waart 2017 excluded participants with stage I cancer.
In addition, Waart 2017, Courneya 2003 and Van Blarigan 2019
included a minority of participants with stage IV cancer; when
contacted Waart 2017 confirmed that no stage IV participants were
included, Courneya 2003 was unable to provide separate data,
excluding the four stage IV participants that were included in the
study. Van Blarigan 2019 included one stage IV participant (2%
of total participants included). Ten studies included participants
who had finished active treatment (Bourke 2011; Brown 2017;
Cantarero-Villanueva 2016; Courneya 2016; Kim 2018; Lee 2017;
Lewis 2016; McDermott 2017; Pinto 2013; Van Blarigan 2019), the
time beyond treatment ranged between two months and five years.
Two studies included participants receiving active treatment (Van
Vulpen 2016; Waart 2017). Two studies were conducted among
participants who were receiving and finished active treatment
(Cramer 2016; Hubbard 2016). It was unclear whether participants
were receiving or finished treatment in two studies (Courneya 2003;
Nuri 2016). The majority of participants had undergone surgery as
treatment; chemotherapy was also common across studies with
less participants receiving radiotherapy. Mean time since diagnosis
was only reported in six studies and ranged between 10 weeks and
2.99 years (Cantarero-Villanueva 2016; Courneya 2016; Lewis 2016;
Pinto 2013; Van Blarigan 2019; Van Vulpen 2016).
The mean age of participants ranged between 51 and 69 years.
FiMeen studies included both males and females, with one study
including only males (Nuri 2016). Comorbidities and ethnicity
were largely unreported in studies. Only two studies reported
comorbidities at baseline (Brown 2017; Waart 2017). Two studies
reported on ethnicity of participants (Brown 2017; Pinto 2013),
in both studies the majority of participants were white. Eight
studies reported on education levels of participants (Cantarero-
Villanueva 2016; Courneya 2003; Cramer 2016; Kim 2018; Lee 2017;
Van Blarigan 2019; Van Vulpen 2016; Waart 2017) with Kim 2018, Lee
2017, Van Vulpen 2016 and Waart 2017 further reporting on martial
status and McDermott 2017, Van Blarigan 2019 and Waart 2017
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reporting on employment status. Five studies reported recruiting
those who were currently inactive (Bourke 2011; Courneya 2016;
Lee 2017; Lewis 2016; McDermott 2017).
Interventions
Type and setting of interventions varied across studies.
Three studies opted for exclusively supervised physical activity
interventions (Cantarero-Villanueva 2016; Cramer 2016; Hubbard
2016), likely due to the modes of exercise which included hatha
yoga, core stabilisation exercise and cardiac rehabilitation exercise
classes. The settings for these interventions were not clearly
reported. Five studies opted for exclusively home-based self-
directed programmes (Brown 2017; Courneya 2003; McDermott
2017; Pinto 2013; Van Blarigan 2019), which consisted of mainly
aerobic physical activity (e.g. treadmill walking, cycling). A
combination of aerobic and resistance exercise was prescribed
in two studies (McDermott 2017 ; Van Blarigan 2019). The Nuri
2016 study involved aerobic physical activity, whether the physical
activity was supervised or self-directed is unclear. Seven studies
opted for a combination of supervised and self-directed physical
activity (Bourke 2011; Courneya 2016; Kim 2018; Lee 2017; Lewis
2016; Van Vulpen 2016; Waart 2017), with physical activity logs
in Lee 2017 and telephone support in Courneya 2016 and Kim
2018. A combination of aerobic and resistance physical activity
was conducted in four of these studies (Bourke 2011; Lee 2017;
Van Vulpen 2016; Waart 2017), with Courneya 2016 encouraging
activity based on individual preference, with a walking prescription
if individuals had no preference.
The intensity of the physical activity varied slightly between
studies. Methods used to measure intensity of the physical
activity included relatively objective measures, such as percentage
of maximum heart rate, heart rate at ventilatory threshold,
percentage of predicted maximum workload and ratings of
perceived exertion. The majority of studies opted for moderate-
intensity physical activity (Bourke 2011; Brown 2017; Courneya
2003; Lee 2017; Lewis 2016; McDermott 2017; Nuri 2016; Pinto 2013;
Waart 2017), with three studies incorporating vigorous physical
activity (Lewis 2016; Van Blarigan 2019; Waart 2017). An arm of
the Waart 2017 study participated in low-intensity exercise. Five
studies did not report intensity of the physical activity programme
(Cantarero-Villanueva 2016; Courneya 2016; Cramer 2016; Hubbard
2016; Kim 2018).
The most common duration of physical activity intervention was 12
weeks (Bourke 2011; Kim 2018; Lee 2017; Lewis 2016; McDermott
2017; Pinto 2013; Van Blarigan 2019). In one study, the length of
the intervention was determined by duration of chemotherapy,
with participants beginning the intervention with the first cycle of
chemotherapy and finishing three weeks aMer the last cycle (Waart
2017). For another study (Hubbard 2016), the length of intervention
varied depending on hospital site (6, 10 or 12 weeks). Two
studies delivered eight-week interventions (Cantarero-Villanueva
2016; Nuri 2016). The duration of the other five studies were 10
weeks (Cramer 2016), 16 weeks (Courneya 2003), 18 weeks (Van
Vulpen 2016), six months (Brown 2017), and three years (Courneya
2016). However, the Courneya 2016 study is ongoing and we
have extracted one-year interim data for this review. All studies
conducted follow-up assessments on completion of the exercise
intervention. Nine studies conducted a further set of equivalent
assessments at a later time point (Cantarero-Villanueva 2016;
Cramer 2016; Hubbard 2016; Lewis 2016; McDermott 2017; Nuri
2016; Pinto 2013; Van Vulpen 2016; Waart 2017). Pinto 2013 was the
only study to conduct three postintervention assessments, these
took place at three, six and 12 months.
Control groups
The control groups received usual care, were not prescribed
physical activity and did not take part in any formal exercise
training during the course of the intervention. Five studies
provided participants with written information on maintaining
a healthy lifestyle (Courneya 2016; Hubbard 2016; Pinto 2013;
Van Blarigan 2019), or provided recommendations for a healthy
lifestyle (Cantarero-Villanueva 2016). Three studies reported asking
participants in the control arm to maintain their usual daily physical
activity levels/lifestyle habits during the intervention (Brown 2017;
Lee 2017; Van Vulpen 2016). One study instructed participants not to
initiate any structured exercise over the course of the intervention
(Courneya 2003). Three studies had a waiting list control group,
providing participants the opportunity to take part in the physical
activity intervention following completion of the study (Brown
2017; Cramer 2016; Lewis 2016). Van Blarigan 2019 oJered a fit bit
flex to control group participants following study completion. Pinto
2013 controlled for frequency of contact with participants by having
a contact control group.
Outcome measures
The most frequently assessed outcome among the 16 included
studies was physical fitness, measured in 12 studies (Bourke
2011; Brown 2017; Cantarero-Villanueva 2016; Courneya 2003;
Courneya 2016; Lee 2017; Lewis 2016; McDermott 2017; Nuri 2016;
Pinto 2013; Van Vulpen 2016; Waart 2017), the most commonly
used tools to measure physical fitness were the six-minute walk
test (Brown 2017; Cantarero-Villanueva 2016; Courneya 2016;
Lee 2017; Lewis 2016), and treadmill tests using a variety of
protocols (Courneya 2003; Lewis 2016; Pinto 2013; Van Vulpen 2016;
Waart 2017). Twelve studies measured levels of physical activity,
objectively, using accelerometer data (Brown 2017; Hubbard 2016;
Lewis 2016; McDermott 2017; Pinto 2013; Van Blarigan 2019), and
subjectively, using a variety of self-report questionnaires (Bourke
2011; Courneya 2003; Courneya 2016; Kim 2018; Lee 2017; Lewis
2016; Pinto 2013; Waart 2017). Lewis 2016 and Pinto 2013 measured
levels of physical activity, both objectively and subjectively. Ten
studies assessed anthropometric measurements (Bourke 2011;
Brown 2017; Cantarero-Villanueva 2016; Courneya 2003; Courneya
2016; Lee 2017; Lewis 2016; McDermott 2017; Nuri 2016; Van Vulpen
2016). All studies except for Courneya 2003 measured weight
and only two did not measure body mass index (BMI) (Courneya
2016; Van Vulpen 2016). Fatigue and health-related quality of life
(HRQoL) were assessed in nine studies, out of the 16 included
(Bourke 2011; Courneya 2003; Cramer 2016; Kim 2018; Lewis 2016;
McDermott 2017; Pinto 2013; Van Vulpen 2016; Waart 2017), most
frequently using the Functional Assessment of Cancer Therapy
– Fatigue (FACT-F) scale and Functional Assessment of Cancer
Therapy – Colorectal (FACT-C) scale, respectively. Adverse events
were reported in eight studies, of these the absence of any adverse
events were reported in four studies (Hubbard 2016; Lewis 2016;
Van Vulpen 2016; Waart 2017), whilst four studies recorded the
number of adverse events that occurred (Brown 2017; Cantarero-
Villanueva 2016; Cramer 2016; Van Blarigan 2019). Six studies
assessed facets of mental health and well-being (Courneya 2003;
Cramer 2016; Kim 2018; McDermott 2017; Van Vulpen 2016; Waart
2017), mainly anxiety and depression, using the Hospital Anxiety
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and Depression Scale (HADS) score. Other outcomes including
overall and recurrence-free survival were not reported in any of the
included studies. Adherence to Enhanced Recovery AMer Surgery
(ERAS) guidelines and length of hospital stay was not reported in
any of the included studies. For detailed information on outcome
measures, see the Characteristics of included studies table.
Excluded studies
We excluded 99 trials from the review due to the following reasons.
1. Wrong patient population (n = 19)
2. Wrong study design (n = 25)
3. Wrong comparator (n = 18)
4. Wrong intervention (n = 16)
5. Intervention too short (n = 10)
6. Did not analyse colorectal cancer patients separately (n = 8)
7. Study was not carried out (n = 2)
8. Outcomes were not relevant (n = 1)
See Characteristics of excluded studies for an overview.
Risk of bias in included studies
We assessed the risk of bias for each included study using the
‘Risk of bias’ assessment tool and recommendations for judging
risk of bias provided in Chapter 8 of the Cochrane Handbook for
Systematic Reviews of Interventions (Higgins 2017). See Figure 2
for an overall assessment of risk of bias presented as percentages
across all included studies. In addition, Figure 3 provides a 'Risk
of bias' summary for each included study. Due to the nature of
the intervention, it was expected that blinding of participants and
personnel delivering the interventions would not be possible. We
therefore judged risk of performance bias as high in all included
studies. See Characteristics of included studies.
 
Figure 2.   Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages
across all included studies.
Random sequence generation (selection bias)
Allocation concealment (selection bias)
Blinding of participants and personnel (performance bias): All outcomes
Blinding of outcome assessment (detection bias): All outcomes
Incomplete outcome data (attrition bias): All outcomes
Selective reporting (reporting bias)
Other bias
0% 25% 50% 75% 100%
Low risk of bias Unclear risk of bias High risk of bias
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Bourke 2011 + ? - + + + ?
Brown 2017 ? ? - + + - +
Cantarero-Villanueva 2016 + + - + + - +
Courneya 2003 + ? - + + + +
Courneya 2016 ? ? - ? + + +
Cramer 2016 + + - ? + + +
Hubbard 2016 + ? - ? - - -
Kim 2018 + ? - ? + + +
Lee 2017 + ? - ? + + +
Lewis 2016 + + - - + + +
McDermott 2017 + + - - + + +
Nuri 2016 ? ? - ? + - +
Pinto 2013 ? ? - + + + -
Van Blarigan 2019 + ? - - + - -
Van Vulpen 2016 + + - + + + +




Twelve studies (75%) were at low risk of selection bias owing
to adequate generation of a randomised sequence (Bourke 2011;
Cantarero-Villanueva 2016; Courneya 2003; Cramer 2016; Hubbard
2016; Kim 2018; Lee 2017; Lewis 2016; McDermott 2017; Van
Blarigan 2019; Van Vulpen 2016; Waart 2017). We considered four
studies to have an unclear risk of selection bias as they did not
describe the generation of a randomised sequence (Brown 2017;
Courneya 2016; Nuri 2016; Pinto 2013).
Allocation concealment
Five studies (36%) were at low risk of selection bias owing to
adequate concealment of allocation, so that participants and
investigators could not foresee assignment to the study groups
Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-
advanced colorectal cancer (Review)









Cochrane Database of Systematic Reviews
(Cantarero-Villanueva 2016; Cramer 2016; Lewis 2016; McDermott
2017; Van Vulpen 2016). The other 11 studies were considered
to have an unclear risk of selection bias owing to allocation
concealment as they did not describe the method of concealment.
Blinding
Blinding of participants and personnel
Due to the nature of physical activity interventions, blinding of
participants and personnel is not possible. Therefore, we judged all
included studies at high risk of performance bias.
Blinding of outcome assessors
Six studies were at low risk of detection bias as outcome assessors
were blinded to participants group assignment (Bourke 2011;
Brown 2017; Courneya 2003; Cantarero-Villanueva 2016; Pinto
2013; Van Vulpen 2016). We considered seven studies to have
unclear risk for detection bias, as blinding of outcome assessors
was not described (Courneya 2016; Cramer 2016; Hubbard 2016;
Kim 2018; Lee 2017; Nuri 2016; Waart 2017). Three studies were at
high risk for detection bias as the outcome assessor was aware of
participants' group allocation (Lewis 2016; McDermott 2017; Van
Blarigan 2019).
Incomplete outcome data
All included studies reported on adherence. All studies except for
Hubbard 2016 were at low risk of attrition bias due to the amount,
nature or handling of incomplete outcome data. Hubbard 2016 was
at high risk of attrition bias due to the amount of missing data.
Adherence to physical activity interventions in other studies varied
between 71% and 97%.
Selective reporting
Ten studies were at low risk of reporting bias (Bourke 2011;
Courneya 2003; Courneya 2016; Cramer 2016; Kim 2018; Lee 2017;
Lewis 2016; McDermott 2017; Pinto 2013; Van Vulpen 2016). Six
studies were at high risk of reporting bias, as study protocols or
methods sections included outcomes which were not reported
in available publications (Brown 2017; Cantarero-Villanueva 2016;
Hubbard 2016; Nuri 2016; Van Blarigan 2019; Waart 2017).
Other potential sources of bias
Baseline imbalances
Eleven studies were at low risk of selection bias owing to the
absence of significant imbalances between group at baseline
(Brown 2017; Cantarero-Villanueva 2016; Courneya 2003; Courneya
2016; Kim 2018; Lee 2017; Lewis 2016; Nuri 2016; Van Vulpen 2016),
or in studies were baseline imbalances were present, appropriate
allocation concealment was described (Cramer 2016; McDermott
2017). Four studies were at high risk of selection bias because
group similarity at baseline was inadequate (Hubbard 2016; Pinto
2013;Van Blarigan 2019; Waart 2017). The risk of selection bias
owing to baseline imbalances was unclear in one study as baseline
imbalances were not reported (Bourke 2011). All included studies
are at risk of participation bias, with the potential for the more
motivated participants agreeing to participate.
E?ects of interventions
See: Summary of findings 1 Physical activity compared with usual
care in adults with non-advanced colorectal cancer
See: Summary of findings 1. For a summary of sensitivity analyses
see: Table 1.
All trial authors reported study results as follow-up values and six
studies also included change in score from baseline to follow-up
(Bourke 2011; Brown 2017; Cantarero-Villanueva 2016; Courneya
2016; Hubbard 2016; Lewis 2016). We completed meta-analyses
for both types of outcomes separately and for each follow-up
time period where data were available. We categorised follow-
up as: up to 12 weeks aMer baseline (immediate); more than 12
weeks but less than or equal to six months aMer baseline (short
term); more than six months but less than or equal to 12 months
aMer baseline (medium term); and more than 12 months aMer
baseline (long term). No included studies reported follow-up of
greater than 12 months aMer baseline. One study reported follow-
up time points to end of chemotherapy treatment and at six
months following completion of chemotherapy treatment (Waart
2017). We calculated follow-up time points in months, using the
reported percentage of chemotherapy treatment received. This
was as a proportion of the average total planned duration of
chemotherapy. Where studies had two intervention arms (Brown
2017; Waart 2017), or reported gender separately (Van Vulpen 2016),
we combined these arms in RevMan to form a single pair-wise
comparison (Review Manager 2014).
Primary outcomes
Physical function
A total of 10 studies reported on physical function, assessed
using a variety of measures, including the 30-Second Chair
Stand Test (Bourke 2011; Courneya 2016; Lee 2017; Lewis 2016;
McDermott 2017), the Physical Functioning subscale of the Short
Form-36 (SF-36) (Brown 2017; Pinto 2013), the functional well-
being subscale of the Functional Assessment of Cancer Therapy-
Colorectal (FACT-C; Courneya 2003), the physical function subscale
of the European Organisation for Research and Treatment of Cancer
Quality of life Questionnaire-Core 30 (EORTC QLQ-C30; Waart 2017),
and the Trial Outcome Index-physical/functional/colorectal (Kim
2018). We conducted separate meta-analyses for objectively and
subjectively measured physical function.
Four studies including 185 participants measured physical function
using the 30-Second Chair Stand Test at immediate-term follow-up
(Bourke 2011; Lee 2017; Lewis 2016; McDermott 2017), we did not
pool these results in a meta-analysis due to considerable variation
in results and inconsistency in direction of eJect. Lewis 2016 and
McDermott 2017 observed no diJerence between the physical
activity and usual care groups for physical function at immediate-
term follow-up, whilst, Bourke 2011 and Lee 2017 reported
significant improvements in physical function in the physical
activity group compared with usual care (P = 0.003 and P = 0.005,
respectively). We observed no evidence of diJerence between
groups at short-term follow-up when measured objectively (mean
diJerence (MD) 0.76, 95% confidence interval (CI) -1.84 to 3.36;
2 studies, 39 participants; I2 = 0%; moderate-quality evidence;
Analysis 1.1; Figure 4), and subjectively at short-term follow-up
(standardised mean diJerence (SMD) 0.09, 95% CI -0.24 to 0.42; 3
studies, 156 participants; I2 = 0%; low-quality evidence; Analysis
1.2; Figure 5). There were insuJicient data to analyse subjective and
objective physical function at medium-term follow-up, subjective
physical function at immediate-term follow-up, and change from
baseline results at all four follow-up time points.
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Figure 4.   Forest plot of comparison: 1 Physical activity versus usual care for physical function (30-sec chair sit-to-
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Figure 5.   Forest plot of comparison: 1 Physical activity versus usual care for physical function, outcome: 1.3






Heterogeneity: Tau² = 0.00; Chi² = 0.48, df = 2 (P = 0.79); I² = 0%
Test for overall effect: Z = 0.54 (P = 0.59)
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Courneya 2016 reported that the structured exercise group (n = 99)
improved relative to the health education material group (n = 98)
for the 30-Second Chair Stand Test (mean between group diJerence
(+1.6 repetitions, 95% CI +0.6 to +2.7); P < 0.001) at one year. Pinto
2013 reported no significant group diJerences at immediate- or
medium-term follow-up for self-reported physical functioning (n =
23 and n = 19 for physical activity and usual care, respectively).
Brown 2017 reported improvements in change from baseline scores
for physical function at short-term follow-up with higher doses
of physical activity resulting in greater improvements. Kim 2018
reported no diJerence between groups at immediate-term follow-
up for physical function (P = 0.254). However, change from baseline
to immediate-term follow-up improved in the intervention group
(mean 64.1 (11.2) versus 66.3 (11.8), P = 0.035).
We performed sensitivity analyses to investigate the choice of
model on the pooled estimate at all included time points.
Sensitivity analyses using a fixed-eJect model were consistent
with findings from a random-eJects model. The sensitivity analysis
revealed no diJerence in eJect when we removed studies that did
not use an intention-to-treat (ITT) analysis; this was only possible
for subjective measures at short-term follow-up (Table 1).
Disease-related mental health
A total of seven studies reported on disease-related mental health,
assessed by the Hospital Anxiety and Depression Scale (HADS)
(Cramer 2016; Van Vulpen 2016; Waart 2017), the Positive and
Negative AJect Scale (PANAS) (McDermott 2017), the State-Trait
Anxiety Inventory (Courneya 2003), the Centre for Epidemiological
Studies Depression Scale (CES-D) (Courneya 2003), and the Patient
Health Questionnaire (Kim 2018). We obtained postintervention
data and separate scores for anxiety and depression through
email correspondence with authors Van Vulpen 2016 and Waart
2017, respectively. We conducted meta-analyses for anxiety and
depression separately at 12 weeks to six months aMer baseline and
more than six months to 12 months aMer baseline.
There was no evidence of diJerence in depression between the
physical activity group and usual care group at short-term follow-
up (SMD -0.21, 95% CI -0.50 to 0.08; 4 studies, 198 participants; I2 =
0%; moderate-quality evidence; Analysis 2.1; Figure 6), or medium-
term follow-up (assessed using HADS) (MD -1.20, 95% CI -2.72 to
0.31; 2 studies, 48 participants; I2 = 32%; low-quality evidence;
Analysis 2.2; Figure 7).
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Figure 6.   Forest plot of comparison: 2 Physical activity versus usual care for disease-related mental health,
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Figure 7.   Forest plot of comparison: 2 Physical activity versus usual care for disease-related mental health (Hospital
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There was no evidence of diJerence in anxiety between the physical
activity group and usual care group at short-term follow-up (SMD
-0.11, 95% CI -0.40 to 0.18; 4 studies, 198 participants; I2 = 0%;
moderate-quality evidence; Analysis 2.3; Figure 8), or medium-
term follow-up (assessed using HADS) (anxiety: MD 1.79, 95% CI
-0.37 to 3.94; 2 studies, 47 participants; I2 = 30%; low-quality
evidence; Analysis 2.4; Figure 9). Data were insuJicient for analysis
of immediate-term follow-up and change scores at all four time
points.
 
Figure 8.   Forest plot of comparison: 2 Physical activity versus usual care for disease-related mental health,
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Figure 9.   Forest plot of comparison: 2 Physical activity versus usual care for disease-related mental health (Hospital
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McDermott 2017 (unpublished data) reported no statistically
significant diJerences between intervention (n = 11) and control
(n = 9) for PANAS-positive aJect and PANAS-negative aJect at
immediate- or short-term follow-up. There were 10 participants in
the control group at 24 weeks follow-up for PANAS-negative aJect.
Kim 2018 reported improvements in change from baseline scores
for depression at immediate-term follow-up in the intervention
group (n = 37) (P = 0.053).
A sensitivity analysis including studies at low risk of bias and those
that performed an ITT analysis suggest there may be no eJect
of physical activity on anxiety (SMD -0.29, 95% CI -0.60 to 0.01; 3
studies, 177 participants; I2 = 0%) or depression (SMD -0.18, CI -0.48
to 0.13; 3 studies, 177 participants; I2= 0%) in the physical activity
group compared to usual care at short-term follow-up (Table 1).
Adverse events
Eight out of the 16 included studies reported on adverse events
(Brown 2017; Cantarero-Villanueva 2016; Cramer 2016; Hubbard
2016; Lewis 2016; Van Blarigan 2019; Van Vulpen 2016; Waart
2017). We did not pool adverse events due to inconsistency in
reporting and measurement. Of the eight studies, four studies
reported that no adverse events (Hubbard 2016; Lewis 2016; Waart
2017) or serious adverse events (Van Vulpen 2016) occurred during
the study period. The method of measurement of adverse events
was not described by authors, Van Vulpen 2016 and Waart 2017.
Van Vulpen 2016 and Lewis 2016 did not make reference to 'non-
serious' adverse events. Hubbard 2016 recorded adverse events in
a participant log and recorded them as "related" or "unrelated" to
the study. In the study by Lewis 2016, serious adverse events were
recorded by the researcher within 24 hours of becoming aware of
the event.
Cramer 2016 recorded all adverse events that occurred during the
study period and asked open-ended questions at weeks 10 and
22 to assess any adverse events not previously mentioned. No
serious adverse events occurred and seven participants reported
minor adverse events in the intervention group, including transient
abdominal pain (n = 1), muscle soreness (n = 3), neck pain (n = 1),
minor vertigo (n = 1) and hip pain (n = 1). One patient in the control
group experienced a serious adverse event that was reported as
"probably not causally related to the study intervention". Brown
2017 assessed adverse events using the Common Terminology
Criteria for Assessing Adverse Events (CTCAE). No serious (grade
3) adverse events were reported at six months aMer baseline.
One hundred and one non-serious (grade 1 and 2) adverse events
occurred in the intervention compared to 49 in the usual care group.
Common non-serious adverse events reported in the intervention
group were: joint pain, back pain, generalised flu-like symptoms,
foot blisters and myalgia. In the study by Cantarero-Villanueva
2016 each participant kept a diary to record adverse events. Six
participants expressed both neck and abdominal discomfort with
some of the exercises in the first sessions. Two participants in
the intervention group and one participant in the usual care
group experienced postoperative ventral hernias. One participant
could not perform the aerobic exercise during one week because
he suJered a peripheral neuropathy. The author did not report
whether these were recorded as "related" or "unrelated" to the
exercise intervention. In the study by Van Blarigan 2019 participants
completed an online health check survey which recorded adverse
events. Commonly reported non-serious adverse events included
low back, knee, joint, muscle and chest pain, inflammation of joints
in both the intervention (n = 39) and control (n = 36) groups.




No RCTs reported overall survival.
Recurrence-free survival
No RCTs reported recurrence-free survival as an outcome. No
studies reported cancer recurrence as reasons for dropout. One
study reported lung metastasis in the intervention group as a
reason for dropout (Lewis 2016).
Physical fitness
Aerobic fitness
A total of 12 studies reported aerobic fitness, using a variety of
diJerent measures including; the six-minute walk test (Brown 2017;
Cantarero-Villanueva 2016; Courneya 2016; Lee 2017; McDermott
2017), the Bruce Protocol Treadmill Test (Bourke 2011; Lewis 2016),
the Modified Balke Treadmill Test (Courneya 2003), V02 peak test
(Van Vulpen 2016); Cycle Ergometer Peak Power Output Test (Van
Vulpen 2016), Rockport Walk Test (Nuri 2016), treadwalk test (Pinto
2013), and the Steep Ramp Test (Waart 2017). Nuri 2016 and Pinto
2013 estimated V02 peak from submaximal fitness tests; we used
this data in our meta-analysis. No included studies reported change
from baseline data at more than 12 months follow-up.
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At immediate-term follow-up, we observed an improvement in
aerobic fitness in the physical activity group compared with the
usual care group (SMD 0.82, 95% CI 0.34 to 1.29; 7 studies, 295
participants; I2 = 68%; low-quality evidence; Analysis 3.1). This
eJect was also observed at short-term follow-up (SMD 0.56, 95% CI
0.29 to 0.82; 7 studies, 248 participants; I2 = 1%; moderate-quality
evidence; Analysis 3.3), but not at medium-term follow-up (SMD
0.44, 95% CI -0.04 to 0.92; 4 studies, 272 participants; I2 = 57%; very
low-quality evidence; Analysis 3.5).
Change in aerobic fitness from baseline showed an improvement
compared with usual care at immediate-term follow-up (SMD 0.89,
95% CI 0.43 to 1.36; 3 studies, 81 participants; I2 = 0%; low-quality
evidence; Analysis 3.2) and short-term follow-up (SMD 0.62, 95% CI
0.05 to 1.19; 2 studies, 51 participants; I2 = 0%; moderate-quality
evidence; Analysis 3.4). We were unable to include data from the
study by Brown 2017 in the meta-analysis as the authors reported
mean change between groups over time. We emailed to request
postintervention and change from baseline data, but no reply was
received.
We conducted a sensitivity analysis excluding studies with an
additional component (dietary advice), studies that did not
conduct an ITT analysis and those at high risk of bias; results
suggest improvements in aerobic fitness in the physical activity
group compared with usual care (SMD 0.38, CI 0.06 to 0.70; 4
studies, 207 participants; I2= 15%; Table 1) at immediate- term
follow-up and short-term follow-up (SMD 0.45, CI 0.15 to 0.75; 5
studies, 187 participants; I2= 0%; Table 1). We also conducted a
sensitivity analysis at medium-term follow-up excluding the study
in which the physical activity intervention was ongoing. Results
of this suggest no improvement in aerobic fitness in the physical
activity group compared with usual care (SMD 0.44, CI 0.41 to 1.29;
3 studies, 86 participants).
Upper body strength
A total of five studies reported upper body strength, including
arm strength, assessed by hand grip dynamometry (Lee 2017;
Lewis 2016; Waart 2017), the 30 second arm-curl test (Lewis 2016;
Courneya 2016), isometric abdominal strength and isometric back
strength assessed by the trunk-curl test and back dynamometry,
respectively (Cantarero-Villanueva 2016), and the push-up test to
assess upper body strength and endurance (Lee 2017). A meta-
analysis was conducted for hand grip strength only, due to the
large variability in measurement of upper body strength. Data were
insuJicient for analysis of more than six months to 12 months
follow-up and for change scores at all four time points.
We observed no diJerence in hand grip strength, assessed using
hand grip dynamometry in the physical activity group compared
with usual care at immediate-term follow-up (MD 1.92, 95% CI -1.17
to 5.00; 2 studies, 147 participants; I2 = 0%, low-quality evidence;
Analysis 4.1) or at short-term follow-up (MD 0.94, 95% CI -5.98 to
7.87; 2 studies, 39 participants; I2 = 0%; very low-quality evidence;
Analysis 4.2). In the study by Lee 2017, hand grip strength was
reported separately for the leM and right hand. We contacted Lee
2017 to request combined data, but we received no response. We
inputted the data from the right hand only.
Lee 2017 reported a significantly greater improvement in the push-
up test (P < 0.001) in the intervention group (n = 62) compared
with control (n = 61) at 12 weeks. The physical activity group
(n = 21) experienced a greater increase in isometric abdominal
strength compared with that of the usual care group (n = 19) at
eight weeks (P = 0.001) but not at six months follow-up in the
study by Cantarero-Villanueva 2016. No significant diJerence was
found between groups for isometric back strength. There were no
significant group diJerences in change in arm-curl repetitions in the
study by Lewis 2016 (n = 12 for the physical activity group and usual
care group at 12 weeks; n = 9 and n = 11 at 6 months, respectively)
or in the study by Courneya 2016 (P = 0.18) (n = 99 and n = 98 for the
physical activity and usual care groups, respectively) at one year.
Flexibility
Three studies measured flexibility, assessed by the Sit and Reach
Test (Courneya 2003; Courneya 2016), and the Modified Sit and
Reach Test (Cantarero-Villanueva 2016). Cantarero-Villanueva 2016
reported flexibility of the right and leM side separately. We emailed
the author, but were unable to obtain combined sit and reach
scores. We used data for the right side in our analysis. Mean scores
were multiplied by minus one to ensure all scales had the same
direction of eJect as discussed in the Cochrane Handbook for
Systematic Reviews of Interventions section, 9.2.3.2 (Deeks 2017).
We observed no diJerence in flexibility in the physical activity group
compared to usual care at short-term follow-up (SMD 0.02, 95%
CI -0.36 to 0.39; 2 studies, 119 participants; I2 = 0%; low-quality
evidence; Analysis 5.1). There were insuJicient data for analysis
of flexibility at immediate- and medium-term follow-up and for
change scores at all four time points.
Courneya 2016 reported that the structured exercise group (n = 99)
improved relative to the health education material group (n = 98)
for the Sit and Reach Test (mean between group diJerence of +2.1
cm; 95% CI -0.6 to +4.7; P = 0.08) at one year.
Lower limb strength
Two studies measured lower body strength, using dynamometry
to assess maximum voluntary torque production of the knee
extensors (Bourke 2011; Waart 2017). Meta-analysis was precluded
as studies measured lower limb strength at diJerent time points.
In the study by Bourke 2011, no diJerence in maximum voluntary
torque was observed between the intervention (n = 9) and control
group (n = 9) over the 12-week intervention period (P = 0.127).
Conversely, Waart 2017 observed improvements in lower body
strength in the usual care control group (n = 6), the onco-move
group (low-intensity home-based exercise; n = 6) and a reduction
in strength in the on-track intervention group (moderate- to high-
intensity supervised exercise; n = 7) at the end of chemotherapy
(calculated as 4.8 to 5 months follow- up). At six months following
chemotherapy (calculated as 10 to 11 months follow-up), the on-
track group (n = 6) recovered to above baseline values (no P values
were reported).
Cancer-related fatigue
A total of 10 studies reported cancer-related fatigue, assessed by
the Functional Assessment of Chronic Illness Therapy - Fatigue
(FACIT-F) (Cramer 2016; Kim 2018; McDermott 2017), the Functional
Assessment of Cancer Therapy - Fatigue (FACT-F) (Bourke 2011;
Courneya 2003; Lewis 2016; Pinto 2013), the Multidimensional
Fatigue Inventory (MFI) (Van Vulpen 2016; Waart 2017), the
Multidimensional Fatigue Symptom Inventory - Short Form (MFSI-
SF) (McDermott 2017), and the Fatigue Symptom Inventory (FSI)
(Brown 2017). Van Vulpen 2016 and Waart 2017 reported results
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separately for subscales of the MFI. We extracted the MFI general
subscale as a comparable measure for inclusion in the meta-
analysis. We chose the general subscale score as it includes general
statements about fatigue and decreased functioning, designed to
encompass both physical and psychological aspects of fatigue (Lin
2009). We multiplied mean scores from the MFI general subscale
by minus one to ensure all scales had the same direction of eJect,
as discussed in the Cochrane Handbook for Systematic Reviews of
Interventions section, 9.2.3.2 (Deeks 2017).
Low-quality evidence suggests an improvement in cancer-related
fatigue in the physical activity group compared with the usual care
group at immediate-term follow-up (MD 2.16, 95% CI 0.18 to 4.15; 6
studies, 230 participants; I2= 18%; Analysis 6.1), short-term follow-
up (SMD 0.34, 95% CI 0.08 to 0.60; 7 studies, 277 participants; I2
= 9%; moderate-quality evidence; Analysis 6.3), but not medium-
term follow-up (SMD 0.25, 95% CI -0.16 to 0.67; 3 studies, 91
participants; I2 = 0%; low-quality evidence; Analysis 6.4). Change
from baseline to 12 weeks suggests no improvement in fatigue in
the physical activity group compared with the usual care group (MD
0.41, 95% CI -1.33 to 2.14; 3 studies, 113 participants; I2 = 70%;
low-quality evidence; Analysis 6.2). There were insuJicient data to
conduct change from baseline analysis at all other time points.
Brown 2017 reported improvements in change from baseline scores
in the high dose intervention group compared with control at short-
term follow-up (P trend = 0.045).
We conducted a sensitivity analysis with studies at low risk of bias
and those that performed an ITT analysis at immediate- and short-
term follow-up. There was no diJerence in fatigue between groups
at immediate- or short-term follow-up (Table 1). Results from the
fixed-eJect sensitivity analysis were consistent with those from the
random-eJects model.
Anthropometric measurements
A total of 10 studies reported anthropometric measurements
assessed by: weight (Bourke 2011; Cantarero-Villanueva 2016;
Courneya 2016; Lee 2017; Lewis 2016; McDermott 2017; Nuri 2016;
Van Vulpen 2016), BMI (Bourke 2011; Brown 2017; Cantarero-
Villanueva 2016; Courneya 2003; Lee 2017; Lewis 2016; McDermott
2017; Nuri 2016), waist measurement (Brown 2017; Cantarero-
Villanueva 2016; Lee 2017; McDermott 2017), waist-to-hip ratio
(Bourke 2011; Brown 2017; Lewis 2016; McDermott 2017), body
fat percentage (Cantarero-Villanueva 2016; Courneya 2003; Lee
2017; Lewis 2016; Nuri 2016), and hip circumference (Brown
2017; Courneya 2016; McDermott 2017). Brown 2017 also assessed
visceral fat, subcutaneous fat and fat mass.
We found no evidence of eJect of physical activity compared
with usual care on weight (Analysis 7.1: moderate-quality evidence
and Analysis 8.3: low-quality evidence), BMI (Analysis 11.1: low-
quality evidence and Analysis 11.3: low-quality evidence), waist
measurement (Analysis 8.1: very low-quality evidence and Analysis
8.2: low-quality evidence), waist-to -hip ratio (Analysis 9.1: very low-
quality evidence and Analysis 9.3: low-quality evidence), or body fat
percentage (Analysis 10.1: low-quality evidence and Analysis 10.3:
very low-quality evidence) at immediate- or short-term follow-up
time points.
Change from baseline to 12 weeks follow-up, but not change from
baseline from 12 weeks to six months follow-up suggests a small
reduction in weight (MD -1.71, 95% CI -2.90 to -0.51; 3 studies, 82
participants; I2 = 1%; low-quality evidence; Analysis 7.2; Analysis
7.3) and body fat percentage (MD -1.57, 95% CI -3.11 to -0.04; 2
studies, 60 participants; I2 = 0%; low-quality evidence; Analysis 10.2
and Analysis 10.4), but not BMI at either time point (Analysis 11.2;
Analysis 11.4; low- and very low-quality evidence, respectively, or
change from baseline up to 12 weeks for waist-to-hip-ratio (Analysis
9.2; very low-quality evidence). Low-quality evidence suggests a
small reduction in waist measurement in change from baseline
from 12 weeks to six months follow-up (MD -2.79, 95% CI -5.21 to
-0.36; 2 studies, 70 participants; I2 = 38%; Analysis 8.3). When we
conducted a sensitivity analysis using a random-eJects model for
waist measurement, the diJerence between the physical activity
and usual care group was no longer significant (MD -4.36 cm, -11.42
to 2.71; 2 studies, 70 participants; I2= 38%).
There was insuJicient postintervention and change from baseline
data at six months to 12 months to report on any anthropometric
measure. InsuJicient data precluded meta-analysis of change from
baseline data to 12 weeks follow-up for waist measurement and
more than 12 weeks to six months follow-up for waist-to-hip-
ratio. We did not pool studies that measured hip circumference
from 12 weeks to six months follow-up (Brown 2017; McDermott
2017), as Brown 2017 reported change from baseline scores whilst
McDermott 2017 reported postintervention scores.
Courneya 2016 reported no statistically significant diJerence
between the structured exercise programme (SEP) group and the
health education materials (HEM) group for weight (SEP = 115,
HEM = 112) (P = 0.38), hip circumference (SEP = 99, HEM = 99) (P =
0.90) or waist circumference (SEP = 99, HEM = 99) (P = 0.31) at one
year. Between-group changes in body weight were not significantly
diJerent between intervention (n = 16) and usual care (n =14)
for both men and women in the study by Van Vulpen 2016 at 18
and 36 weeks. Changes in waist-to-hip ratio were not statistically
significance in the study by Lewis 2016 (P = 0.43) or Brown 2017 (P
= 0.054). Cantarero-Villanueva 2016 reported a significant change
from baseline scores to eight weeks and six months between the
physical activity group (n = 21) and usual care group (n = 19)
for waist circumference. Changes in hip circumference up to six
months were not significant in the study by Brown 2017 (P = 0.518),
whilst McDermott 2017 reported an increase in hip circumference in
the control group at week 12 (n = 9) and a decrease at week 24 (n =
9), but not to pre-intervention levels, whilst the intervention group
decreased at week 12 (n = 11) and increased at week 24 (n = 10) but
not to pre-intervention levels (P = 0.012).
We conducted a sensitivity analysis for weight, waist-to-hip-ratio,
BMI and body fat percentage at immediate-term follow-up, we
excluded the study by Bourke 2011 because the intervention
contained a dietary advice component and the study by Nuri 2016
as an ITT analysis was not conducted. Results of the sensitivity
analysis suggests no diJerence in eJect of physical activity
compared with usual care on weight, BMI, waist measurement,
waist-to-hip ratio or body fat percentage. The choice of model (fixed
or random) did not eJect the estimates of eJect at this time point. A
sensitivity analysis for change from baseline to 12 weeks follow-up
suggested no reduction in weight or BMI when the study by Bourke
2011 was removed. A sensitivity analysis with studies at low risk
of bias was conducted for weight and BMI for change scores from
12 weeks to six months, results suggest no diJerence in eJect of
physical activity compared with usual care on weight or BMI at this
time point.
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Health-related quality of life (HRQoL)
A total of 10 studies reported HRQoL; seven of these studies
assessed HRQoL using the Functional Assessment of Cancer
Therapy-Colorectal (FACT-C; Bourke 2011; Brown 2017; Courneya
2003; Cramer 2016; Kim 2018; McDermott 2017; Pinto 2013), the
Functional Assessment of Cancer Therapy-General (FACT-G; Lewis
2016), the European Organisation for Research and Treatment of
Cancer Quality of life Questionnaire-Core 30 (EORTC QLQ-C30; Van
Vulpen 2016; Waart 2017), the EuroQol-Visual Analogue Scales
(EQ-VAS; Lewis 2016), and the Satisfaction With Life Scale (SWLS;
Courneya 2003).
Moderate-quality evidence suggests a small positive eJect for the
physical activity group compared with the usual care group on
HRQoL at immediate-term follow-up (SMD 0.36, 95% CI 0.10 to
0.62; 6 studies, 230 participants; I2 = 0%; Analysis 12.1) and short-
term follow-up (SMD 0.45, 95% CI 0.03 to 0.88; 7 studies, 278
participants; I2 = 61%; Analysis 12.3) but no evidence of diJerence
between groups at medium-term follow-up (SMD 0.05, 95% CI -0.37
to 0.47; 3 studies, 89 participants; I2 = 0%; low-quality evidence;
Analysis 12.5) or change from baseline up to 12 weeks follow-up
(SMD -0.10, 95% CI -0.47 to 0.28; 3 studies, 113 participants; I2 =
16%; low-quality evidence; Analysis 12.2). We observed a small
positive eJect on change from baseline scores at more than 12
weeks to six months follow-up (SMD 0.70, 95% CI 0.14 to 1.26;
2 studies, 58 participants; I2 = 0%; low-quality evidence; Analysis
12.4). Data were insuJicient to conduct a meta-analysis of change
from baseline scores at more than six months to 12 months follow-
up.
A sensitivity analysis suggests that physical activity interventions
may have a positive eJect on HRQoL compared to usual care at
immediate-term follow-up, (excluding the study by Bourke 2011),
and including studies at low risk of bias and those that conducted
an ITT analysis (SMD 0.37, 95% CI 0.07 to 0.68; 4 studies, 169
participants; I2 = 0%; Table 1).
Levels of physical activity
A total of 12 studies reported on levels of physical activity,
assessed objectively and subjectively. Objective physical activity
was assessed by accelerometry (Brown 2017; Hubbard 2016;
Lewis 2016; McDermott 2017; Van Blarigan 2019). We pooled
total minutes of moderate to vigorous physical activity for the
meta-analysis. Subjective physical activity was assessed by the
Godin Leisure Time Exercise Questionnaire (Bourke 2011; Courneya
2003; Kim 2018; Lee 2017), the International Physical Activity
Questionnaire (IPAQ; Lewis 2016), the Seven-Day Physical Activity
Recall (7-day PAR) questionnaire (Courneya 2003; Pinto 2013),
the Tartu Physical Activity Questionnaire (TPAQ; Courneya 2016),
the Community Healthy Activities Model Programme for Seniors
(CHAMPS; Courneya 2016), and the Physical Activity Scale for the
Elderly (PASE; Waart 2017).
We found no evidence of diJerence in levels of physical activity in
the physical activity group compared to usual care at immediate-
term follow-up (MD -8.34, 95% CI -21.05 to 4.37; 4 studies, 94
participants; I2 = 43%; very low-quality evidence; Analysis 13.1) or
short-term follow-up (MD 13.50, 95% CI -56.73 to 83.74; 2 studies,
36 participants; I2 = 13%; Analysis 13.4) when measured objectively
using accelerometry. We found no evidence of diJerence in change
from baseline scores up to 12 weeks between groups (SMD -0.13,
95% CI -0.77 to 0.52; 2 studies, 37 participants; I2 = 0%; very low-
quality evidence; Analysis 13.2).
Subjective measures of levels of physical activity suggest an
increase in levels of physical activity in the physical activity group
compared to the usual care group at immediate-term follow-up
(SMD 0.70, 95% CI 0.38 to 1.03; 4 studies, 156 participants; I2 =
0%; very low-quality evidence; Analysis 13.3), short-term follow-up
(SMD 0.39, 95% CI -0.05 to 0.82; 4 studies, 176 participants; I2 = 38%;
low-quality evidence; Analysis 13.5) and medium-term follow-up
(SMD 0.35, 95% CI 0.11 to 0.59; 3 studies, 274 participants; I2 = 21%;
very low-quality evidence; Analysis 13.6).
We were unable to extract data from studies by Brown 2017 and
Lee 2017 because Brown 2017 reported mean change in moderate
to vigorous physical activity and Lee 2017 reported moderate
and vigorous physical activity separately. We emailed authors but
received no response. In the study by Brown 2017, both the low
dose (n = 14) and high dose (n = 12) exercise group increased their
moderate to vigorous physical activity compared to the usual care
group (n = 13) (P trend = < 0.001) over six months. Lee 2017 reported
an increase in moderate to vigorous physical activity in the exercise
group (n = 62) with no change in the usual care group at three
months (group x time interaction, P < 0.01). Data were insuJicient to
conduct a meta-analysis for change from baseline from more than
12 weeks to six months follow-up and more than six months to 12
months follow-up for objective measures and subjective measures
at all time points.
We performed a sensitivity analysis, excluding studies with dietary
advice co-interventions up to 12 weeks follow-up aMer baseline.
Objectively measured physical activity suggests no diJerence in
levels of physical activity in the physical activity group compared to
usual care in immediate-term follow-up (MD -2.84, 95% CI -12.40 to
6.73; 3 studies, 80 participants; I2 = 0%; Table 1). Sensitivity analysis
of subjective measures of physical activity suggest an increase in
levels of physical activity in the physical activity group compared to
the usual care group in immediate-term follow-up (SMD 0.68, 95%
CI 0.33 to 1.02; 3 studies, 138 participants; I2 = 0%; Table 1). At short-
term follow-up, we included studies at low risk of bias and studies
that conducted an ITT analysis; this sensitivity analysis suggests no
diJerence between levels of physical activity in the physical activity
group compared to the usual care group.
Subgroup analysis
Subgroup analyses were precluded as we were unable to extract
suJicient compatible data to undertake the predefined subgroup
analysis
D I S C U S S I O N
Summary of main results  
Summary of main results
This review included 16 randomised controlled trials (RCTs) with a
total of 992 participants diagnosed with non-advanced colorectal
cancer. We are uncertain whether physical activity interventions
improve physical function. We found no evidence of eJect of
physical activity interventions on disease-related mental health,
anthropometric measures or levels of physical activity (measured
objectively). Interestingy, when levels of physical activity were
measured subjectively they were higher in the physical activity
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group compared to the usual care group at immediate-, short- and
medium-term follow-up. We found no evidence of serious adverse
events in the intervention or usual care groups in the eight studies
that reported on adverse events. There was inconsistency in the
measurement and reporting of adverse events between studies.
Where reported, adverse events were generally minor. We found
evidence of positive eJects of physical activity interventions on
physical fitness (aerobic fitness, but not other components of
fitness), cancer-related fatigue and health-related quality of life
(HRQoL) at immediate- and short-term follow-up but not medium-
term follow-up. Only three studies reported medium-term follow-
up for cancer-related fatigue and HRQoL. No studies assessed
outcomes at long-term follow-up. One study that assessed fatigue
and levels of physical activity at four years is currently awaiting
classification (Van Vulpen 2016).
No studies reported on overall survival or recurrence-free survival.
Our findings should be interpreted with caution as we rated the
quality of evidence between very low to moderate overall. Further,
higher quality studies are required to assess the eJectiveness
and safety of physical activity interventions for non-advanced
colorectal cancer patients.
Overall completeness and applicability of evidence
This systematic review includes studies from nine diJerent
countries. All studies except for one were undertaken in higher-
income countries (Nuri 2016). This evidence may therefore limit
the applicability to low-middle income countries. All studies in
this version of the review except for one, exclusively included
individuals with non-advanced colorectal cancer; Courneya 2003
included four stage IV participants. The majority of studies
included only participants that had finished active treatment,
this was apparent across all outcomes, especially at immediate-
term follow-up, limiting applicability to those undergoing active
treatment. Ethnicity was only reported in three studies; these
studies included mostly white people. Level of education was
reported in nine studies and there was some variation in
the percentage of participants educated to degree level. The
physical activity interventions varied somewhat in their frequency,
intensity, time, mode and duration, and because of this we
are unable to ascertain optimal mode, frequency, intensity
or duration of physical activity interventions for eJects on
the primary and secondary outcomes assessed in this review,
limiting recommendations for clinical practice. We were unable
to undertake subgroup analysis according to physical activity
intervention or participant characteristics, cancer characteristics,
treatment stages and length of time since diagnosis due to
lack of comparable data, which limits applicability of findings.
The objective measure of physical fitness that was used most
commonly amongst included studies was the 6-minute walk test.
This is not the gold standard of measuring physical fitness and
has been shown to underestimate VO2 peak in cancer survivors
(Schumacher 2017). This may also limit the applicability of the
evidence in this population. The highest incidence of colorectal
cancer occurs in people aged between 65 and 74, the mean age
of participants included in this review ranged between 51 and 69,
this may therefore limit the applicability of this evidence to the
population with the highest incidence of colorectal cancer.
For primary outcomes, such as physical function and disease-
related mental health, the greatest number of studies included in
a meta-analysis at any given time point was four. These findings
should be interpreted with caution due to the limited number of
studies and small sample sizes, especially at longer periods of
follow-up, where fewer studies were included. In addition, some
of the outcome data included were not normally distributed which
may have aJected study results. Therefore, findings should be
interpreted with caution. We were unable to undertake a meta-
analysis of adverse events due to inconsistencies in measurement
and reporting of this data. Less than half of the included studies
reported on adverse events and four of these reported that no
adverse events occurred. In future, RCTs should systematically
record and report adverse events and define whether these events
are 'related' or 'unrelated' to the intervention. We could not provide
an analysis of eJects of physical activity interventions on important
outcomes, such as overall survival or recurrence-free survival
because no included studies reported these outcomes. No studies
assessed the long-term eJects (more than 12 months follow-
up) of physical activity interventions on any of the primary and
secondary outcomes. One study is currently awaiting classification,
which reports on four-year eJects of exercise on fatigue and
levels of physical activity (Van Vulpen 2016). In addition, across
all outcomes, few studies conducted follow-up measurements at
medium-term follow-up; these findings should be interpreted with
caution
Quality of the evidence
The quality of the findings are reported in Summary of findings 1 for
the main comparison. We assessed the quality of evidence for each
outcome using GRADE methodology (GRADE Working Group 2004).
For the immediate-term follow-up, GRADE revealed low-quality
evidence for physical function, adverse events, physical fitness
(aerobic fitness) and cancer-related fatigue. Moderate-quality
evidence was revealed for HRQoL (immediate-term follow-up) and
disease-related mental health (anxiety and depression) at short-
term follow-up. The quality of evidence for change from baseline
scores and all other time points, ranged between very low to
moderate quality. We downgraded the quality of evidence, namely
in light of imprecision and indirectness due to the small number
of studies/participants included and considering the majority of
studies were conducted in participants who had finished active
treatment. In addition, three studies included a health education
component which may also introduce indirectness, although only
one of these studies reported outcomes at immediate-term follow-
up. Due to the nature of the intervention it was not possible to
blind personnel or participants to the intervention, putting all
studies at high risk of performance bias, which may be accentuated
where participants completed subjective assessments. We found
discrepancy in direction of eJect of interventions when levels
of physical activity were measured subjectively compared to
objectively. It has been recently documented that people with
cancer self-report their physical activity levels to be nearly
four-fold higher when compared to objective physical activity
monitoring data (Vassbakk-Brovold 2016). Most of the uncertainty
in judging study bias came from a lack of clarity around allocation
concealment and blinding of outcome assessors. The 'Risk of bias'
table and graph are available in Figure 2 and Figure 3. In addition,
some of the data included in the meta-analysis for measures of
mental health, cancer-related fatigue, aerobic fitness and levels of
physical activity were not normally distributed, which may have
aJected the quality of the evidence.
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Potential biases in the review process
This systematic review included comprehensive search strategies
of eight electronic databases, and four clinical trial registries.
We (MMG and MAT) independently screened reference lists of all
included studies and any relevant systematic reviews identified.
We handsearched conference and meeting abstracts of relevant
organisations and undertook data extraction and 'Risk of bias
judgement' independently. We sent emails to seven authors of
studies registered in clinical trial registries with recent completion
dates and received correspondence from six of these authors. We
emailed four authors of unpublished studies, two of these studies
are included in this review (Lewis 2016; McDermott 2017). We sent
a further 13 emails to study authors that included colorectal cancer
participants alongside other cancer cohorts, to request colorectal
cancer participant data separately and emailed authors to request
missing data,some did not reply and exclusion of these results may
also be a source of bias. We were unable to explore publication
bias because there were less than 10 studies included in each
comparison. The mean age of participants ranged between 51 and
69, which is markedly lower than the incidence of colorectal cancer.
The review therefore does not include a cohort of the relevant
population, which is a source of selection bias. Furthermore, the
mean age range of participants may be indicative of participation
bias, where healthier participants are more likely to agree to
participate in the physical activity intervention research.
A limitation of this review is that three included studies involved
additional components, e.g. healthy eating seminars and a dietary
information pack (Bourke 2011), health education materials for
the usual care group (Courneya 2016), and weekly education
sessions on a range of topics (Hubbard 2016), which could have
potential synergistic eJects of exercise or physical activity on
some outcomes. We investigated their eJect on outcomes through
exclusion in sensitivity analysis when possible.
Agreements and disagreements with other studies or
reviews
To our knowledge only two other systematic reviews have
investigated the eJectiveness of physical activity interventions
in colorectal cancer patients. One if these reviews published
in 2014 included 5 RCTs and 238 patients assessing the eJect
of exercise on HRQoL, fatigue, physical fitness, survival and/
or tumour-associated biomarkers in colorectal cancer patients
(Cramer 2014b). The meta-analysis for physical fitness, fatigue
and HRQoL included three studies all of which are included in
our review (Bourke 2011; Courneya 2003; Pinto 2013). At short-
term follow-up (corresponding to our immediate-term follow-up)
authors observed improvements in physical fitness aMer aerobic
exercise compared with controls which is in agreement with our
review. Also in agreement with our review, no studies reported
on survival. Conversely, authors found no evidence for short-term
eJects on quality of life or cancer-related fatigue, whereas we found
evidence of favouring eJects of physical activity interventions
on these outcomes at the same time point. We also observed
this eJect at short-term follow-up. Cramer 2014b was unable
assess outcomes at this time point due to insuJicient data. In
addition, authors were unable to report on safety data, whereas we
reported adverse events narratively due to the extent of variation
in measurement and reporting of this outcome. The diJerences
between these reviews are due to the time of the literature search,
indeed all of our other included studies were conducted aMer 2014.
The second review conducted by van Rooijen 2018 highlighted the
lack of evidence available on exercise training in those explicitly
undergoing active treatment, which was also evident in this review.
Six of the seven studies included in the van Rooijen 2018 review
included mixed cancer populations, we therefore did not compare
results.
A U T H O R S '   C O N C L U S I O N S
Implications for practice
We are uncertain whether physical activity interventions improve
physical function compared to usual care. Physical activity
interventions may have no eJect on disease-related mental health.
Physical activity interventions may be beneficial for aerobic
fitness, cancer-related fatigue and HRQoL at immediate-and short-
term follow-up. There were no serious adverse events in any of
the studies that provided safety data. Where reported, adverse
events were generally minor. The findings of this review should
be interpreted with caution due to the low number of studies
included and the quality of the evidence. Due to inconsistency in
measuring and reporting of this data, more research is required
to inform clinical practice. In addition, the current evidence is
based on a small number of studies with few participants. The
evidence is graded between low and moderate for the main
outcomes, which precludes informed decision making in the
clinical setting. Adequately powered RCTs of high methodological
quality with longer-term follow-up are required to assess the
eJect of physical activity interventions on disease-related physical
and mental health and on survival of people with non-advanced
colorectal cancer. Adverse events should also be adequately
reported. Further, it would be extremely important to understand
whether certain exercise components (mode, frequency, duration
and intensity) have optimal eJects on physical and disease-related
mental health of CRC patients both during and following active
treatment.
Implications for research
This review highlights the need for further large-scale RCTs to
assess the eJect of physical activity interventions on the disease-
related physical and mental health of people with non-advanced
colorectal cancer. Future RCTs should be of high methodological
quality and adequately powered, and include longer-term follow-
up to investigate the sustainability of short-term benefits of
physical activity. We identified only two ongoing studies that are
investigating disease-free survival, recurrence-free survival and
overall survival (Piringer 2017; NCT03885817) and only two studies
explicitly stating "side eJects of the intervention" and "safety"
as outcome measures (Ho 2013; Piringer 2017). It is important
for future RCTs to investigate the eJects of physical activity on
overall survival and recurrence-free survival and report adherence
to Enhanced Recovery AMer Surgery (ERAS) guidelines and length
of stay and systematically record and adequately report adverse
events, defining whether these events are 'related' or 'unrelated'
to the intervention. More research is also required exclusively
in those undergoing active cancer treatment for non-advanced
colorectal cancer. Indeed, RCTs undertaken with mixed cancer
populations should report data separately for the specific cancers,
when appropriate. More robust measures to reduce bias, especially
in relation to allocation concealment and blinding of outcome
assessors are required. In addition, future research should aim
to recruit older participants to increase applicability of results to
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those with the highest incidence of colorectal cancer. Importantly,
a better understanding of the optimal training duration, pattern,
intensity, volume, setting and composition of such interventions
will be needed to maximise eJicacy. This requires a shiM in how we
record and report these components.
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C H A R A C T E R I S T I C S   O F   S T U D I E S
Characteristics of included studies [ordered by study ID]
 
Study characteristics
Methods Study design: RCT
Study location: UK
Inclusion criteria:
1. patients who had histologically confirmed colon cancer (Dukes stages A–C) resected 6 to 24 months
previously
Exclusion criteria:
1. existing participation in regular physical activity (purposeful activity of at least a moderate-intensity
of 30 minutes or more, 3 times a week)
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5. recent myocardial infarction, or a pacemaker
Participants Number randomised: 18; 9 control; 9 intervention
Baseline imbalances: not reported
Withdrawals and exclusions: 1 dropout in intervention group (stroke)
Age, mean (SD) - total: 69 years (range 52-80 years); control: 70.3 (8.7) years; intervention: 67.9 (5.7)
years





Colorectal cancer stage: Dukes A-C
Type of treatment n: surgery: 8 control, 9 intervention; chemotherapy: 2 control, 4 intervention; pallia-
tive care: 1 control, 0 intervention
Receiving or finished treatment: finished
Time beyond treatment (months): 16.7 control; 16.4 intervention
Time since diagnosis: not reported
Interventions Physical activity description
Frequency: 2 group-based supervised sessions weekly and one home-based
Intensity: 55% to 85% of age predicted maximum heart rate or rate of perceived exertion between 11
and 15
Time: 30 minutes of aerobic exercise per session, 2 and 4 sets of 8 to 12 repetitions of resistance exer-
cises
Type: aerobic (treadmills, rowing ergometers, and cycling ergometers) and resistance
Volume: not reported
Progression: during the final 6 weeks of the intervention, participants attended the university facility
once a week and were asked to perform two home-based sessions a week
Length of intervention: 12 weeks
Control group: usual care
Setting: exercise suite in university and home-based
Supervised or self-directed: both
Co-interventions: dietary advice information pack, on a fortnightly basis throughout the intervention,
engaged in healthy eating seminars in a group format, lasting approximately 15 to 30 minutes
Outcomes 1. Total exercise behaviour (Godin Leisure Score Index questionnaire)
2. (Macro/micronutrient outcomes (three-day diet diaries)
3. Fatigue (FACT-F, isometric fatigue protocol was also administered at 20% of maximum voluntary
torque with simultaneous assessment of motor unit recruitment using sEMG)
4. QoL (FACT-C)
5. Aerobic exercise tolerance (Bruce Protocol Treadmill Test)
6. Functional capacity (sit to stand test)
Bourke 2011  (Continued)
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7. Lower-limb strength (isokinetic dynamometry)
Time points measured: baseline and 12 weeks
Time points reported: baseline and 12 weeks
Adverse events: a stroke occurred in the intervention group
Notes Funding source: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Randomised via code numbers using nQuery statistical software
Allocation concealment
(selection bias)





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes









Low risk There appears to be no selective reporting of outcomes.





Methods Study design: RCT
Study location: USA
Inclusion criteria:
1. histologically confirmed stage I-III colon cancer
2. completed adjuvant therapy
3. age ≥18 years
4. written physician approval
5. the ability to walk unaided for six minutes
Exclusion criteria:
Brown 2017 
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1. history of another primary cancer (other than non-melanoma skin cancer)
2. evidence of metastatic colon cancer
3. planning to receive any additional adjuvant chemotherapy or surgery (i.e. ostomy reversal); pregnant
or breast feeding
4. unable to provide baseline blood sample
5. cardiac conditions
6. any other condition which, may impede testing of the study hypothesis or make it unsafe to engage
in the exercise programme
Participants Number randomised: 39; 13 to usual care, 14 to low-dose exercise (150 minutes), 12 to high-dose exer-
cise (300 minutes)
Baseline imbalances: no significant differences at baseline
Withdrawals and exclusions: 38/39 participants completed study (1 lost to follow-up in usual care con-
trol group)
Age, mean (SD):
Total; 56.5 (10.0) years
Usual care; 57.9 (9.7)
Low dose; 58.2 (9.8)
High dose; 53.1 (10.5)
Gender, n (%):
Total; Male and female (57%)
Control; male 4(31%), female 9 (69%)
Low dose; Male 7 (50%), female 7 (50%)
High dose; Male (33%), female 8 (67%)
Ethnicity: Majority white (80)%
Comorbidities, n (%): hypertension 13 (33%), hyperlipidaemia 6 (15%), T2DM 5 (13%), CVD 4 (10%)
SES: not reported
Cancer type: colon
Cancer stage, n (%):
Stage I; 5 (13%)
Stage II; 14 (36%)
Stage III; 20 (51%)
Type of treatment: surgical resection and adjuvant chemotherapy
Receiving or finished treatment: finished
Time beyond treatment, mean (SD) months: Total; 10.9 (6.1) months
(less than or equal to 12 months 25 (64%) greater than 12 months 14 (36%))
Time since diagnosis: not reported
Interventions Physical activity description
Frequency: not reported
Brown 2017  (Continued)
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Intensity: moderate-intensity (70.7% of age predicted maximum heart rate)
Time: the initial exercise dose prescribed in week one of the study is 60 min
Type: home-based treadmill walking
Progression: low-dose and high-dose exercise groups increase their exercise to 150 min in week 1 and
300 min in week 1, respectively. Exercise increased by 30 min/week 1 as the participant successfully re-
sponds to the exercise dose prescribed in the prior week
Length of intervention: 6 months
Control group: maintained their pre- study levels of physical activity and/or followed the recommenda-
tions provided by their physician
Setting: home-based
Supervised or self-directed: self-directed
Co-interventions: none
Outcomes 1. Physical activity (accelerometry)
2. Anthropometric
3. Cardiopulmonary & Functional Status
4. Clinical outcomes
5. Quality of Life
6. Biomarkers including soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular adhe-
sion molecule-1 (sVCAM-1) prognostic biomarkers
Time points measured: baseline, six months
Time points reported: baseline, six months
Adverse events: graded using the Common Terminology Criteria for Adverse Events version 4.0
Notes Funding source: National Cancer Institute and the National Center for Advancing Translational Science
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not described
Allocation concealment
(selection bias)





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes









High risk Study protocol included outcomes (dietary intake, cardiopulmonary and QoL)
data that are not presented in available reports
Brown 2017  (Continued)
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Methods Study design: RCT
Study location: Spain
Inclusion criteria:
1. more than 18 years old
2. received curative treatment due to cancer (surgery, chemotherapy and/or radiotherapy)
3. diagnosed with grades I to III A of colorectal cancer
4. completed coadjuvant treatment
Exclusion criteria:
1. presented cancer recurrence
2. underwent previous abdominal surgeries
3. were diagnosed with concomitant conditions, such as previous lower-back pain or musculoskeletal
conditions (e.g. osteoarthritis, fibromyalgia or chronic fatigue syndrome)
Participants Number randomised:46; 23 to the intervention group and 23 patients to the usual care group
Baseline imbalances: no significant differences at baseline
Withdrawals and exclusions: six dropouts (2 in intervention group, 4 in usual care group)
Age, mean (SD) years:
60 years (usual care: 62.3 (7.9) years, intervention: 57.5 (8.0) years)
Gender, n (%):
Total: 26 males, 14 females
usual care: male 13 (68.4%), female 8 (31.6%)
Intervention: male 13 (61.9%) female 6 (38.1%)
Ethnicity: not reported
Comorbidities: not reported
SES: University degree, n (%)
Usual care 2 (10.5%)
Intervention 6 (28.6%)
Cancer type: colon
Cancer stage n (%):
stage II 14; usual care 7 (36.8%), intervention = 7 (33.3%)
stage IIIa 26; usual care 12 (63.2%), intervention 14 (66.7%)
Type of treatment: surgery, other treatment not reported
Cantarero-Villanueva 2016 
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Receiving or completed treatment: finished
Time beyond treatment, mean (SD): 13.3 months
Usual care = 14.6 (10) Months
Intervention = 12 (7.4) months
Time since diagnosis: mean (SD): 15.4 months
Usual care: 17.1 (11.3) months
Intervention: 13.8 (7.8) months
Interventions Physical activity description
Frequency: 3 times per week
Intensity: not reported
Time: 90 minutes
Type: core stabilisation and stretching exercises
Volume, progression =1 set of 8-10 reps to 2 sets of 10 reps
Length of intervention: 8 weeks
Control group: usual care, including written general recommendations for a healthy lifestyle
Setting: activity centre
Supervised or self-directed: supervised
Co-interventions: none
Outcomes 1. Physical fitness/physical function: abdominal isometric endurance (trunk-curl test), flexibility ("chair
sit and reach test"), functional capacity (6-min walk test with treadmill), static balance (Flamingo Test),
fitness perceived (International Fitness Scale), lower back muscle strength (dynamometry)
2. Fatigue (Piper Fatigue Scale)
3. Body composition (bioelectrical impedance analysis)
4. Pain (Brief Pain Inventory)
5. Quality of life
6. Pressure Pain Thresholds
7. Muscle structure
Time points measured: baseline, 8 weeks and 6-month follow-up
Time points reported: baseline 8 weeks and 6-month follow-up
Adverse events: reported
Notes Funding source: Universidad de Granada
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated numbers
Allocation concealment
(selection bias)
Low risk Sequence created was introduced in numbered, opaque, sealed envelopes by




High risk Not possible to blind participants and personnel
due to the nature of the intervention
Cantarero-Villanueva 2016  (Continued)
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All outcomes
Blinding of outcome as-
sessment (detection bias)
All outcomes





Low risk Reasons for missing outcome data were described. 13% attrition
Selective reporting (re-
porting bias)
High risk Study protocol included outcome data that are not presented in available re-
ports






Methods Study design: RCT
Study location: Canada
Inclusion criteria:
1. surgery for colorectal cancer within the past 3 months
2. recovery from surgery as indicated by an attending physician
3. ability to understand and provide written informed consent in English
4. passed the revised Physical Activity Readiness Questionnaire (rPAR-Q; Thomas et al. 1992)
5. no contraindications to exercise as determined by a submaximal cardiorespiratory fitness test
Exclusion criteria: not reported
Participants Number randomised: 102; 69 to the exercise group and 33 to a waiting list control group
Baseline imbalances: no significant differences at baseline
Withdrawals and exclusions: 9 lost to follow-up in total (7 in intervention group 2 in control group)
Age, mean (SD) years:
Total; 60.3 years
Control; 61.1 (9.93) years
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Control group: 35% completed university; 53.6% with income > USD 40,000
Intervention group: 46.4% completed university; 65.5% with income > USD 40,000










intervention; 6.9% (4 participants)










surgery plus RT and CT
control 16.1%
intervention 21.3%
Receiving or finished treatment: not reported (most likely a combination of both as surgery had taken
place in passed 3 months)
Time beyond treatment: surgery within last 3 months
Time since diagnosis: not reported
Interventions Physical activity description
Frequency: 3 to 5 times per week
Intensity: to 65% to 75% of heart rate maximum
Time: 20 to 30 minutes
Type: participants were allowed to choose the mode of exercise they preferred (e.g. swimming, cycling)
but if they had no preference they were prescribed walking
Length of intervention: 16 weeks
Total number of exercise sessions: 48 to 80
Control group: were asked not to initiate any structured exercise over the course of the intervention
(wait list)
Setting: home based
Supervised or self-directed: self-directed
Co-interventions: none
Outcomes 1. Quality of life (FACT-C scale, FACT-G, TOI score- sum of physical and FWB subscale and colorectal sub-
scale)
2. Satisfaction with life, measured (Satisfaction with Life scale)
3. Depression and anxiety, (CES-D scale and STAI, respectively)
Courneya 2003  (Continued)
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4. Cardiovascular fitness (Modified Balke Treadmill Test)
5. Body composition (Harpenden callipers)
6. Flexibility, (sit and reach test)
Time points measured: baseline and 16 weeks
Time points reported: baseline and 16 weeks
Adverse events: not reported
Notes Funding source: National Cancer Institute of Canada, the Alberta Heritage Foundation for Medical Re-
search and Sociobehavioral Cancer Research Network
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A random numbers table was used
Allocation concealment
(selection bias)





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes









Low risk There appears to be no selective reporting of outcomes






Methods Study design: RCT
Study location: Canada and Australia
Inclusion criteria:
1. high risk stage II or stage III colon cancer
2. received adjuvant chemotherapy within the past 2–6 months
3. an Eastern Cooperative Oncology Group performance status of 0 or 1
4. are not currently meeting physical activity guidelines (i.e. the equivalent of 150 minutes/week of
moderate-intensity exercise)
5. able to complete at least two stages of a submaximal treadmill test
Courneya 2016 
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Exclusion criteria: not reported
Participants Number randomised: 273; 136 to a structured exercise programme (SEP) and 137 to health education
materials (HEM)
Baseline imbalances: no significant differences at baseline
Withdrawals and exclusions: 62 excluded from primary analysis at year 1 (211 analysed; 105 in the con-
trol (HEM) group, 106 in the intervention group)
Age, n (%) analysed group:
less than 65:
Control (HEM): 71 (68%)
Intervention: 71 (67%)
Gender, n (%) analysed group:
Control (HEM) male; 46 (44%), female 59 (56%)





Cancer stage, n (%):
High risk stage II:
control (HEM): 12 (11%)
Intervention: 14 (13%)
Stage III:
control (HEM): 93 (89%)
intervention: 92 (87%)
Type of treatment: 100% received chemotherapy
Receiving or finished treatment: finished
Time beyond treatment: 2-6 months
Time since diagnosis, median (range):
Control; 12 (0-16) months
Intervention; 12 (8-17) months
Interventions Physical activity description:
Frequency: biweekly face-to-face counselling sessions combined with supervised exercise, with the op-




Volume/progression: increase recreational aerobic physical activity by at least 10 MET-hours/week
from baseline in the first 6
months and sustain this change for 3 years
Courneya 2016  (Continued)
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Length of intervention: 3 years altogether (three phases- phase 1 adoption, 2 consolidation and 3 main-
tenance)
Control group: health education material (HEM) intervention receive general health education materi-
als promoting physical activity and healthy nutrition as well as standard surveillance follow-up
Setting: not reported
Supervised or self-directed: supervised or telephone support
Co-interventions: HEM
Outcomes 1. Disease-free survival
2. Overall survival
3. Patient reported outcomes (using SF-36, FACIT-F, PSQI, and HADS questionnaires)
4. Physical fitness (i.e. body mass index, hip and waist circumference, cardiovascular fitness, and physi-
cal function)
5. Physical activity levels (TPAQ)
6. Safety profile according to NCI CTCAE version 3.0
7. Correlative biological markers including biochemical and molecular markers associated with in-
sulin-related growth factor and cytokines associated with the mechanisms of fatigue
8. Economic evaluations including cost-effective analysis and cost utility analysis
9. Predictors of physical activity adherence as assessed by Social Cognitive Determinants of Exercise
questionnaire
Time points measured: baseline and 1 year
Time points reported: baseline and 1 year
Adverse events: not reported
Notes Funding sources: Canada Research Chairs Program Alberta Innovates-Health Solutions,
Alberta Cancer Foundation's Weekend to End Women's Cancers Breast Cancer Chair and 
Canadian Cancer Society Research Institute National Health and Medical Research Council (Australia)
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not described
Allocation concealment
(selection bias)





High risk This is an open-label study. However, it is not possible to blind participants
and personnel due to the nature of the intervention
Blinding of outcome as-
sessment (detection bias)
All outcomes





Low risk Missing data balanced across intervention groups with reasons. 22% attrition
Selective reporting (re-
porting bias)
Low risk There appears to be no selective reporting of outcomes
Courneya 2016  (Continued)
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2. UICC stage I-III
3. Between 2-48 months postsurgery
4. aged at least 18
5. physical and cognitive ability to follow the yoga intervention
Exclusion criteria:
1. UICC stage IV
2. further active oncological diseases
3. diagnosed and pharmacologically
4. treated psychiatric disorder except for cancer-related depression or adjustment disorder
pregnancy or breastfeeding
Participants Number randomised: 54; 27 intervention, 27 usual care control
Baseline imbalances: more patients in the yoga group treated with colostomy
Withdrawals and exclusions: 6 in the intervention group and 5 from the control group dropped out
Age (SD) (age range):
Total 68.26 (9.69) years (40–87)
control: 67.81 (10.37) years (40–84)
intervention: 68.70 (9.13) years (49–87)
Gender, n (%):
Total; Male, 33 (61.1%) Female, 21 (38.9%)
Control; Male, 16 (59.3%) Female, 11 (40.7%)
Intervention; Male, 17 (63.0%) Female, 10 (37.0%)
Ethnicity: not reported
Comorbidities: not reported
SES, n (%): university degree 16 (29.6%), employed full time 7 (13%), retired 35 (64.8%)
Cancer type: colorectal; colon 24 (44.4%); rectum 29 (53.7%)
Cancer stage:
Stage I = 20 (37.0%)
Stage II = 11 (20.4%)
Stage III = 21 (38.9%)
Type of treatment, mean (SD):
Cramer 2016 
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Time since surgery 22.76 (13.09) months (range 3–46 months)
current chemotherapy n (%)
yes 2 (3.7%)
No 52 (96.3%)
Receiving or finished treatment:






Time beyond treatment: 3- 46 months postsurgery 3.7% still receiving chemotherapy
Time since diagnosis: not reported
Interventions Physical activity description




Progression: postures in each class built up on the previous ones, and difficulty and intensity levels in-
creased during
the course of the programme patients were encouraged to practice at home although no minimum
practice time was required
Length of intervention: 10 weeks of Hatha yoga
Control group: Waiting list control (usual care)
Setting: on-site
Supervised or self-directed: supervised
Co-interventions: none
Outcomes 1. Health-related quality of life (FACT-C)
2. Fatigue (FACIT-F)
3. Anxiety, depression (HADS)
4. Sleep quality (PSQI)
5. Safety (number and severity of adverse events)
6. Spiritual well-being (Functional Assessment of Chronic Illness Therapy - Spirituality)
7. Body awareness/bodily dissociation (Scale of Body Connection (SBC))
8. Body efficacy expectation (Body Efficacy-Expectation Scale)
9. Qualitative Interviews
Time points measured: baseline, week 10, week 22
Time points reported: baseline week 10, week 22
Adverse events: all adverse events occurring during the study period were recorded
Notes Funding source: no external funding
Risk of bias
Bias Authors' judgement Support for judgement
Cramer 2016  (Continued)
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Random sequence genera-
tion (selection bias)
Low risk Block randomisation using the random allocation software was used
Allocation concealment
(selection bias)





High risk This was an open-label RCT. It is not possible however to blind participants
and personnel due to the nature of the intervention
Blinding of outcome as-
sessment (detection bias)
All outcomes









Low risk Clinical trial registry outcomes are consistent with those reported in publica-
tion










2. diagnosed with primary CRC
3. in recovery period following CRC surgery
Exclusion criteria:
1. advanced disease
2. failure of clinical/risk assessment for cardiac rehabilitation
3. deemed unsafe to participate in exercise by cancer nurses during screening
4. severe cognitive impairment
5. unable to communicate in English (no funds available in study for translation services)
Participants Number randomised: 41; 21 intervention, 20 usual care
Baseline imbalances: Seven (33.3 %) participants allocated to intervention group and four (20%) al-
located to the usual care group were classified as T3. More participants allocated to the intervention
group had laparoscopic surgery (n = 6) (28.8%) versus n = 3 (15%)). Four (19%) participants allocated to
the intervention group had a temporary stoma or permanent stoma, versus nine (45%) in usual care (no
rehabilitation)
Withdrawals and exclusions:
Follow-up 1; missing 10 participants questionnaire data, and 18 participants accelerometer data
Hubbard 2016 
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Follow-up 2; missing 16 participants questionnaire data, and 27 participants accelerometer data
Age, mean (SD):
66 (11.31) years
Control, 64.2 (11.10) years








Colorectal cancer stage: T 0-4, N 0-1, M0
Type of treatment, n, (%):
Colon surgery, yes 25 (61%), no 16 (39%)
Rectal surgery, yes 16 (39%), no 25 (61%)
Laparoscopic surgery, yes 9 (22%), no 18 (43.9%)
Chemotherapy, missing 7 (17.1%), no 27 (65.9%), yes 7 (17.1%)
Radiotherapy, missing 7 (17.1%), no 29 (70.7%), yes 5 (12.2%)
Other treatment, missing 3 (7.3%), no 35 (85.4%), yes 3 (7.3%)
Receiving or finished treatment: both
Time beyond treatment: postsurgery (in recovery period), exact time not reported
Time since diagnosis: not reported
Interventions Physical activity description
Frequency: site 1 & 2 once weekly, site 3 twice weekly exercise
Intensity: not reported
Time: 60–90 min educational sessions
Type: cardiac rehabilitation exercise classes of aerobic and strength training
Volume: not reported
Progression: not reported
Length of programme: varied depending on site (site one: 1 hour class over 10 weeks, site two 12
weeks, site 3 twice weekly over 6 weeks)
Control group: usual care patients were given a booklet by Bowel Cancer UK (a cancer charity)—Staying
healthy after bowel cancer
Setting: not reported
Supervised or self-directed: supervised
Co-interventions: weekly education sessions (e.g. diet, physical activity, relaxation/ stress management
and cardiac-specific sessions)
Outcomes 1. Feasibility and acceptability
2. Levels of physical activity (accelerometry, Scottish Physical Activity Questionnaire)
Hubbard 2016  (Continued)
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3. Quality of life (EQ5D, FACT-C)
4. Anxiety and depression (HADS)
5. Fatigue (FACIT-Fatigue)
6. Healthcare resource (seven-item self-report questionnaire developed by the research team for the
purposes for the study)
7. Physical activity self-efficacy (12- item questionnaire developed by investigators of the Act Well trial
8. Risk perception (operationalisation of the concept in the context of behaviour change research)
Time points measured: baseline, weeks 6, 10, 12 (depending on site), second follow-up assessment was
approximately 3 months after the participant had finished cardiac rehabilitation
Time points reported: baseline, up to 12 weeks, 3 months after completion of Cardiac rehabilitation
Adverse events: no adverse events occurred
Notes Funding source: National Institute for Health Research—Health Service and Development Research
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk An automated online randomisation system was used
Allocation concealment
(selection bias)





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes





High risk Due to missing data at follow-up time points. Time point 1: attrition 24% and
43% for subjective and objective measures respectively. Time point 2: attrition
39% and 65% for subjective and objective measures, respectively.
Selective reporting (re-
porting bias)
High risk Some outcomes described in methods section have not been reported





Methods Study design: RCT
Study location: Korea
Inclusion criteria:
1. between 18 and 75 years of age
2. confirmed stage II to III CRC
3. completed surgery, radiotherapy, and/or chemotherapy within four weeks to two years prior to study
enrolment
Kim 2018 
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4. ECOG performance status of 0 or 1




3. any condition that would make them unsuitable for the study
Participants Number randomised: 71 (37 intervention, 34 usual care)
Baseline imbalances: no significant difference at baseline






male control 17 (50%)




Income > USD 3000/month control (38.2%) intervention (54.1%)
Married control (79.5%) intervention (75.7%)
Completed university control (32.4%) intervention (51.4%)
Cancer type, n (%):
colon control (55.9%) intervention (73%)
rectal control (44.1%) intervention (27%)
Colorectal cancer stage:
stage II-III;
stage II control (35.3%) intervention (56.8%)
stage III control (64.7%) intervention (43.2%)
Type of treatment, n (%):
chemotherapy 98 (80.3%)
chemo+radiotherapy 13 (10.7%)
Receiving or finished treatment: finished
Time beyond treatment, mean (SD):
control 10.6 months (8.4) intervention 10.8 months (5.8)
Time since diagnosis: not reported
Interventions Physical activity description
Kim 2018  (Continued)
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Frequency: not reported 
Intensity: moderate and vigorous intensity
Time: not reported 
Type: aerobic and resistance home-based exercise e.g. brisk walking,
hiking and stationary bike riding were recommended for
aerobic exercise 30 min resistance exercise (12-15 reps) DVD provided
Volume: weeks 1-6 18 MET/hours per week
progression: after week 6 increase to 27 MET hours per week
Length of programme: 12 weeks
Control group: usual care
Setting: home-based with four meetings with exercise trainer, telephone calls and small group sessions
Supervised or self-directed: self-directed, physical activity logs checked by exercise specialists
Co-interventions: none
Outcomes 1. Quality of life
Secondary outcomes:
2. Fatigue
3. Levels of physical activity
4. Anthropometric measurements
5. Levels of physical activity
Time points measured: baseline and 12 weeks
Time points reported: baseline and 12 weeks
Adverse events: not reported
Notes Funding source: not described
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A computer-generated random number sequence was used
Allocation concealment
(selection bias)





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes




Low risk Attrition 18.9% in intervention and 17.6% in control group. Exclusions report-
ed with reasons. ITT analysis conducted
Selective reporting (re-
porting bias)
Low risk There appears to be no selective reporting of outcomes
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Methods Study design: RCT
Study location: South Korea
Inclusion criteria:
1. resident of Seoul or Gyeonggi-do
2. between 18 and 75 years of age
3. confirmed stage II to III CRC
4. completed surgery, radiotherapy, and/or chemotherapy within four weeks to two years prior to study
enrolment
5. ECOG performance status of 0 or 1
6. ability to understand and provide written informed consent
7. not planning extended absences in the three months subsequent to enrolment
Exclusion criteria:
1. evidence of recurrent or metastatic disease
2. participation in regular structured physical activity at moderate-intensity exceeding 200 min/week
3. pregnant or planning to be pregnant within six months
4. we additionally excluded ostomy patients due to lack of evidence in safety of strength training
Participants Number randomised: 123; (62 intervention; 61 usual care)
Baseline imbalances: no significant difference at baseline








male control 28 (45.9%)
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Type of treatment, n (%):
chemotherapy 98 (80.3%)
chemo+radiotherapy 13 (10.7%)
Receiving or finished treatment: finished
Time beyond treatment, mean (SD):
9.8 (6.3) months
Time since diagnosis: not reported
Interventions Physical activity description:
Frequency: encouraged to do 10,000 steps daily and daily resistance exercise programme
Intensity: of these 10,000 steps, participants were asked to complete
3000 steps as exercise that increased their heart rate up to 65%
of their age-predicted maximum heart rate
Time: not reported 
Type: aerobic and resistance home-based exercise e.g. brisk walking,
hiking and stationary bike riding were recommended for
aerobic exercise 30 min resistance exercise using
their own body weight that could be performed daily at home
Volume: weeks 1-6 18 MET/hours per week
progression: after week 6 increase to 27 MET hours per week
Length of programme: 12 weeks
Control group: usual care
Setting: home based with three sessions in hospital based clinic
Supervised or self-directed: self-directed, physical activity logs checked by exercise specialists
Co-interventions: none





5. Levels of physical activity
Time points measured: baseline and 12 weeks
Time points reported: baseline and 12 weeks
Adverse events: not reported
Notes Funding source: National R&D programme for cancer control and the national research foundation of
Korea
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Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated random number sequence was used
Allocation concealment
(selection bias)





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes








Low risk There appears to be no selective reporting of outcomes






Methods Study design: RCT
Study location: UK
Inclusion criteria:
1. a histologically confirmed diagnosis of colorectal cancer with Dukes stages A-C
2. completed cancer treatment within the last 24 months (later increased to 3 years)
3. be able to understand spoken and written English score of 80 or more on the Karnofsky Performance
Status Scale
Exclusion criteria:
1. already meeting general physical activity guidelines of 150 min of moderate physical activity or 75
min of vigorous intensity physical activity per week




Participants Number randomised: 28; 14 control; 14 intervention
Baseline imbalances: no significant difference between groups at baseline
Withdrawals and exclusions:
Lewis 2016 
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Control; 3 dropouts (two at three months, one at six months)
Intervention: 5 dropouts (two at three months, three at six months)
Age, mean (SD):




Control: 7 male, 7 female





Colorectal cancer stage: Dukes A-C
Type of treatment, n (%):
Surgery; 28 (100%)
Chemotherapy; 10 control (71%), 2 intervention (14%)
Receiving or finished treatment: finished treatment
Time beyond treatment: within three years of completion of treatment
Time since diagnosis, months: control 13, intervention 12 months
Interventions Physical activity description
Frequency: supervised exercise sessions took place twice per week for the first four weeks. This was ta-
pered oJ to once per week for the second four weeks. During the last month of the intervention partici-
pants continued with the exercise at home
Intensity: moderate and vigorous
Time: not reported
Type: not reported
Volume: encouraged to achieve 150 min of moderate to vigorous physical activity per week
Progression: not reported
Length of programme: supervised exercises for three months
Control group: encouraged to continue with their usual lifestyle habits. Supervised exercise sessions
were offered after their last appointment
Setting: home and supervised
Supervised or self-directed: both
Co-interventions: none
Outcomes 1. Moderate and vigorous intensity physical activity (International Physical Activity Questionnaire long
version and accelerometry)
2. Behavioural regulation (Behavioural Regulation in Exercise Questionnaire version 2)
Lewis 2016  (Continued)
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3. Psychological needs satisfaction (psychological needs satisfaction in exercise scale)
4. QoL (FACT-G, FACT-C)
5. Fatigue (FACT-F)
6. Intention to exercise (Intention to exercise scale)
7. Barriers to exercise (Barriers to Exercise scale)
8. Physical fitness (treadmill test)
9. Upper body strength (grip strength, arm-curl test, 30-Second Chair Stand Test)
10. Body composition (Bioelectrical impedence, waist and waist to hip ratio, height weight, BMI)
Time points measured: baseline, 3 and 6 months
Time points reported: baseline, 3 and 6 months
Adverse events: exercise was deemed safe; there were no adverse events throughout the intervention
Notes Funding source: University of East Anglia
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Participants randomised using computer generated list (nQuery software)
Allocation concealment
(selection bias)
Low risk A person independent of the research team kept the randomisation sequence.
After the completion of the baseline assessments, the research team phoned





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes









Low risk Clinical trial registry outcomes are consistent with those reported in publica-
tion
Other bias Low risk The study appears to be free of other problems that could put it at a high risk





Methods Study design: RCT
Study location: Northern Ireland
Inclusion criteria:
McDermott 2017 
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1. Dukes A-C colorectal cancer patients at least 6 weeks post any type anticancer treatment, as identi-
fied by the colorectal oncologic and surgical teams.
2. males and females over 18 years of age
3. physically able to undertake the intervention
4. ambulatory and without use of a walking aid
Exclusion criteria:
1. still undergoing and/or scheduled for further anti-cancer treatment
2. any presence of cognitive impairment
3. pregnant or possibility of being pregnant
4. known comorbidities which would severely impact upon physical functioning or nutritional status
5. already meeting the current recommended physical activity guidelines
6. unable to understand and communicate in written and oral English
Participants Number randomised: 23; 11 control; 12 intervention
Baseline imbalances: mean weight and hip circumference, FACT-C and FACIT-F results were significantly
higher in the intervention group. Fatigue scores were significantly lower in the intervention group
Withdrawals and exclusions: 3 dropouts before week 12 (2 control; 1 intervention), 1 further dropout in
intervention group at week 24
Age, mean (SD): total 63 (9) years; control 62.6 (9.1) intervention 63.6 (9.5)
Gender n (%):
Male; 6 (54.5%) control; 10 (83.3%) intervention




Professional: 5 (45.5%) control; 5 (41.6%) intervention
Managerial: 0 control; 3 (25%) intervention
Clerical; 1 (9%) control; 2 (16.7%) intervention
Manual; 5 (45.5%) control; 2 (16.7%) intervention
Cancer type: colorectal
Colon; 9 (81.8%) control; 8 (66.7%) intervention
Rectal; 2 (18.2%) control; 4 (33.3%) intervention
Colorectal cancer stage:
1a: 0 control; 1 (8.3%) intervention
2a/2b: 6 (54.5%) control; 7 (58.3%) intervention
3a/3b/3c: 5 (45.5%) control; 4 (33.3%) intervention
Type of treatment:
Surgery only: 1 (18.2%) control; 4 (33.3%) intervention
Surgery and chemotherapy; 8 (72.7%) control; 6 (50%) intervention
Radio/chemo and surgery: 1 (9.1%) control; 2 (16.7%) intervention
Receiving or finished treatment: finished (at least 6 weeks post-treatment)
McDermott 2017  (Continued)
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Time beyond treatment: an average of 24 months post-treatment (25 (17) months in control group; 23
(19) months in the intervention group)
Time since diagnosis: not reported




Type: walking and strengthening intervention
Volume: not reported
Progression: aim to reach at least 150 minutes a week of moderate-intensity aerobic activity and
strengthening goal of 3 sets of 8-15 repetitions, 2-3 days a week
Length of programme: 12 weeks
Control group: usual care; participants will receive the intervention information on their last visit
Setting: home based
Supervised or self-directed: self-directed with weekly telephone calls
Co-interventions: none
Outcomes 1. Feasibility
2. Levels of physical activity (accelerometer)
3. Cardiovascular endurance (6-minute walk test)
4. Lower limb strength (timed sit to stand)
5. Quality of life (FACT-C, EQ5D-3L, PANAS)
6. Demographics
7. Anthropometric tests (BMI, height, weight, hip and waist measurements)
8. Biological markers (venous and capillary blood samples)
9. Fatigue (MFSI-SF)
Time points measured: baseline 12, 24 weeks
Time points reported: baseline 12, 24 weeks
Adverse events: not reported
Notes Funding source: University of Ulster
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk A random numbers table was used
Allocation concealment
(selection bias)





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes
High risk Researcher carrying out the outcome measures was aware of the participants
group allocation
McDermott 2017  (Continued)
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Low risk Outcomes reported are consistent with outcomes to be reported in clinical tri-
al register






Methods Study design: RCT
Study location: Iran
Inclusion criteria: not reported
Exclusion criteria: not reported
Participants Number randomised: 30; 15 control, 15 intervention
Baseline imbalances: no significant differences at baseline
Withdrawals and exclusions: three subjects in control group who did not participate in the final exami-
nations were excluded
Age, mean (SD): 51.56 (11.28) years





Colorectal cancer stage: stage I-III, confirmed via email from author
Type of treatment: surgery (no other treatment reported)
Receiving or finished treatment: not reported
Time beyond treatment: between 2 and 3 months postsurgery
Time since diagnosis: not reported
Interventions Physical activity description:
Frequency: 3 times per week
Intensity: 50% to 60% of target heart rate




Length of programme: 8 weeks
Nuri 2016 
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Control group: usual care
Setting: not reported
Supervised or self-directed: not reported
Co-interventions: participants completed the 3‑day diet recall forms and were instructed to maintain
normal dietary habits throughout the study
Outcomes 1. Leptin and ghrelin
2. Anthropometric and body composition measures (BMI, waist circumference, waist, hip ratio, fat
mass, lean mass)
3. Metabolic characteristics (glucose, insulin, HOMA-IR)
4. Composition of subjects' diets
5. Physical fitness: Rockport one mile fitness walking
Time points measured: baseline, 8 weeks and 9 weeks (i.e. after 1 week of detraining)
Time points reported: baseline, 8 weeks and 9 weeks (i.e. after 1 week of detraining)
Adverse events: not reported
Notes Funding source: not reported
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Method of randomisation not reported
Allocation concealment
(selection bias)





High risk Insufficient information available to permit a judgement but probably 'high
risk'
Blinding of outcome as-
sessment (detection bias)
All outcomes





Low risk 20% attrition
Selective reporting (re-
porting bias)
High risk Some outcomes described in methods section have not been reported






Methods Study design: RCT
Pinto 2013 
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2. stage 1-3 colorectal cancer
3. finished treatment surgery and/or adjuvant therapy
4. less than 5 years postdiagnosis
5. English speaking
6. access to a telephone
7. CVD or diabetes with consent
Exclusion criteria:
1. prior history of cancer
2. medical or current psychiatric illness (e.g. orthopaedic problems) that could make compliance with
the study protocol difficult or unsafe
Participants Number randomised: 46; 20 to physical activity group, 26 to control group
Baseline imbalances: more people in employment in the control group
Withdrawals and exclusions: 4 withdrew; 1 in physical activity group, 3 in control group
Age: 57.3 years (SD 9.7); intervention 55.6 (8.24) control 59.5 (11.2)
Gender: male and female (57%)
Ethnicity: majority white
Comorbidities: not reported
SES: majority attended college and had a median household income of USD 60,000
Cancer type: colorectal cancer; 57% colon cancer, 43% rectal cancer
Cancer stage: stage I-III
Type of treatment: 100% surgery or surgery with adjuvant therapy 20/46 radiotherapy; 38/46
chemotherapy
Receiving or finished treatment: finished
Time beyond treatment: < 5 years since completion of treatment
Time since diagnosis: mean 2.99 years since diagnosis
Interventions Physical activity description:
Frequency: encouraged 10 minutes at least 2 days per week for three weeks, goals were increased over
the 12 weeks to 30 minutes a day, 5 days per week
Intensity: moderate 64% to 76% estimated heart rate max
Type: e.g. brisk walking, biking, home-based exercise equipment
Length of intervention: 12 weeks
Control group: contact control group (received weekly calls to match frequency of contact with physi-
cal activity group and survivorship tip sheets)
Setting: home based
Supervised or self-directed: self-directed
Co-interventions: none
Pinto 2013  (Continued)
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Outcomes 1. Levels of physical activity (7-day recall, Community Healthy Activities Model Program for Seniors, ac-
celerometry),
2. Movement to action/maintenance stage of motivational
readiness,
3. Submaximal aerobic fitness (Treadwalk test)
4. Psychological outcomes (FACT-C)
5. Fatigue (FACT-F)
6. Anthropometric measurements (height, weight, BMI)
Time points measured: baseline, 3, 6 and 12 months
Time points reported:
Adverse events: not reported
Notes Funding source: National Cancer Institute
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Unclear risk Not described
Allocation concealment
(selection bias)





High risk Not possible to blind participants and personnel
due to the nature of the intervention
Blinding of outcome as-
sessment (detection bias)
All outcomes





Low risk Reasons for missing outcome data were described (9% attrition)
Selective reporting (re-
porting bias)
Low risk Outcomes reported are consistent with study protocol





Methods Study design: RCT
Study location: USA
Inclusion criteria:
1. stage II-III colon or rectal cancer then expanded to include stage I and stage IV
2. previous completion of cancer-directed therapy ≥ 3 months and < 2years prior to enrolment (time af-
ter completion of treatment was dropped)
Van Blarigan 2019 
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3. disease free status at enrolment
4. ability to reliably access the Internet and a mobile phone and navigate websites
5. ability to speak and read English
Exclusion criteria:
1. any of 19 specific contraindications to moderate-to-vigorous physical activity
2. very active at baseline (defined as engaging in exercise for ≥ 30min for ≥ 5days a week)
Participants Number randomised: 42; 21 to intervention group, 21 to control group
Baseline imbalances: control group more active than intervention group
Withdrawals and exclusions: 0 lost to follow-up in intervention group, 2 in control group
Age: 54 years (SD 11); intervention 56 (12); control 54 (11)
Gender: male (41%) and female (59%)
Ethnicity: white (73%), African American/black (2%), Asian (12%), other (12%)
Comorbidities: not reported
SES: college degree (93%), employed (63%)
Cancer type: colon (56%), rectal (44%)
Cancer stage: stage I (20%), II (20%), III (59%), IV (2%)
Type of treatment: 100% surgery or surgery with adjuvant therapy 20/46 radiotherapy; 38/46
chemotherapy
Receiving or finished treatment: finished
Time beyond treatment: not reported
Time since diagnosis: mean 1.5 years (SD 1.5)
Interventions Physical activity description
Frequency: encouraged to build up to 150 mins per week of moderate activity or 75 min per week of
vigorous activity
Intensity: moderate or vigorous
Type: e.g. brisk walking, biking, jogging, resistance exercise
Length of intervention: 12 weeks
Control group: received printed educational material about exercise after cancer
Setting: home based
Supervised or self-directed: fit bit flex, daily text messages and counselled through print materials
Co-interventions: none
Outcomes 1. Levels of physical activity (Actigraph),
2. Fitbit wear time (# days with data / # days of observation),
3. Response to text messages (# of messages responded to / # of messages that asked for a response),
Time points measured: baseline and 12 weeks (adverse events measured at baseline 4, 8 and 12 weeks)
Time points reported: baseline, 12 weeks
Van Blarigan 2019  (Continued)
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Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer-generated randomisation scheme was used
Allocation concealment
(selection bias)
Unclear risk Whether the treatment assignment was concealed from study personnel and





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes








High risk Some outcomes described in methods section have not been reported





Methods Study design: RCT
Study location: The Netherlands
Inclusion criteria:
1. a histological diagnosis of colon cancer less than 10 wk before study recruitment
2. stage M0
3. scheduled for chemotherapy
4. age 25 to 75 yr
5. able to read and understand the Dutch language
6. Karnofsky Performance Status of 60 or higher
7.able to walk 100m or more
Exclusion criteria:
1. the presence of contraindications for physical activity (as assessed through the Revised Physical Ac-
tivity Readiness Questionnaire)
2. treatment for cancer in the 5 years preceding recruitment (except for basal skin cancer)
Participants Number randomised: 33; 17 intervention, 16 control
Van Vulpen 2016 
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Baseline imbalances: participants in the intervention group were, on average, shorter and heavier
Withdrawals and exclusions: 5 lost to follow-up; 3 in control group, 2 in intervention group
Age, mean (SD):
Total mean age 58.1; intervention 58.1 (10.3); control 58.1 (9.6)
Gender, n (%):
Male; 11 (68.8%) control; 10 (58.8%) intervention




High-income; 9 (56.2%) control; 8 (47.1%) intervention
Married; 11 (68.8%) control; 12 (70.6%) intervention
Education; low; 3 (18.8%) control; 1 (5.9%) intervention; medium; 4 (25.0%) control; 7 (41.2%) interven-
tion; high; 9 (56.2%) control; 8 (47.1%) intervention; unknown 1 (5.9%) intervention
Cancer type: colon
Colorectal cancer stage: stage M0
Type of treatment: 100% received surgery, 100% received chemotherapy, 18.4% received radiotherapy
Receiving or finished treatment: 81.8% undergoing chemotherapy
Time beyond treatment: majority receiving treatment
Time since diagnosis: diagnosis of colon cancer less than 10 weeks before study recruitment
Interventions Physical activity description:
Frequency: supervised (2 times per week), unsupervised (3 times per week)
Intensity: based on heart rate at ventilatory threshold and Borg
Time: supervised (1-hour session) unsupervised (30 mins)
Type: supervised - aerobic and muscle strengthening exercise (all large muscle groups)
Volume: not reported
Progression: the muscle strengthening training started with 2 x 10 repetitions (65% 1-repetition maxi-
mum (RM) and gradually increased to reach 1 x 10 repetitions (75% 1-RM) and 1 x 20 repetitions (45% 1-
RM)) by the end of the programme
Length of programme: 18 weeks
Control group: were instructed to maintain their usual physical activity pattern.
Setting: not reported
Supervised or self-directed: both
Co-interventions: none
Outcomes 1. Fatigue (Multidimensional Fatigue Inventory (MFI) and the Fatigue Quality List)
2. QoL, anxiety, and depression: (EORTC QLQ-C30), and a general measure of QoL, SF-36 and (HADS)
3. Physical fitness (peak oxygen uptake (VO2peak)-Cardiopulmonary exercise test, anthropometry
(bodyweight and height)
4. Chemotherapy completion rate: weeks
5. Adherence (attendance percentage of the total offered class)
6. Physical activity level (short questionnaire to assess health-enhancing physical activity)
Time points measured: baseline, 18 and 36 weeks
Van Vulpen 2016  (Continued)
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Time points reported: baseline, 18 and 36 weeks
Adverse events: no serious adverse events related to exercise were observed during the study period
Notes Funding source: The Netherlands Organisation for Health Research and Development, the Dutch Can-
cer Society and the Dutch Pink Ribbon Foundation
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)
Low risk Computer generated randomisation was used
Allocation concealment
(selection bias)






High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes





Low risk Attrition balanced across groups, attrition (16%) and exclusions were reported
with reasons. ITT analysis conducted
Selective reporting (re-
porting bias)
Low risk Outcomes reported are consistent with those in study protocol






Methods Study design: RCT
Study location: The Netherlands
Inclusion criteria:
1. there was no upper age limit
Exclusion criteria:
1.serious orthopedic, cardiovascular, or cardiopulmonary conditions
2. were suffering from malnutrition
3. had serious psychiatric or cognitive problems
4. did not have basic fluency in Dutch
Participants Number randomised: 23; 7 on-track, 8 onco-move, 8 usual care
Waart 2017 
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Baseline imbalances: participants in onco-move were more frequently male, had lower education and
more often received laparoscopic surgery while participants in on-track had less comorbidity. Partici-
pants in onco-move tended to have higher physical fitness levels than those in on-track or usual care
Withdrawals and exclusions: on-track (n = 7) T2: 1 missing onco-move (n = 8)
T1 (1 missing for questionnaires, 2 missing physical performance tests) same at T2
UCC (n = 8) T1 (1 missing for questionnaires, 2 missing physical performance tests) T2 (none missing for
questionnaires, 2 missing for physical performance tests)
Age, mean (SD):
Total 58.2 (10.1) years
On-track; 57.7 (13.2) years
Onco-move; 60.1 (7.3) years
usual care; 56.7 (10.6)
Gender, n (%):
Total 14 (61%) female
On-track; 5 (71%) female
Onco-move; 3 (38%) female
Usual care; 6 (75%) female
Ethnicity: not reported
Comorbidities, n (%): 15 (65%) of total participants
SES, n (%):
Married 16 (70%) of total
College/university education 11 (48%) of total
Full or part-time work 8 (35%) of total
Cancer type: colon
Colorectal cancer stage: stage II 3 (13%); stage III 18 (78%); stage IV 2 (9%) - author contacted corre-
spondence received confirmed no stage IV patients were included
Type of treatment:
Larascopic surgery 12 (52%); control 2 (25%); on-track 4 (57%); onco-move 6 (75%)
Radiotherapy 1 (4%) control
Chemotherapy 23 (100%)
Receiving or finished treatment: receiving both interventions started with the first cycle of chemothera-
py and continued until 3 weeks after the last cycle
Time beyond treatment: N/A
Time since diagnosis: not reported
Interventions Physical activity description
Onco-move:
Frequency: 5 days a week
Intensity: low-intensity 12–14 on the Borg Scale of Perceived Exertion participants
Time: at least 30 min
Waart 2017  (Continued)
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Intensity: moderate- to high-intensity
Time: six large muscle groups were trained for 20 min per session in two series of eight repetitions at
80% of one-repetition maximum, 30 mins of aerobic exercises at an intensity of 50% to 80% of the pre-
dicted maximal workload of the steep ramp test. Were also encouraged to be physically active 5 days a
week for 30 min and to keep an activity diary
Type: resistance and aerobic exercise
Progression: the intensity was further adjusted using the Borg
Length of programme: started with the first cycle of chemotherapy and continued until 3 weeks after
the last cycle
Control group: usual care
Setting: onco-move was home based; on-track not specified
Supervised or self-directed: onco-move was unsupervised; on-track was partially supervised
Co-interventions: none
Outcomes 1. Cardiorespiratory fitness (steep ramp test)
2. Muscle strength (hand-held dynamometer for elbow flexion and knee extension and the Jamar grip
strength dynamometer, and lower-limb muscle endurance with the 30-s chair stand test)
3. Fatigue (MFI)
4. HRQoL (EORTC QLQ-C30)
5. Psychological distress (HADS)
6. Self-reported physical activity (Physical Activity Scale for the Elderly (PASE))
7. Exercise behaviour and attitudes (questions about exercise stage self-efficacy, social support bene-
fits barriers, and attitudes toward exercise during chemotherapy)
Time points measured: T0 baseline prior to chemotherapy,T1 at completion of chemotherapy, T2 6
months after completion of chemotherapy
Time points reported: as above
Adverse events: no adverse events occurred
Notes Funding source: funding PACES was supported by the Alpe d’HuZes/KWF Fund. The research grant was
provided by the Dutch Cancer Society and CZ Fund. The interventions were funded by Zilveren Kruis
Achmea and The Comprehensive Cancer Centre
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence genera-
tion (selection bias)




Unclear risk Whether the treatment assignment was concealed from study personnel and





High risk Not possible to blind participants and personnel due to the nature of the inter-
vention
Blinding of outcome as-
sessment (detection bias)
All outcomes
Unclear risk Insufficient information available to permit a judgement of ‘low risk’ or ‘high
risk’
Waart 2017  (Continued)
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Low risk Attrition (low) reported without reasons, however it is balanced across groups
Selective reporting (re-
porting bias)
High risk Study protocol included outcomes (anthropometric measurements, return to
work) data that are not presented in available reports
Other bias High risk Due to baseline imbalances alongside unclear allocation concealment
Waart 2017  (Continued)
BMI: body mass index; CES-D - Centre for Epidemiological Studies Depression Scale; CRC: colorectal cancer; CTCAE - Common Terminology
Criteria for Assessing Adverse Events; ECOG: Eastern Oncology Cooperative Group; EORTC QLQ-C30 - European Organisation for Research
and Treatment of Cancer Quality of life; EQ-5D: EuroQol five-dimension scale; FACIT-F - Functional Assessment of Chronic Illness Therapy-
Fatigue; FACT-C - Functional Assessment of Cancer Therapy-Colorectal; FACT-F - Functional Assessment of Cancer Therapy-Fatigue; FACT-G
- Functional Assessment of Cancer Therapy-General; HADS - Hospital Anxiety and Depression Scale; ITT: intention-to-treat; MET: metabolic
equivalents; MFSI-SF: Multidimensional Fatigue Symptom Inventory- Short Form; PANAS - Positive and Negative AJect Scale; PSQI:
Pittsburgh Sleep Quality Index; QoL: quality of life; RCT: randomised controlled trial; SD: standard deviation; SES: socioeconomic status;
SF-36 - Medical Outcomes Study Short Form-36 General Health Survey; STAI: State trait anxiety inventory; TOI: trial outcome index; TPAQ
- Tartu Physical Activity Questionnaire; UICC: Union for International Cancer Control; UK: United Kingdom; USA: United States of America
 
Characteristics of excluded studies [ordered by study ID]
 
Study Reason for exclusion
ACTRN12618001855213 Wrong intervention
Adamsen 2009 Wrong patient population (includes advanced disease and a range of cancer diagnoses)
Adlard 2016 Wrong comparator (moderate- versus high-intensity exercise)
Ahn 2013 Intervention was too short (less than 4 weeks in duration)
Allgayer 2004b Intervention was too short (less than 4 weeks in duration)
An 2012 Intervention was too short (less than 4 weeks in duration)
Anderson 2010 Wrong study design (not a randomised controlled trial)
Arving 2013 Wrong intervention (stress management intervention) for people with a range of cancer diagnoses
Backman 2014 Wrong patient population (includes patients with advanced disease) emailed no reply
Basen-Engquist 2015 Wrong patient population (advanced colorectal cancer)
Beck 2015 Wrong patient population (only one CRC patient included)
Beeken 2016 Wrong intervention (lifestyle advice on a range of behaviours) for people with a range of cancer di-
agnoses
Bennett 2007 Wrong patient population (majority breast cancer patients, other cancer types not specified)
Berntsen 2017 Wrong comparator (moderate- versus high-intensity exercise)
Broderick 2014 Did not analyse CRC patients separately
Buffart 2014 Did not analyse CRC patients separately
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Study Reason for exclusion
Burnham 2002 Did not analyse CRC patients separately
ChiCTROON15005952 Wrong study design (not a randomised control trial)
Demark-Wahnefried 2012 Wrong patient population (greater than or equal to 5 years postdiagnosis)
DeTroye 2018 Wrong study design
Devin 2016 Wrong comparator (moderate- versus high-intensity exercise)
Dimeo 2004 Intervention too short (less than 4 weeks in duration)
Dodd 2010 Wrong patient population (only one CRC patient included)
DRKS00005793 wrong comparator (both arms received exercise training)
Eakin 2015 Wrong study design (non-randomised trial)
Forbes 2017 CRC patients not analysed separately - email confirming this
Freitag 2018 Wrong study design
Gabrys 2017 Wrong study design (non-randomised trial)
Gillis 2014 Wrong comparator (prehabilitation versus rehabilitation)
Gray 2013 Intervention was too short (less than 4 weeks in duration)
Grimmett 2015 Wrong study design (feasibility study: non-randomised)
Hawkes 2014 Wrong Intervention (multiple health behaviour change intervention)
Hernon 2016 Wrong patient population (exercise delivered prior to surgery)
Hung 2016 Wrong intervention
Ibfelt 2011 Intervention was too short (6-day retreat) and focused on multiple health behaviours
ISRCTN56928944 Intervention was too short (less than 4 weeks in duration)
ISRCTN62859294 Wrong patient population (exercise intervention delivered prior to surgery)
ISRCTN96374224 Wrong intervention (multiple components: lifestyle and well-being support)
Kalter 2015 CRC not analysed separately
Kampshoff 2015 Did not analyse CRC patients separately
Kanera 2017 Wrong intervention (multiple health behaviour change intervention)
laStayo 2011 Wrong patient population (> 5 years postdiagnosis)
Lee 2013 Wrong comparator (both arms received exercise training)
Lee 2018a Dietary co-intervention included
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Study Reason for exclusion
Ligibel 2012 Did not analyse CRC patients separately "the majority of our participants were breast cancer sur-
vivors. We were thus not able to conduct a separate analysis in the colorectal cancer subgroup"
Lin 2011 Wrong comparator (both arms received exercise training)
Lin 2014 Wrong study design (non-randomised trial)
Lin 2016 Wrong intervention
Loughney 2014 Wrong patient population (exercise delivered prior to surgery)
Lyons 2017 Wrong patient population (CRC patients not included)
Macleod 2018 Wrong intervention
Mayer 2017 Wrong comparator (control group received a pedometer)
McCall 2015 Wrong comparator (all arms received the yoga intervention)
Meyerhardt 2017 Outcomes not relevant (email received "Only 40% of participants were colorectal and the end
points were all blood based markers so not sure if this will help your analysis")
Midtgaard 2011 Did not analyse CRC patients separately (email confirmation received)
Min 2017 intervention was too short (less than 4 weeks in duration)
Morielli 2018 Wrong intervention
NCT00373022 Wrong comparator (all arms received physical activity)
NCT00977613 Wrong study design (not a randomised controlled trial)
NCT00985400 Wrong patient population (includes stage IV patients)
NCT01032590 Wrong patient population (includes CRC > 5 years postdiagnosis)
NCT01146769 Wrong intervention
NCT01210313 Wrong study design (observational)
NCT01325909 Wrong study design (non-randomised trial)
NCT01453452 Wrong study design (non-randomised trial)
NCT01991847 Wrong study design (non-randomised trial)
NCT02052050 Wrong study design (non-randomised trial)
NCT02056691 Wrong study design (non-randomised trial)
NCT02264496 Wrong patient population (exercise delivered prior to surgery)
NCT02442583 Wrong study design (non-randomised trial)
NCT02512263 Study was not carried out
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Study Reason for exclusion
NCT02522520 Wrong comparator (both arms received a pedometer intervention)
NCT02586701 Wrong comparator (both arms received exercise training)
NCT02647398 Wrong comparator (both arms received exercise)
NCT02677389 Wrong comparator (both arms received physical activity)
NCT02837159 Study has been suspended due to financing issues
NCT02889276 Wrong comparator (both arms received physical activity)
NCT03036436 Wrong study design (non-randomised trial)
NCT03082495 Wrong patient population (exercise during neoadjuvant treatment)
NCT03120104 Wrong comparator
NCT03232814 Wrong study design (non-randomised trial)
NCT03630354 Wrong comparator
NTR6383 Wrong intervention
Oh 2008 Wrong intervention and wrong patient population (mixed cancer diagnoses - three CRC patients in-
cluded, all in the control arm)
Onerup 2017 Wrong patient population (exercise intervention delivered pre- and postsurgery)
Phipps 2018 Wrong study design
Piringer 2013 Wrong study design (non-randomised trial)
Piringer 2018 Wrong study design
Ratjen 2018 Wrong intervention
Ray 2018 Wrong study design
Sandler 2017 Wrong intervention (intervention group received CBT along with exercise) mixed cancer diagnoses
Sellar 2014 Wrong study design (non-randomised trial)
Sohl 2016 Intervention was too short (less than 4 weeks in duration)
Sprod 2015 Wrong patient population (less than 3% of patients had gastrointestinal cancers)
Ungar 2016 Wrong comparator
van Rooijen 2018 Wrong study design
Wang 2012 Intervention was too short (less than 4 weeks in duration)
West 2015 Wrong patient population (exercise intervention delivered prior to surgery)
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Study Reason for exclusion
Zopf 2018 Wrong study design
 
Characteristics of studies awaiting classification [ordered by study ID]
 
Methods RCT
Participants 57 patients (age 24 to 73 years) who had received chemotherapy for lymphomas, breast, gynaeco-
logic, testicular, or colorectal cancer (8 CRC participants)
Interventions Intervention details: 18-week high-intensity strength training programme in cancer survivors
Comparator details: standard care
Outcomes 1. Muscular strength (1-repetition maximum)
2. Cardiopulmonary function (VO2 max)
3. Maximal short exercise capacity (MSEC)
4. Body composition
5. Health-related quality of life (HRQOL)





Participants 510 prostate and colorectal cancer patients (during treatment or up to 1 year post-treatment)
Interventions Intervention details: onco-active (computer-tailored physical activity intervention participants re-
ceived tailored advice at 3 time points, a pedometer and access to interactive content on the web-
site)
Comparator: usual care waiting list control
Outcomes 1. Physical activity behaviour (self-report Short Questionnaire to Assess Health Enhancing Physical
Activity (SQUASH) and accelerometer data) intention be physically active,
2. HRQoL (EORTC QLQ-C30)
3. Fatigue (Checklist Individual Strength)





Participants 222 colorectal cancer patients who completed curative treatment without evidence of recurrence
will be recruited into the study
Ho 2013 
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Interventions intervention:
Arm 1: dietary intervention (< 5 servings of red/processed meat weekly, 2 servings of refined grains
daily)
Arm 2: physical activity intervention (general health target - 30 minutes moderate to vigorous phys-
ical activity, 5 days per week (i.e. 10 MET-hours/week); cancer outcome target - 60 minutes of mod-
erate to vigorous physical activity 5 days per week (i.e. 18-20 MET-hours/week))
Arm 3: dietary and physical activity intervention (meeting both physical activity and dietary tar-
gets)
comparator: usual care
Outcomes 1. Whether physical activity and dietary targets are met
2. Magnitude and mechanism of behavioural change
3. The degree and determinants of compliance
4. The additional health benefits and side effects of the intervention






Participants 119 patients with colorectal cancer (96), diverticulitis (7) and non-malignant disease (16)
Interventions Intervention details: demanding exercises covering mobilisation, strength training of upper and
lower extremities, and aerobic training
comparator: performed relaxation exercises and received hot wrappings and massage
Outcomes 1. Fatigue (visual analogue scale)
2. Muscular strength
3. Walking speed
4. Physical performance test
5. Physical function questions (SF-36)





Participants Adults with CRC, Duke stage A-C2, completed surgery in the past 12 months
Interventions Intervention details: physical activity consultation after baseline (lasting 1-2 hours) and one at 3
months
ISRCTN07465566 
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Comparator: usual care
Outcomes 1. Feasibility (measured by rates of recruitment, completion, adherence),
2. Change in physical activity (Actigraph)
3. Mental well-being (HADS)
4. QoL (FACT-G and FACT-C)
5. Body composition
6. Predictors of change in physical activity
7. Perceptions of cancer risk in partners
8. Fear of cancer recurrence
9. Key components of the revised theory of planner behaviour will be measured in individuals living
with colorectal cancer and their partner.
10. The quality of the relationship between the individual living with cancer and their partner will
be measured to test if it affects adherence to the physical activity intervention or moderates any of
the intervention effects





Participants 460 cancer patients receiving chemotherapy representing a range of cancer diagnoses (15 colon
cancer, 6 rectal/anal cancer)
Interventions Intervention details:
arm 1: stress management
arm 2: exercise (participants were advised to participate in home-based exercise 3–5 times per
week for 20 to 30 min at approximately 50% to 75% of their estimated heart rate reserve)
arm 3: combined stress management and exercise
comparator: usual care
Outcomes 1. Mental and physical well-being
2. Depression and anxiety
3. Exercise
4. Stress reduction activity






Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-
advanced colorectal cancer (Review)









Cochrane Database of Systematic Reviews
Participants 72 colon and rectal cancer patients (38 intervention; 34 usual care)
Interventions Home-based six-week exercise programme





4. Levels of physical activity
Time points measured: baseline and 12 weeks
Time points reported: baseline and 12 weeks
Adverse events: not reported
Notes Emailed author to clarify if participants in this study are the same as participants in Kim 2018. If not





Participants Colorectal or endometrial cancer patients at cardiovascular risk
Interventions Intervention details: a wearable tracker, two group sessions and a support phone call
Comparator: received printed materials describing physical activity guidelines









Participants breast or colon (33%) cancer patients
Interventions Intervention details
arm 1: 12-week hospital-based, supervised group exercise intervention of moderate- to high-inten-
sity three times weekly, health promotion counselling and symptom management coaching or
arm 2: 12 week home-based individual pedometer programme, health promotion counselling and
symptom management
Moller 2015 
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comparator: a control group
Outcomes 1. Maximal oxygen uptake (V02 peak)
2. Psychological well-being (HADS)
3. QOL (EORTC QLQ-C30)
4. General well-being (SF-36)
5. Perception of pain (Brief Pain Inventory)
6. Leisure time physical activity level (self-reported)
7. Motivational readiness and ability and barriers to engage in exercise activities ‘stages of motiva-
tional readiness’ ‘decisional balance’ and ‘exercise self-efficacy’ (using validated questionnaires),
8. Social support and network (Multidimensional Scale of Perceived Social Support)





Participants 42 CRC patients who had completed surgery for local stage disease and patients who had complet-
ed surgery and any adjuvant chemotherapy for locally advanced stage disease
Interventions Intervention details: home-based walking intervention (150 minutes per week)
comparator: usual care (waiting list control)
Outcomes 1. Cardiopulmonary fitness (V02 peak during CPET test)
2. Feasibility (inclusion rate, attrition rate, adherence)
3. Body composition (DXA scan)
4. Blood biochemistry (fasting blood samples)
5. Glycaemic control (oral glucose tolerance test)
6. Patient reported outcome measures (health-related quality of life by FACT-C, sleep quality by
Pittsburgh Sleep Quality Index and exercise motivation by Behavioral Exercise Regulations Ques-
tionnaire)
Notes The “Interval Walking in Colorectal Cancer” (I-WALK-CRC) study: design, methods and recruitment





Participants 27 CRC survivors (any stage)
Interventions Intervention details:
NCT02564835 
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arm 1: yoga programme - two 90-minute classes every week tor a total of 12 weeks
arm 2: physical activity - two 90-minute classes every week for a total of 12 weeks, nine resistance
exercises (e.g. squats) and 8 flexibility exercises (e.g. shoulder stretch) targeted for the whole body
as well as a brief warm up and cool down (walking)
comparator: usual care
Outcomes 1. Program evaluation (participant experience and satisfaction with the interventions)
2. Attention Network Test, attention and cognitive control (Digit Span, Digit Symbol Substitution
Test, Trail Making Test, Attentional Function Index),
3. Functional Assessment of Cancer Therapy - Cognitive Function
4. Pro-inflammatory Markers
5. attendance, Adherence and Attrition Log
6. Safety Log
7. Demographic and Medical Information Questionnaires
8. Profile of Mood States-Brief Form






Participants 162 early stage breast (n = 122, 75.3 %) and colorectal cancer survivors (n = 40, 24.7%) who com-
pleted primary and adjuvant treatments
Interventions Intervention details:
arm 1: oncologists’ exercise recommendation
arm 2: oncologists’ exercise recommendation with exercise motivation package (pedometer, exer-
cise education and exercise diary)
comparator: control
Outcomes 1. Amount of exercise participation (Godin LeisureTime Exercise Questionnaire)
2. Quality of life





Methods RCT? There is a control group and exercise group, report does not specify whether participants are
randomly allocated
Schulz 2002 
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Participants 49 colon cancer patients; 24 control, 25 intervention
Interventions Intervention details: ergometer exercise training performed once a day for approximately 40 min-
utes, 5 days per week for 5 weeks at a moderate training level
Comparator: control group
Outcomes 1. Psychological parameters (EORTC QLQ-C30, FPI-R)
2. Immunological parameters





Participants 112 females with breast, lymphoma and colon cancer
Interventions Intervention details:
arm 1: 12 months, aerobic exercise, moderate-intensity home-based exercise 4 days per week. The
duration of each specific exercise programme ranged from 20 to 30 minutes
arm 2: 12 months, resistance exercise home-based exercise 4 days per week. The duration of each
specific exercise programme ranged from 20 to 30 minutes.
comparator: usual care control
Outcomes 1. Body weight
2. Aerobic capacity (12-minute walk)
3. Muscle strength (1-repetition maximum tests)
4. Body fat (dual energy x-ray absorptiometry scans)





Participants 128 postsurgical colorectal cancer patients; 65 control, 63 intervention
Interventions Intervention details: 12-week home-based moderate-intensity exercise programme
Comparator: usual care, maintained their normal daily activity
Outcomes 1. Fatigue
2. Psychological distress (depression)
Notes Emailed, no reply received
Shun 2016 
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BMI: body mass index; CRC: colorectal cancer; EORTC QLQ-C30 - European Organisation for Research and Treatment of Cancer Quality
of life; FACT-C - Functional Assessment of Cancer Therapy-Colorectal; FACT-G - Functional Assessment of Cancer Therapy-General; FPI-
R- Freiburg Personality Inentory; HADS - Hospital Anxiety and Depression Scale; HRQoL- health related quality of life; MET: metabolic
equivalents; QoL: quality of life; RCT: randomised controlled trial; SF-36 - Medical Outcomes Study Short Form-36 General Health Survey;
UTC- unable to contact
 
Characteristics of ongoing studies [ordered by study ID]
 
Study name The impact of resistance training combined with aerobic exercises on the functional recovery and
quality of life of colorectal cancer survivors postsurgeries
Methods Study design: Randomised parallel controlled trial
Country where study is being conducted: China
Participants Inclusion criteria:
1. clinically diagnosed as colorectal cancer in stage I to III by the TNM staging system
2. waiting for surgical treatment
3. willing to participate in the study
Exclusion criteria:
1. secondary or recurrent cancer
2. serious neurological or cardiovascular conditions (e.g. recent stroke)
3. severe mental or cognitive disorders
4. other illnesses and contraindications to exercise
Interventions Intervention details: postoperative cancer survivors in the experimental group would participate in
low-intensity resistance and aerobic exercise for 7 days, supervised by an experienced physiothera-
pist. And then the patients would follow a 12-week moderate- to high-intensity home exercise pro-
gramme
Comparator details: will only receive conventional treatment
Outcomes 1. The FACIT (Functional Assessment of Chronic Illness Therapy) measurement system
2. Six-minute walk test
3. muscle strength of major muscles in upper and lower limbs
Time points measured: day 1 preoperation, day 7 postoperation, month 3 postoperation
Starting date 18 May 2016
Contact information Yuling Wang
Tel: +86 13054445587
Email: wangyul@mail.sysu.edu.cn
Notes Trial registration identifier: ChiCTR-IOR-17012037
Trial registration link: http://www.chictr.org.cn/showprojen.aspx?proj=20476
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Study name Physical activity intervention for older patients during chemotherapy for colorectal cancer
Methods Study design: RCT
Country where study is being conducted: USA
Participants Inclusion criteria:
1. ≥ Age 60 years (no upper age limit)
2. Diagnosis of stage II-III colon or rectal cancer planned for treatment with adjuvant chemotherapy
scheduled as part of standard treatment
3. Able to read English
4. Approval from their treating physician to engage in moderate-intensity physical activity
5. Patient-assessed ability to walk and engage in moderate physical activity
6. Signed, IRB-approved written informed consent
Exclusion criteria:
1. Other active, invasive malignancy requiring ongoing therapy or expected to require systemic ther-
apy
2. Already walking or engaging in other physical activity > 120 minutes per week as documented via
subject self-report
3. Unable to walk or engage in moderate-intensity physical activity
4. One or more significant medical conditions that in the physician's judgment preclude participa-
tion in the walking intervention
Interventions Intervention details: participants will take part in the Walk With Ease (WWE) programme during the
course of their chemotherapy treatment. They will be requested to initiate the WWE starting on
Day 1 of adjuvant chemotherapy. Participants are asked to walk at a safe and comfortable pace, in-
creasing their minutes per day at a rate they can sustain, with the ultimate goal of 30 minutes/day
for at least 5 days/week. They are asked to maintain a daily walking log that is provided to them,
entering total minutes per day.
Participants will be asked to do the walking programme independently (self-directed, not in a for-
mal group with an instructor) throughout chemotherapy.
Comparator details: standard care
Outcomes Primary outcome measures:
1. change in fatigue (measured via PROMIS-Fatigue)
2. changes in physical function (measured via PROMIS-PF and SPPB)
3. adherence to the physical activity intervention (measured through self-reported minutes of walk-
ing per days and walking minutes per week)
4. difference in p16INK4a levels (change in p16INK4a and muscle mass measurements pre-/postad-
juvant chemotherapy)
5. change in muscle mass measurements (change in p16INK4a and muscle mass measurements)
6. association of p16INK4a and muscle mass with any differences in fatigue, physical function or QoL
during chemotherapy
7. quality of life (FACT-FCSI and PROMIS-PI)
8. changes in activities of daily living
9. changes in instrumental activities of daily living
10.changes in self-efficacy (measured by PSEFSM and OEE)
Time points measured: baseline, 3 months, and after completion of chemotherapy (24 weeks),
some outcomes measured at 1 year
NCT02191969 
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Starting date June 2014
Contact information Kirsten A Nyrop knyrop@med.unc.edu
Amy L Garrrett amy_garrett@med.unc.edu
Notes Trial registration identifier:NCT02191969
Trial registration link: https://clinicaltrials.gov/ct2/show/NCT02191969




Study name Exercise training for rectal cancer patients. A randomized controlled trial
Methods Study design: RCT
Country where study is being conducted: Norway
Participants 150 people with rectal cancer
Inclusion criteria:
1. Rectal cancer
2. Planned curative LAR with preoperative radiotherapy
3. Cancer stadium I-III
4. Able to speak and understand Norwegian
Exclusion criteria:
1. Previous radiotherapy
2. Previous pelvic surgery
3. Diseases affecting the anal sphincter
Interventions Intervention details: daily pelvic floor muscle training and individualised regular exercise training
(aerobic and strength exercise) three days per week.
Comparator details: standard care
Outcomes Primary outcome:
1. Anal incontinence (3 and 12 months postsurgery)
Secondary outcomes:
1. Urinary incontinence (3 and 12 months postsurgery)
2. Bowel and sexual dysfunction (3 and 12 months postsurgery)
3. Physiology of the anal sphincter ( 3 and 12 months postsurgery)
4. Quality of life (3 and 12 months postsurgery)
5. Maximal oxygen uptake (VO2 max) (1 week pre-surgery)
6. Postoperative complications (up to 5 years postsurgery)
7. Physical activity level (1 week pre-surgery and 3 months postsurgery)
8. In-hospital time (up to 12 months postsurgery)
Time points measured: multiple time points measured see above
NCT02538913 
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Starting date September 2015
Contact information Signe N Stafne, PhD, +47 480 71 766, signe.n.stafne@ntnu.no
Notes Trial registration identifier: NCT02538913
Trial registration link: https://clinicaltrials.gov/ct2/show/NCT02538913




Study name The Aasessment of the feasibility of a home based exercise programme in the older patient follow-
ing major surgery (POETold)
Methods Study design: RCT
Country where study is being conducted: UK
Participants 30 participants undergoing major body surgery including those with colorectal carcinoma
Inclusion criteria:
1. Male and Female patients
2. Age greater than 70 years
3. Patients undergoing neoadjuvant chemotherapy
Exclusion criteria:
1. Participation in a formal exercise regime
2. A BMI > 35 kg/m2
3. Active cardiovascular disease: uncontrolled hypertension (BP > 180/100), angina, heart failure
(class III/IV), arrhythmia, right to leM cardiac shunt, recent cardiac event
4. Taking beta-adrenergic blocking agents
5. Cerebrovascular disease: untreated aneurysm (large vessel or intracranial)
6. Respiratory disease including: pulmonary hypertension
7. Metabolic disease: hyper and hypoparathyroidism, untreated hyper and hypothyroidism, Cush-
ing's disease
8. Musculoskeletal or neurological disorders
9. Family history of early (< 55 years) death from cardiovascular disease
10.Severe rheumatoid arthritis limiting ability to perform any part of the assessment process
11.Unable to complete the consent process
Interventions Intervention details: participants will complete a High-Intensity Functional Exercise (HIFE) pro-
gramme.
Comparator details: standard NHS care
Outcomes Primary:
1. Feasibility of a home-based exercise programme following surgery in the older patient
Secondary:
1. Maximal oxygen uptake (V02max)
2. Muscle architecture ultrasound
NCT03064308 
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6. Quality of life
7. Hand strength test
8. Intervention compliance questionnaire
Time points measured: baseline, 3 and 6 months
Starting date 26 June 2017
Contact information Laura Carrick, BSc MBChB 07429377430 msxlc2@nottingham.ac.uk
Bethan Phillips, BSc PhD 01332 724731
Notes Trial registration number: NCT03064308
Trial registration link: https://clinicaltrials.gov/ct2/show/NCT03064308




Study name Motivational Interviewing to Increase Physical Activity behaviour in Cancer patients (MIPAClux)
Methods Study design: RCT
Country where study is being conducted: Luxembourg
Participants 70 breast, endometrial or colorectal cancer participants
Inclusion:
1. cancer stage ≤ stage III
2. > 3 months after primary treatment
3. < 24 months after primary treatment
4. ECOG performance score < 2
5. signed Informed consent
Exclusion:
1. recurrent cancer
2. history of other types of cancer
3. second primary tumour
4. planned surgery within the duration of the study
5. known or obvious cognitive or psychiatric impairments
6. positive pregnancy test
Interventions Intervention details: 12 motivational interviewing sessions exploring self-assessed confidence, am-
bivalence, and personal values concerning changes in active lifestyle
Comparator details: standard care
Outcomes Primary outcome:
1. Change in physical activity behaviour
NCT03210129 
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Secondary outcomes:
1. Body mass index
2. Physical fitness
3. Cost-effectiveness
Time points measured: weeks 1, 14 and 26
Starting date 6 July 2017
Contact information Alexis Lion, PhD, +35226970849 alexis.lion@lih.lu
Eric Besenius, M.Sc., +35226970917
Notes Trial registration number:
Trial registration link: https://clinicaltrials.gov/ct2/show/NCT03210129




Study name Novel individualized intervention for behavioral change among high-risk group cancer survivors:
Physical Activities by Technology Help (PATH)
Methods Study design: RCT
Country where study is being conducted: USA
Participants 42 cancer survivors of breast, prostate, lung, colorectal, cervical or oral cancer survivor
Inclusion:
1. Finished active cancer treatment at least three months ago
2. Overweight or obese and do not exercise daily
3. Do not have any physical limitation to do mild to moderate physical activities
4. Have a smart phone and actively use an email account
5. Willing to sign the consent form
Exclusion:
1. Already doing moderate to high physical activities in their daily life (rapid screener)
2. Planning to relocate within the next 4-5 weeks
3. Stage 4 cancer
4. Already using physical activity tracker or part of a physical activity programme
5. Part of another study that may interfere with our outcome of interest, unstable mental condition
6. Mental condition that prevents patient from performing the study activities and requirements
7. Pregnancy
Interventions Intervention details:
Arm 1: Mycoach Smart Text - personalised text messages to cell phone to help participants to in-
crease activity
Arm 2: MyCoach via Amazon Alexa- will interact with intelligent coach to increase activity
Comparator details: control participants will self-motivate to increase physical activities
NCT03212079 
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Outcomes Primary outcome:
1. Average number of steps
Secondary outcomes:
1. Total number and duration of activity bouts
2. Transitions between active/inactive periods
3. Daily patterns of activity
Time points measured: 5 weeks
Starting date 3 April 2017
Contact information Ahmed Hassoon, MD, MPH, PMP 443 287 2775 ahassoo1@jhu.edu
Notes Trial registration number: NCT03212079
Trial registration link: https://clinicaltrials.gov/ct2/show/NCT03212079




Study name Effects of high-intensity training compared to resistance training in cancer patients undergoing ra-
diotherapy
Methods Study design: RCT
Country where trial is being conducted: Belgium
Participants Inclusion criteria:
1. primary diagnosis of prostate cancer, head and neck cancer (oral cavity, pharynx, larynx, nasal
cavity/sinuses, or salivary gland) or rectum cancer
2. age over 18 years
3. no distant metastases and/or disease progression
4. at least 25 scheduled radiation treatments (5 weeks)
5. ability to read, write, and speak French
Exclusion criteria:
1. uncontrolled cardiac, hypertensive or pulmonary diseases
2. uncontrolled insulin-dependent diabetes mellitus
3. neuropsychiatric disorders or orthopaedic conditions that would impair exercise participation
4. abnormal electrocardiogram
Interventions Intervention details
Arm 1: high-intensity aerobic training group will be conducted on cycle ergometers or treadmill
with heart rate measured throughout each session
Arm 2: resistance training group muscle strengthening will incorporate eight exercises targeting
major muscle groups at 60% to 85% of their estimated 1-repetition maximum (1RM)
Comparator details: no intervention, usual care
Outcomes Primary outcome measures:
NCT03252821 
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1. Change in fatigue (FACIT-fatigue questionnaire)
Secondary outcome measures
1. Change in functional capacity (6-minute walk test)
2. Change in quality of life (Functional Assessment of Cancer Therapy-General)
3. Change in sleep disturbances (Pittsburgh Sleep Quality Index)
4. Change in somnolence syndrome (Epworth Sleepiness Scale)
5. Change in insomnia (Insomnia Severity Index)
6. Change in depression symptoms (Center for Epidemiologic Studies Depression Scale)
7. Change in executive functions (Trail Making Test)
8. Change in dyspnoea (Multidimensional Dyspnea Profile)
9. Adherence (Percentage of completed sessions)
Time points measured: baseline, 5 weeks for rectum cancer
Starting date 15 August 2017
Contact information Gilles Caty gilles.caty@uclouvain.be
Elise Piraux elise.piraux@uclouvain.be
Notes Trial registration identifier: NCT03252821
Trial registration link: https://clinicaltrials.gov/ct2/show/NCT03252821




Study name Physically active during cancer treatment (FAKT)
Methods Study design: RCT
Country where study is being conducted: Norway
Participants 64 participants with CRC radical resection within past 3 months
Interventions Intervention details: exercise training and nutritional guide
Comparator details: usual care
Outcomes Primary:
1. Patient-reported peripheral sensory neuropathy
Secondary:
1. Fatigue
2. Change in patient reported peripheral sensory, autonomic and motor neuropathy
3. Change in BMI and body composition
4. Change in blood pressure and Tx of hypertension, cholesterol, glucose
5. Change in nutritional status
6. Change in QOL
7. Physical capacity (balance, muscle strength aerobic capacity)
8. Levels of physical activity
9. Overall- and disease-free survival
NCT03885817 
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14.Diagnosed with type 2 diabetes
Starting date Not described - not yet recruiting
Contact information Contact: Ingunn Hatlevoll, +47 90866361
ingunn.hatlevoll@stolav.no






Study name Phase III randomised trial of endurance exercise following adjuvant chemotherapy for colorectal
cancer "aBCSG C08-II trial"
Methods Study design: RCT
Country where study is being conducted: Austria
Participants 788 patients with newly diagnosed, locally advanced colorectal cancer after adjuvant chemothera-
py
Interventions Intervention details: one year endurance exercise intervention






3. Physical activity end points
4. PROMS
5. Cost-effectiveness
6. Utility and safety
Time points measured: not reported
Starting date Not known
Contact information Not known
Notes Supplement in magazine of European Medical Oncology
Piringer 2017 
BMI: body mass index; ECOG: Eastern Oncology Cooperative Group; EORTC QLQ-C30 - European Organisation for Research and Treatment
of Cancer Quality of life; FACIT-F - Functional Assessment of Chronic Illness Therapy-Fatigue; IRB-approved; institutional review board
approved; LAR-low anterior resection; OEE- Outcome Expectations for Exercise Scale; PROMIS- patient reported outcome measures
Physical activity interventions for disease-related physical and mental health during and following treatment in people with non-
advanced colorectal cancer (Review)









Cochrane Database of Systematic Reviews
information system, PROMIS PF - patient reported outcome measures information system physical function; PROMIS PI-patient reported
outcome measures information system pain interference; PROMS- patient reported outcome measures; PSEFSM- perceived self-eJicacy
for fatigue self-management TNM- classification of malignant tumours; Tx- treatment QoL: quality of life; RCT: randomised controlled trial;
UK: United Kingdom; USA: United States of America
 
 
D A T A   A N D   A N A L Y S E S
 
Comparison 1.   Physical activity versus usual care for physical function





Statistical method Effect size
1.1 Objective measures more than 12 weeks to 6
months follow-up (30-Second Chair Stand Test)




1.2 Subjective measures more than 12 weeks to 6
months follow-up






Analysis 1.1.   Comparison 1: Physical activity versus usual care for physical function, Outcome





Heterogeneity: Chi² = 0.61, df = 1 (P = 0.44); I² = 0%
Test for overall effect: Z = 0.58 (P = 0.57)




























IV, Fixed, 95% CI
-0.10 [-3.48 , 3.28]
2.00 [-2.05 , 6.05]
0.76 [-1.84 , 3.36]
Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Usual care Physical activity
 
 
Analysis 1.2.   Comparison 1: Physical activity versus usual care for physical function,






Heterogeneity: Tau² = 0.00; Chi² = 0.48, df = 2 (P = 0.79); I² = 0%
Test for overall effect: Z = 0.54 (P = 0.59)



































IV, Random, 95% CI
0.02 [-0.41 , 0.45]
0.10 [-0.50 , 0.71]
0.38 [-0.54 , 1.29]
0.09 [-0.24 , 0.42]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Usual care Physical activity
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Comparison 2.   Physical activity versus usual care for disease-related mental health





Statistical method Effect size
2.1 Depression: more than 12 weeks to 6 months
follow-up




2.2 Depression: more than 6 months to 12
months follow-up (HADS)
2 48 Mean Difference (IV, Fixed, 95% CI) -1.20 [-2.72,
0.31]
2.3 Anxiety: more than 12 weeks to 6 months fol-
low-up




2.4 Anxiety: more than 6 months to 12 months
follow-up (HADS)




Analysis 2.1.   Comparison 2: Physical activity versus usual care for disease-related







Heterogeneity: Tau² = 0.00; Chi² = 2.76, df = 3 (P = 0.43); I² = 0%
Test for overall effect: Z = 1.42 (P = 0.15)










































IV, Random, 95% CI
-0.10 [-0.54 , 0.33]
-0.38 [-0.91 , 0.16]
-0.56 [-1.29 , 0.18]
0.33 [-0.59 , 1.24]
-0.21 [-0.50 , 0.08]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Physical activity Usual care
 
 
Analysis 2.2.   Comparison 2: Physical activity versus usual care for disease-related mental





Heterogeneity: Chi² = 1.47, df = 1 (P = 0.23); I² = 32%
Test for overall effect: Z = 1.56 (P = 0.12)




























IV, Fixed, 95% CI
-1.99 [-3.96 , -0.01]
-0.08 [-2.44 , 2.27]
-1.20 [-2.72 , 0.31]
Mean Difference
IV, Fixed, 95% CI
-10 -5 0 5 10
Physical activity usual care
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Analysis 2.3.   Comparison 2: Physical activity versus usual care for disease-related







Heterogeneity: Tau² = 0.00; Chi² = 1.97, df = 3 (P = 0.58); I² = 0%
Test for overall effect: Z = 0.75 (P = 0.45)










































IV, Random, 95% CI
-0.17 [-0.60 , 0.26]
-0.25 [-0.78 , 0.29]
-0.08 [-0.79 , 0.64]
0.49 [-0.43 , 1.42]
-0.11 [-0.40 , 0.18]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Physical activity Usual care
 
 
Analysis 2.4.   Comparison 2: Physical activity versus usual care for disease-related





Heterogeneity: Chi² = 1.42, df = 1 (P = 0.23); I² = 30%
Test for overall effect: Z = 1.63 (P = 0.10)




























IV, Fixed, 95% CI
0.65 [-2.20 , 3.50]
3.30 [0.01 , 6.58]
1.79 [-0.37 , 3.94]
Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Physical activity Usual care
 
 
Comparison 3.   Physical activity versus usual care for physical fitness (aerobic fitness)





Statistical method Effect size
3.1 Up to 12 weeks follow-up 7 295 Std. Mean Difference (IV, Random, 95% CI) 0.82 [0.34, 1.29]
3.2 Change from baseline up to 12
weeks follow-up
3 81 Std. Mean Difference (IV, Random, 95% CI) 0.89 [0.43, 1.36]
3.3 More than 12 weeks to 6 months
follow-up
7 248 Std. Mean Difference (IV, Random, 95% CI) 0.56 [0.29, 0.82]
3.4 Change from baseline more than 12
weeks to 6 months follow-up
2 51 Std. Mean Difference (IV, Fixed, 95% CI) 0.62 [0.05, 1.19]
3.5 More than 6 months to 12 months
follow-up
4 272 Std. Mean Difference (IV, Random, 95% CI) 0.44 [-0.04, 0.92]
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Analysis 3.1.   Comparison 3: Physical activity versus usual care for










Heterogeneity: Tau² = 0.26; Chi² = 18.95, df = 6 (P = 0.004); I² = 68%
Test for overall effect: Z = 3.39 (P = 0.0007)































































IV, Random, 95% CI
1.20 [0.18 , 2.22]
0.89 [0.24 , 1.55]
0.19 [-0.16 , 0.55]
0.26 [-0.54 , 1.07]
0.49 [-0.41 , 1.39]
1.28 [0.43 , 2.12]
1.66 [0.95 , 2.37]
0.82 [0.34 , 1.29]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Usual care Physical activity
 
 
Analysis 3.2.   Comparison 3: Physical activity versus usual care for physical fitness






Heterogeneity: Tau² = 0.00; Chi² = 1.09, df = 2 (P = 0.58); I² = 0%
Test for overall effect: Z = 3.78 (P = 0.0002)



































IV, Random, 95% CI
1.35 [0.27 , 2.43]
0.69 [0.05 , 1.33]
0.96 [0.11 , 1.82]
0.89 [0.43 , 1.36]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Usual care Physical activity
 
 
Analysis 3.3.   Comparison 3: Physical activity versus usual care for physical










Heterogeneity: Tau² = 0.00; Chi² = 6.07, df = 6 (P = 0.41); I² = 1%
Test for overall effect: Z = 4.11 (P < 0.0001)































































IV, Random, 95% CI
0.82 [0.08 , 1.55]
0.47 [0.02 , 0.92]
0.80 [-0.13 , 1.72]
0.41 [-0.50 , 1.32]
0.84 [0.21 , 1.48]
-0.14 [-0.87 , 0.59]
1.02 [-0.01 , 2.06]
0.56 [0.29 , 0.82]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Usual care Physical activity
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Analysis 3.4.   Comparison 3: Physical activity versus usual care for physical fitness (aerobic





Heterogeneity: Chi² = 0.61, df = 1 (P = 0.44); I² = 0%
Test for overall effect: Z = 2.15 (P = 0.03)




























IV, Fixed, 95% CI
0.81 [0.07 , 1.54]
0.35 [-0.54 , 1.24]
0.62 [0.05 , 1.19]
Std. Mean Difference
IV, Fixed, 95% CI
-2 -1 0 1 2
Usual care Physical activity
 
 
Analysis 3.5.   Comparison 3: Physical activity versus usual care for physical







Heterogeneity: Tau² = 0.13; Chi² = 7.02, df = 3 (P = 0.07); I² = 57%
Test for overall effect: Z = 1.79 (P = 0.07)










































IV, Random, 95% CI
0.39 [0.10 , 0.68]
1.11 [0.45 , 1.77]
-0.24 [-1.02 , 0.54]
0.38 [-0.61 , 1.37]
0.44 [-0.04 , 0.92]
Std. Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Usual care Physical activity
 
 
Comparison 4.   Physical activity versus usual care for physical fitness (hand grip strength)





Statistical method Effect size
4.1 Up to 12 weeks follow-up (hand dynamome-
try)




4.2 More than 12 weeks to 6 months follow-up
(hand dynamometry)






Analysis 4.1.   Comparison 4: Physical activity versus usual care for physical fitness





Heterogeneity: Chi² = 0.09, df = 1 (P = 0.77); I² = 0%
Test for overall effect: Z = 1.22 (P = 0.22)




























IV, Fixed, 95% CI
1.70 [-1.70 , 5.10]
2.90 [-4.37 , 10.17]
1.92 [-1.17 , 5.00]
Mean Difference
IV, Fixed, 95% CI
-10 -5 0 5 10
Usual care Physical activity
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Analysis 4.2.   Comparison 4: Physical activity versus usual care for physical fitness (hand





Heterogeneity: Chi² = 0.29, df = 1 (P = 0.59); I² = 0%
Test for overall effect: Z = 0.27 (P = 0.79)




























IV, Fixed, 95% CI
1.90 [-5.86 , 9.66]
-2.78 [-18.08 , 12.53]
0.94 [-5.98 , 7.87]
Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Usual care Physical activity
 
 
Comparison 5.   Physical activity versus usual care for physical fitness (flexibility)




Statistical method Effect size
5.1 More than 12 weeks to 6 months fol-
low-up





Analysis 5.1.   Comparison 5: Physical activity versus usual care for physical





Heterogeneity: Chi² = 0.77, df = 1 (P = 0.38); I² = 0%
Test for overall effect: Z = 0.08 (P = 0.93)




























IV, Fixed, 95% CI
0.29 [-0.42 , 0.99]
-0.09 [-0.53 , 0.35]
0.02 [-0.36 , 0.39]
Std. Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Usual care Physical activity
 
 
Comparison 6.   Physical activity versus usual care for cancer-related fatigue





Statistical method Effect size
6.1 Up to 12 weeks follow-up (FACT-F and
FACIT-F)
6 230 Mean Difference (IV, Random, 95% CI) 2.16 [0.18, 4.15]
6.2 Change from baseline up to 12 weeks fol-
low-up (FACT-F and FACIT-F)
3 113 Mean Difference (IV, Fixed, 95% CI) 0.41 [-1.33,
2.14]
6.3 More than 12 weeks to 6 months follow-up 7 277 Std. Mean Difference (IV, Random,
95% CI)
0.34 [0.08, 0.60]
6.4 More than 6 months to 12 months fol-
low-up
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Analysis 6.1.   Comparison 6: Physical activity versus usual care for cancer-









Heterogeneity: Tau² = 1.09; Chi² = 6.07, df = 5 (P = 0.30); I² = 18%
Test for overall effect: Z = 2.14 (P = 0.03)
























































IV, Random, 95% CI
5.00 [0.29 , 9.71]
2.57 [-1.33 , 6.47]
0.30 [-3.42 , 4.02]
2.20 [-2.81 , 7.21]
9.30 [0.59 , 18.01]
0.30 [-3.16 , 3.76]
2.16 [0.18 , 4.15]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Usual care Physical activity
 
 
Analysis 6.2.   Comparison 6: Physical activity versus usual care for cancer-related






Heterogeneity: Chi² = 6.69, df = 2 (P = 0.04); I² = 70%
Test for overall effect: Z = 0.46 (P = 0.65)



































IV, Fixed, 95% CI
4.00 [0.20 , 7.80]
-1.50 [-3.80 , 0.80]
1.90 [-1.78 , 5.58]
0.41 [-1.33 , 2.14]
Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Usual care Physical activity
 
 
Analysis 6.3.   Comparison 6: Physical activity versus usual care for cancer-










Heterogeneity: Tau² = 0.01; Chi² = 6.56, df = 6 (P = 0.36); I² = 9%
Test for overall effect: Z = 2.56 (P = 0.01)































































IV, Random, 95% CI
0.05 [-0.38 , 0.49]
0.35 [-0.19 , 0.89]
-0.20 [-1.09 , 0.68]
0.90 [-0.09 , 1.88]
0.59 [-0.03 , 1.21]
0.83 [0.07 , 1.59]
0.31 [-0.60 , 1.23]
0.34 [0.08 , 0.60]
Std. Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Usual care Physical activity
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Analysis 6.4.   Comparison 6: Physical activity versus usual care for cancer-






Heterogeneity: Chi² = 1.32, df = 2 (P = 0.52); I² = 0%
Test for overall effect: Z = 1.19 (P = 0.23)



































IV, Fixed, 95% CI
0.09 [-0.52 , 0.70]
0.63 [-0.13 , 1.39]
0.10 [-0.78 , 0.98]
0.25 [-0.16 , 0.67]
Std. Mean Difference
IV, Fixed, 95% CI
-2 -1 0 1 2
Usual care Physical activity
 
 
Comparison 7.   Physical activity versus usual care for anthropometric measure of weight (kg)





Statistical method Effect size
7.1 Up to 12 weeks follow-up 6 252 Mean Difference (IV, Random, 95% CI) 0.29 [-2.55, 3.14]
7.2 Change from baseline up to 12 weeks
follow-up
3 82 Mean Difference (IV, Random, 95% CI) -1.71 [-2.90, -0.51]
7.3 Change from baseline more than 12
weeks to 6 months follow-up
3 89 Mean Difference (IV, Random, 95% CI) -0.73 [-2.17, 0.72]
7.4 More than 12 weeks to 6 months fol-
low-up
3 74 Mean Difference (IV, Random, 95% CI) 0.59 [-6.87, 8.04]
 
 
Analysis 7.1.   Comparison 7: Physical activity versus usual care for









Heterogeneity: Tau² = 0.00; Chi² = 2.08, df = 5 (P = 0.84); I² = 0%
Test for overall effect: Z = 0.20 (P = 0.84)
























































IV, Random, 95% CI
-0.80 [-10.86 , 9.26]
-1.90 [-9.54 , 5.74]
0.10 [-3.71 , 3.91]
1.10 [-8.25 , 10.45]
11.00 [-5.41 , 27.41]
1.28 [-7.60 , 10.16]
0.29 [-2.55 , 3.14]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Physical activity Usual care
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Analysis 7.2.   Comparison 7: Physical activity versus usual care for anthropometric






Heterogeneity: Tau² = 0.01; Chi² = 2.02, df = 2 (P = 0.36); I² = 1%
Test for overall effect: Z = 2.80 (P = 0.005)



































IV, Random, 95% CI
-1.40 [-3.14 , 0.34]
-0.30 [-3.22 , 2.62]
-2.70 [-4.64 , -0.76]
-1.71 [-2.90 , -0.51]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Physical activity Usual care
 
 
Analysis 7.3.   Comparison 7: Physical activity versus usual care for anthropometric measure






Heterogeneity: Tau² = 0.00; Chi² = 0.54, df = 2 (P = 0.76); I² = 0%
Test for overall effect: Z = 0.98 (P = 0.32)



































IV, Random, 95% CI
-0.85 [-2.55 , 0.85]
-1.30 [-5.06 , 2.46]
0.60 [-3.36 , 4.56]
-0.73 [-2.17 , 0.72]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Physical activity Usual care
 
 
Analysis 7.4.   Comparison 7: Physical activity versus usual care for anthropometric






Heterogeneity: Tau² = 15.05; Chi² = 3.04, df = 2 (P = 0.22); I² = 34%
Test for overall effect: Z = 0.15 (P = 0.88)



































IV, Random, 95% CI
-2.90 [-11.53 , 5.73]
-1.10 [-9.87 , 7.67]
13.50 [-3.07 , 30.07]
0.59 [-6.87 , 8.04]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Physical activity Usual care
 
 
Comparison 8.   Physical activity versus usual care for anthropometric measure of waist circumference





Statistical method Effect size
8.1 Up to 12 weeks follow-up 3 183 Mean Difference (IV, Random, 95%
CI)
0.02 [-2.88, 2.93]
8.2 More than 12 weeks to 6 months fol-
low-up
2 50 Mean Difference (IV, Fixed, 95% CI) 1.58 [-5.58, 8.74]
8.3 Change from baseline more than 12
weeks to 6 months follow-up
2 70 Mean Difference (IV, Fixed, 95% CI) -2.79 [-5.21, -0.36]
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Analysis 8.1.   Comparison 8: Physical activity versus usual care for anthropometric






Heterogeneity: Tau² = 0.00; Chi² = 1.66, df = 2 (P = 0.44); I² = 0%
Test for overall effect: Z = 0.02 (P = 0.99)



































IV, Random, 95% CI
-3.80 [-11.09 , 3.49]
0.50 [-2.76 , 3.76]
5.00 [-8.50 , 18.50]
0.02 [-2.88 , 2.93]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Physical activity Usual care
 
 
Analysis 8.2.   Comparison 8: Physical activity versus usual care for anthropometric





Heterogeneity: Chi² = 1.43, df = 1 (P = 0.23); I² = 30%
Test for overall effect: Z = 0.43 (P = 0.67)




























IV, Fixed, 95% CI
-1.00 [-9.31 , 7.31]
9.00 [-5.09 , 23.09]
1.58 [-5.58 , 8.74]
Mean Difference
IV, Fixed, 95% CI
-20 -10 0 10 20
Physical activity Usual care
 
 
Analysis 8.3.   Comparison 8: Physical activity versus usual care for anthropometric measure of





Heterogeneity: Chi² = 1.61, df = 1 (P = 0.20); I² = 38%
Test for overall effect: Z = 2.25 (P = 0.02)




























IV, Fixed, 95% CI
-11.35 [-24.79 , 2.09]
-2.50 [-4.97 , -0.03]
-2.79 [-5.21 , -0.36]
Mean Difference
IV, Fixed, 95% CI
-10 -5 0 5 10
Physical activity Usual care
 
 
Comparison 9.   Physical activity versus usual care anthropometric measure of waist to hip ratio





Statistical method Effect size
9.1 Up to 12 weeks follow-up 3 62 Mean Difference (IV, Random, 95% CI) -0.01 [-0.12, 0.10]
9.2 Change from baseline up to 12
weeks follow-up
2 42 Mean Difference (IV, Fixed, 95% CI) -0.00 [-0.02, 0.02]
9.3 More than 12 weeks to 6 months
follow-up
2 43 Mean Difference (IV, Fixed, 95% CI) 0.06 [-0.03, 0.14]
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Analysis 9.1.   Comparison 9: Physical activity versus usual care anthropometric






Heterogeneity: Tau² = 0.01; Chi² = 12.88, df = 2 (P = 0.002); I² = 84%
Test for overall effect: Z = 0.16 (P = 0.87)



































IV, Random, 95% CI
-0.11 [-0.17 , -0.05]
0.06 [-0.02 , 0.14]
0.03 [-0.05 , 0.11]
-0.01 [-0.12 , 0.10]
Mean Difference
IV, Random, 95% CI
-0.5 -0.25 0 0.25 0.5
Physical activity Usual care
 
 
Analysis 9.2.   Comparison 9: Physical activity versus usual care anthropometric measure





Heterogeneity: Chi² = 4.28, df = 1 (P = 0.04); I² = 77%
Test for overall effect: Z = 0.02 (P = 0.99)




























IV, Fixed, 95% CI
-0.06 [-0.12 , 0.00]
0.01 [-0.02 , 0.04]
-0.00 [-0.02 , 0.02]
Mean Difference
IV, Fixed, 95% CI
-0.2 -0.1 0 0.1 0.2
Physical activity Usual care
 
 
Analysis 9.3.   Comparison 9: Physical activity versus usual care anthropometric





Heterogeneity: Chi² = 0.00, df = 1 (P = 0.95); I² = 0%
Test for overall effect: Z = 1.37 (P = 0.17)




























IV, Fixed, 95% CI
0.06 [-0.03 , 0.15]
0.05 [-0.27 , 0.37]
0.06 [-0.03 , 0.14]
Mean Difference
IV, Fixed, 95% CI
-100 -50 0 50 100
Physical activity Usual care
 
 
Comparison 10.   Physical activity versus usual care for anthropometric measure of body fat (%)





Statistical method Effect size
10.1 Up to 12 weeks follow-up 4 214 Mean Difference (IV, Random, 95% CI) -1.93 [-4.04, 0.18]
10.2 Change from baseline up to 12 weeks
follow-up
2 60 Mean Difference (IV, Fixed, 95% CI) -1.57 [-3.11, -0.04]
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Statistical method Effect size
10.3 More than 12 weeks to 6 months fol-
low-up
3 139 Std. Mean Difference (IV, Fixed, 95%
CI)
-0.08 [-0.42, 0.27]
10.4 Change from baseline more than 12
weeks to 6 months follow-up
2 51 Mean Difference (IV, Fixed, 95% CI) -1.26 [-3.11, 0.59]
 
 
Analysis 10.1.   Comparison 10: Physical activity versus usual care for







Heterogeneity: Tau² = 0.00; Chi² = 2.38, df = 3 (P = 0.50); I² = 0%
Test for overall effect: Z = 1.79 (P = 0.07)










































IV, Random, 95% CI
0.60 [-5.45 , 6.65]
-1.70 [-4.53 , 1.13]
-4.70 [-9.22 , -0.18]
-0.30 [-6.90 , 6.30]
-1.93 [-4.04 , 0.18]
Mean Difference
IV, Random, 95% CI
-20 -10 0 10 20
Physical activity Usual care
 
 
Analysis 10.2.   Comparison 10: Physical activity versus usual care for anthropometric





Heterogeneity: Chi² = 0.02, df = 1 (P = 0.90); I² = 0%
Test for overall effect: Z = 2.01 (P = 0.04)




























IV, Fixed, 95% CI
-1.50 [-3.42 , 0.42]
-1.70 [-4.26 , 0.86]
-1.57 [-3.11 , -0.04]
Mean Difference
IV, Fixed, 95% CI
-10 -5 0 5 10
Physical activity Usual care
 
 
Analysis 10.3.   Comparison 10: Physical activity versus usual care for anthropometric






Heterogeneity: Chi² = 2.05, df = 2 (P = 0.36); I² = 2%
Test for overall effect: Z = 0.45 (P = 0.66)



































IV, Fixed, 95% CI
0.05 [-0.65 , 0.76]
0.01 [-0.43 , 0.45]
-0.69 [-1.61 , 0.22]
-0.08 [-0.42 , 0.27]
Std. Mean Difference
IV, Fixed, 95% CI
-100 -50 0 50 100
Physical activity Usual care
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Analysis 10.4.   Comparison 10: Physical activity versus usual care for anthropometric measure





Heterogeneity: Chi² = 0.14, df = 1 (P = 0.71); I² = 0%
Test for overall effect: Z = 1.34 (P = 0.18)




























IV, Fixed, 95% CI
-1.75 [-4.90 , 1.40]
-1.00 [-3.28 , 1.28]
-1.26 [-3.11 , 0.59]
Mean Difference
IV, Fixed, 95% CI
-4 -2 0 2 4
Physical activity Usual care
 
 
Comparison 11.   Physical activity versus usual care for anthropometric measure of BMI





Statistical method Effect size
11.1 Up to 12 weeks follow-up 6 252 Mean Difference (IV, Random, 95% CI) 0.14 [-0.73, 1.02]
11.2 Change from baseline up to 12 weeks
follow-up
3 82 Mean Difference (IV, Random, 95% CI) -0.32 [-0.81, 0.17]
11.3 More than 12 weeks to 6 months fol-
low-up
4 158 Std. Mean Difference (IV, Random, 95%
CI)
0.00 [-0.32, 0.33]
11.4 Change from baseline more than 12
weeks to 6 months follow-up
3 89 Mean Difference (IV, Random, 95% CI) -0.26 [-1.17, 0.66]
 
 
Analysis 11.1.   Comparison 11: Physical activity versus usual care for









Heterogeneity: Tau² = 0.00; Chi² = 1.77, df = 5 (P = 0.88); I² = 0%
Test for overall effect: Z = 0.32 (P = 0.75)
























































IV, Random, 95% CI
-0.30 [-3.49 , 2.89]
0.10 [-2.97 , 3.17]
0.10 [-1.04 , 1.24]
-0.70 [-3.31 , 1.91]
2.60 [-2.09 , 7.29]
0.80 [-1.86 , 3.46]
0.14 [-0.73 , 1.02]
Mean Difference
IV, Random, 95% CI
-10 -5 0 5 10
Physical activity usual care
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Analysis 11.2.   Comparison 11: Physical activity versus usual care for anthropometric






Heterogeneity: Tau² = 0.07; Chi² = 3.31, df = 2 (P = 0.19); I² = 40%
Test for overall effect: Z = 1.28 (P = 0.20)



































IV, Random, 95% CI
-0.20 [-0.80 , 0.40]
0.00 [-0.63 , 0.63]
-0.90 [-1.67 , -0.13]
-0.32 [-0.81 , 0.17]
Mean Difference
IV, Random, 95% CI
-2 -1 0 1 2
Physical activity Usual care
 
 
Analysis 11.3.   Comparison 11: Physical activity versus usual care for anthropometric







Heterogeneity: Tau² = 0.00; Chi² = 1.96, df = 3 (P = 0.58); I² = 0%
Test for overall effect: Z = 0.01 (P = 0.99)










































IV, Random, 95% CI
-0.36 [-1.25 , 0.53]
-0.07 [-0.51 , 0.37]
0.13 [-0.58 , 0.83]
0.50 [-0.42 , 1.41]
0.00 [-0.32 , 0.33]
Std. Mean Difference
IV, Random, 95% CI
-50 -25 0 25 50
Physical activity Usual care
 
 
Analysis 11.4.   Comparison 11: Physical activity versus usual care for anthropometric






Heterogeneity: Tau² = 0.28; Chi² = 3.49, df = 2 (P = 0.18); I² = 43%
Test for overall effect: Z = 0.55 (P = 0.58)



































IV, Random, 95% CI
-0.42 [-1.03 , 0.18]
0.40 [-0.70 , 1.50]
-2.90 [-6.71 , 0.91]
-0.26 [-1.17 , 0.66]
Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Physical activity Usual care
 
 
Comparison 12.   Physical activity versus usual care for HRQoL





Statistical method Effect size
12.1 Up to 12 weeks follow-up 6 230 Std. Mean Difference (IV, Random, 95% CI) 0.36 [0.10, 0.62]
12.2 Change from baseline up to 12
weeks follow-up
3 113 Std. Mean Difference (IV, Fixed, 95% CI) -0.10 [-0.47, 0.28]
12.3 More than 12 weeks to 6 months
follow-up
7 278 Std. Mean Difference (IV, Random, 95% CI) 0.45 [0.03, 0.88]
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Statistical method Effect size
12.4 Change from baseline more than 12
weeks to 6 months follow-up
2 58 Std. Mean Difference (IV, Fixed, 95% CI) 0.70 [0.14, 1.26]
12.5 More than 6 months to 12 months
follow-up
3 89 Std. Mean Difference (IV, Fixed, 95% CI) 0.05 [-0.37, 0.47]
 
 









Heterogeneity: Tau² = 0.00; Chi² = 4.44, df = 5 (P = 0.49); I² = 0%
Test for overall effect: Z = 2.68 (P = 0.007)
























































IV, Random, 95% CI
1.11 [0.10 , 2.12]
0.26 [-0.28 , 0.79]
0.28 [-0.19 , 0.75]
0.66 [-0.17 , 1.48]
0.70 [-0.21 , 1.62]
0.04 [-0.56 , 0.65]
0.36 [0.10 , 0.62]
Std. Mean Difference
IV, Random, 95% CI
-0.2 -0.1 0 0.1 0.2
Usual care Physical activity
 
 
Analysis 12.2.   Comparison 12: Physical activity versus usual care for






Heterogeneity: Chi² = 2.39, df = 2 (P = 0.30); I² = 16%
Test for overall effect: Z = 0.51 (P = 0.61)



































IV, Fixed, 95% CI
-0.44 [-1.37 , 0.50]
0.13 [-0.34 , 0.59]
-0.52 [-1.33 , 0.30]
-0.10 [-0.47 , 0.28]
Std. Mean Difference
IV, Fixed, 95% CI
-4 -2 0 2 4
Usual care Physical activity
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Analysis 12.3.   Comparison 12: Physical activity versus usual care










Heterogeneity: Tau² = 0.18; Chi² = 15.26, df = 6 (P = 0.02); I² = 61%
Test for overall effect: Z = 2.10 (P = 0.04)































































IV, Random, 95% CI
-0.14 [-0.57 , 0.29]
0.44 [-0.10 , 0.98]
2.04 [0.91 , 3.16]
0.94 [-0.02 , 1.91]
0.27 [-0.34 , 0.88]
0.40 [-0.34 , 1.14]
0.12 [-0.79 , 1.03]
0.45 [0.03 , 0.88]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Usual care Physical activity
 
 
Analysis 12.4.   Comparison 12: Physical activity versus usual care for HRQoL,





Heterogeneity: Chi² = 0.03, df = 1 (P = 0.85); I² = 0%
Test for overall effect: Z = 2.46 (P = 0.01)




























IV, Fixed, 95% CI
0.74 [0.03 , 1.45]
0.63 [-0.28 , 1.54]
0.70 [0.14 , 1.26]
Std. Mean Difference
IV, Fixed, 95% CI
-2 -1 0 1 2
Usual care Physical activity
 
 
Analysis 12.5.   Comparison 12: Physical activity versus usual care






Heterogeneity: Chi² = 0.33, df = 2 (P = 0.85); I² = 0%
Test for overall effect: Z = 0.22 (P = 0.83)



































IV, Fixed, 95% CI
0.01 [-0.60 , 0.62]
-0.05 [-0.81 , 0.70]
0.27 [-0.63 , 1.17]
0.05 [-0.37 , 0.47]
Std. Mean Difference
IV, Fixed, 95% CI
-2 -1 0 1 2
Usual care Physical activity
 
 
Comparison 13.   Physical activity versus usual care for levels of physical activity





Statistical method Effect size
13.1 Objective measures up to 12 weeks follow-up (ac-
celerometry moderate to vigorous physical activity mins/
per day)
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Statistical method Effect size
13.2 Change from baseline in objective measures up to
12 weeks follow-up (accelerometry moderate to vigorous
physical activity)








13.4 Objective measures more than 12 weeks to 6 months
follow-up (accelerometry moderate to vigorous physical
activity mins/week)





13.5 Subjective measures more than 12 weeks to 6 months
follow-up




13.6 Subjective measures more than 6 months to 12
months follow-up






Analysis 13.1.   Comparison 13: Physical activity versus usual care for levels of physical activity, Outcome 1:







Heterogeneity: Tau² = 72.04; Chi² = 5.28, df = 3 (P = 0.15); I² = 43%
Test for overall effect: Z = 1.29 (P = 0.20)










































IV, Random, 95% CI
-32.00 [-56.08 , -7.92]
-3.40 [-15.73 , 8.93]
1.94 [-17.60 , 21.48]
-7.90 [-31.89 , 16.09]
-8.34 [-21.05 , 4.37]
Mean Difference
IV, Random, 95% CI
-100 -50 0 50 100
Usual care Physical activity
 
 
Analysis 13.2.   Comparison 13: Physical activity versus usual care for levels of
physical activity, Outcome 2: Change from baseline in objective measures up





Heterogeneity: Chi² = 0.28, df = 1 (P = 0.60); I² = 0%
Test for overall effect: Z = 0.38 (P = 0.70)




























IV, Fixed, 95% CI
-0.37 [-1.47 , 0.74]
0.00 [-0.80 , 0.80]
-0.13 [-0.77 , 0.52]
Std. Mean Difference
IV, Fixed, 95% CI
-2 -1 0 1 2
Usual care Physical activity
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Analysis 13.3.   Comparison 13: Physical activity versus usual care for levels of







Heterogeneity: Tau² = 0.00; Chi² = 0.78, df = 3 (P = 0.85); I² = 0%
Test for overall effect: Z = 4.23 (P < 0.0001)










































IV, Random, 95% CI
0.90 [-0.08 , 1.88]
0.72 [0.24 , 1.21]
0.39 [-0.42 , 1.20]
0.77 [0.15 , 1.40]
0.70 [0.38 , 1.03]
Std. Mean Difference
IV, Random, 95% CI
-4 -2 0 2 4
Usual care Physical activity
 
 
Analysis 13.4.   Comparison 13: Physical activity versus usual care for levels of
physical activity, Outcome 4: Objective measures more than 12 weeks to 6 months





Heterogeneity: Chi² = 1.15, df = 1 (P = 0.28); I² = 13%
Test for overall effect: Z = 0.38 (P = 0.71)




























IV, Fixed, 95% CI
-31.00 [-138.36 , 76.36]
46.80 [-46.06 , 139.66]
13.50 [-56.73 , 83.74]
Mean Difference
IV, Fixed, 95% CI
-200 -100 0 100 200
Usual care Physical activity
 
 
Analysis 13.5.   Comparison 13: Physical activity versus usual care for levels of physical







Heterogeneity: Tau² = 0.07; Chi² = 4.86, df = 3 (P = 0.18); I² = 38%
Test for overall effect: Z = 1.74 (P = 0.08)










































IV, Random, 95% CI
0.08 [-0.35 , 0.51]
1.24 [0.26 , 2.21]
0.48 [-0.14 , 1.10]
0.18 [-0.73 , 1.09]
0.39 [-0.05 , 0.82]
Std. Mean Difference
IV, Random, 95% CI
-1 -0.5 0 0.5 1
Usual care Physical activity
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Analysis 13.6.   Comparison 13: Physical activity versus usual care for levels of physical






Heterogeneity: Chi² = 2.54, df = 2 (P = 0.28); I² = 21%
Test for overall effect: Z = 2.85 (P = 0.004)



































IV, Fixed, 95% CI
0.40 [0.13 , 0.68]
0.40 [-0.21 , 1.01]
-0.35 [-1.23 , 0.54]
0.35 [0.11 , 0.59]
Std. Mean Difference
IV, Fixed, 95% CI
-1 -0.5 0 0.5 1
Usual care Physical activity
 
 
A D D I T I O N A L   T A B L E S
 





Statistical method Effect size
1 Physical function d          
1.1 Subjective measure
of physical function
Short-term follow-up 2 114 SMD (IV, random, 95%
CI)
0.08 (-0.31 to 0.47)a
2 Disease-related men-
tal health
         
2.1 Anxiety Short-term follow-up 3 177 SMD (IV, random, 95%
CI)
-0.29 (-0.60 to 0.01)a,b
2.2. Depression Short-term follow-up 3 177 SMD (IV, random, 95%
CI)
-0.18 (-0.48 to 0.13)a,b
3 Physical fitness          







SMD (IV, random, 95%
CI)
0.38 (0.06 to 0.70)a,b










MD (IV, random, 95% CI)
SMD (IV, random, 95%
CI)
2.22 (-0.34 to 4.79)a,b
0.32 (-0.04 to 0.67)a,b
5 Anthropometric mea-
sures d
         
5.1 Weight Immediate-term fol-
low-up
Change from base-






MD (IV, random, 95% CI) 0.27 (-2.87 to 3.42)a,c
-1.76 [-4.06 to 0.54]c
Table 1.   Summary of sensitivity analysis 
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5.2 Waist to hip ratio Immediate-term fol-
low-up
2 44 MD (IV, random, 95% CI) 0.04 [-0.01 to 0.10]a,c
5.3 BMI Immediate-term fol-
low-up
Change from base-






MD (IV, random, 95% CI) 0.10 [-0.87 to 1.06]a,c
-0.42 [-1.30 to 0.46]
5.4 Body fat % Immediate-term fol-
low-up
3 187 MD (IV, random, 95% CI) -2.13 [-4.46 to 0.21]a,d
6 HRQoL Immediate-term fol-
low-up
4 169 SMD (IV, random, 95%
CI)
0.37 [0.07 to 0.68]a,b,c
7 Levels of physical ac-
tivity
         
7.1 Objective measures Immediate-term fol-
low-up
3 80 MD (IV, random, 95% CI) -2.84 [-12.40 to 6.73]c
7.2 Subjective measures Immediate-term fol-
low-up
3 138 SMD (IV, random, 95%
CI)
0.68[0.33 to 1.02]c
Table 1.   Summary of sensitivity analysis  (Continued)
BMI: body mass index; CI: confidence interval; HRQoL: health-related quality of life; MD: mean diJerence: SD: standard deviation; SMD:
standardised mean diJerence (used when studies assess the same outcome but measure it in a variety of ways).
a Removal of studies that did not conduct an ITT analysis
b Exclusion of studies at high risk of bias
c Exclusion of studies with an additional intervention component
d Results from choice of model (fixed or random) were consistent
 
 
A P P E N D I C E S
Appendix 1. CENTRAL search strategy
Cochrane Central Register of Controlled Trials (CENTRAL): year, issue number in the Cochrane Library (searched day, month, year)
#1 MeSH descriptor: [Colorectal Neoplasms] explode all trees
#2 ((colorect* or colon* or rect* or anal* or anus* or intestin* or bowel*) near/5 (carcinom* or neoplas* or adenocarcinom* or cancer* or
tumor* or tumour* or sarcom* or malignan*)):ti,ab,kw (Word variations have been searched)
#3 #1 or #2
#4 MeSH descriptor: [Exercise] explode all trees
#5 MeSH descriptor: [Exercise Therapy] explode all trees
#6 MeSH descriptor: [Sports] explode all trees
#7 "physical fitness" (Word variations have been searched)
#8 (physical* near/5 (fit* or train* or activ* or endur* or exer*)):ti,ab,kw (Word variations have been searched)
#9 (exercis* near/5 (train* or physical* or activ*)):ti,ab,kw (Word variations have been searched)
#10 sport*:ti,ab,kw (Word variations have been searched)
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#11 walk*:ti,ab,kw (Word variations have been searched)
#12 swim*:ti,ab,kw (Word variations have been searched)
#13 pilates*:ti,ab,kw (Word variations have been searched)
#14 tai ji or tai chi or tai-ji or tai-chi:ti,ab,kw (Word variations have been searched)
#15 resistance near/3 train*:ti,ab,kw (Word variations have been searched)
#16 #4 and #5 or #6 or #7 or #8 or #9 or #10 or #11 or #12 or #13 or #14 or #15
#17 #3 and #16
Appendix 2. MEDLINE search strategy
 
Ovid MEDLINE(R) Epub Ahead of Print, In-Process & Other Non-Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R)
1946 to present (day, month, year)
1. exp colorectal neoplasms/
2. ((colorect* or colon* or rect* or anal* or anus* or intestin* or bowel*) adj5 (carcinom* or neoplas* or adenocarcinom* or cancer* or
tumor* or tumour* or sarcom* or malignan*)).mp.
3. 1 or 2
4. exp exercise/
5. exp exercise therapy/
6. exp sports/
7. Physical Fitness/
8. (physical* adj5 (fit* or train* or activ* or endur* or exer*)).ti,ab.





14. (tai ji or tai chi or tai-ji or tai-chi).ti,ab.
15. (resistance adj3 train*).ti,ab.
16. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15
17. 3 and 16
18. randomized controlled trial.pt.
19. controlled clinical trial.pt.
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20. randomized.ab.
21. placebo.ab.
22. clinical trials as topic.sh.
23. randomly.ab.
24. trial.ti.
25. 18 or 19 or 20 or 21 or 22 or 23 or 24
26. exp animals/ not humans.sh.
27. 25 not 26
28. 17 and 27
  (Continued)
 
Appendix 3. Embase search strategy
 
Ovid Embase: 1974 to year week
1. exp large intestine tumor/
2. ((colorect* or colon* or rect* or anal* or anus* or intestin* or bowel*) adj5 (carcinom* or neoplas* or adenocarcinom* or cancer* or
tumor* or tumour* or sarcom* or malignan*)).mp.





8. (physical* adj5 (fit* or train* or activ* or endur* or exer*)).ti,ab.





14. (tai ji or tai chi or tai-ji or tai-chi).ti,ab.
15. (resistance adj3 train*).ti,ab.
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16. 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15




21. (crossover* or cross over*).ti,ab.
22. placebo*.ti,ab.
23. (doubl* adj blind*).ti,ab.
24. allocat*.ti,ab.
25. trial.ti.
26. RANDOMIZED CONTROLLED TRIAL.sh.
27. random*.ti,ab.
28. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27
29. (exp animal/ or exp invertebrate/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans or man or
men or wom?n).ti.)
30. 28 not 29
31. 17 and 30
  (Continued)
 
Appendix 4. Criteria for judging risk of bias in the 'Risk of bias' assessment tool
 
Random sequence generation
Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence
Criteria for a judgement of
‘low risk’ of bias
The investigators describe a random component in the sequence generation process such as:
1. referring to a random number table;
2. using a computer random number generator;
3. coin tossing;
4. shuffling cards or envelopes;
5. throwing dice;
6. drawing of lots;
7. minimisation*.
*Minimisation may be implemented without a random element, and this is considered to be equiv-
alent to being random.
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Criteria for the judgement of
‘high risk’ of bias
The investigators describe a non-random component in the sequence generation process. Usually,
the description would involve some systematic, non-random approach, for example:
1. sequence generated by odd or even date of birth;
2. sequence generated by some rule based on date (or day) of admission;
3. sequence generated by some rule based on hospital or clinic record number.
Other non-random approaches happen much less frequently than the systematic approaches men-
tioned above and tend to be obvious. They usually involve judgement or some method of non-ran-
dom categorisation of participants, for example:
1. allocation by judgement of the clinician;
2. allocation by preference of the participant;
3. allocation based on the results of a laboratory test or a series of tests;
4. allocation by availability of the intervention.
Criteria for the judgement of
‘unclear risk’ of bias.
Insufficient information about the sequence generation process to permit judgement of ‘low risk’
or ‘high risk’.
Allocation concealment
Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment
Criteria for a judgement of
‘low risk’ of bias
Participants and investigators enrolling participants could not foresee assignment because one of
the following, or an equivalent method, was used to conceal allocation:
1. central allocation (including telephone, web-based and pharmacy-controlled randomisation);
2. sequentially numbered drug containers of identical appearance;
3. sequentially numbered, opaque, sealed envelopes.
Criteria for the judgement of
‘high risk’ of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus in-
troduce selection bias, such as allocation based on:
1. using an open random allocation schedule (e.g. a list of random numbers);
2. assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed
or nonopaque or not sequentially numbered);
3. alternation or rotation;
4. date of birth;
5. case record number;
6. any other explicitly unconcealed procedure.
Criteria for the judgement of
‘unclear risk’ of bias
Insufficient information to permit judgement of ‘low risk’ or ‘high risk’. This is usually the case if
the method of concealment is not described or not described in sufficient detail to allow a definite
judgement – for example if the use of assignment envelopes is described, but it remains unclear
whether envelopes were sequentially numbered, opaque and sealed.
Blinding of participants and personnel
Performance bias due to knowledge of the allocated interventions by participants and personnel during the study
Criteria for a judgement of
‘low risk’ of bias
Any one of the following:
1. no blinding or incomplete blinding, but the review authors judge that the outcome is not likely to
be influenced by lack of blinding;
2. blinding of participants and key study personnel ensured, and unlikely that the blinding could
have been broken.
  (Continued)
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Criteria for the judgement of
‘high risk’ of bias
Any one of the following:
1. no blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding;
2. blinding of key study participants and personnel attempted, but likely that the blinding could
have been broken, and the outcome is likely to be influenced by lack of blinding.
Criteria for the judgement of
‘unclear risk’ of bias
Any one of the following:
1. insufficient information to permit judgement of ‘low risk’ or ‘high risk’;
2. the study did not address this outcome.
Blinding of outcome assessment
Detection bias due to knowledge of the allocated interventions by outcome assessors
Criteria for a judgement of
‘low risk’ of bias
Any one of the following:
1. no blinding of outcome assessment, but the review authors judge that the outcome measurement
is not likely to be influenced by lack of blinding;
2. blinding of outcome assessment ensured, and unlikely that the blinding could have been broken.
Criteria for the judgement of
‘high risk’ of bias
Any one of the following:
1. no blinding of outcome assessment, and the outcome measurement is likely to be influenced by
lack of blinding;
2. blinding of outcome assessment, but likely that the blinding could have been broken, and the
outcome measurement is likely to be influenced by lack of blinding.
Criteria for the judgement of
‘unclear risk’ of bias
Any one of the following:
1. insufficient information to permit judgement of ‘low risk’ or ‘high risk’;
2. the study did not address this outcome.
Incomplete outcome data
Attrition bias due to amount, nature or handling of incomplete outcome data
Criteria for a judgement of
‘low risk’ of bias
Any one of the following:
1. no missing outcome data;
2. reasons for missing outcome data unlikely to be related to true outcome (for survival data, cen-
soring unlikely to be introducing bias);
3. missing outcome data balanced in numbers across intervention groups, with similar reasons for
missing data across groups;
4. for dichotomous outcome data, the proportion of missing outcomes compared with observed
event risk not enough to have a clinically relevant impact on the intervention effect estimate;
5. for continuous outcome data, plausible effect size (difference in means or standardised difference
in means) among missing outcomes not enough to have a clinically relevant impact on observed
effect size;
6. missing data have been imputed using appropriate methods.
Criteria for the judgement of
‘high risk’ of bias
Any one of the following:
1. reason for missing outcome data likely to be related to true outcome, with either imbalance in
numbers or reasons for missing data across intervention groups;
2. for dichotomous outcome data, the proportion of missing outcomes compared with observed
event risk enough to induce clinically relevant bias in intervention effect estimate;
  (Continued)
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3. for continuous outcome data, plausible effect size (difference in means or standardised difference
in means) among missing outcomes enough to induce clinically relevant bias in observed effect
size;
4. ‘as-treated’ analysis done with substantial departure of the intervention received from that as-
signed at randomisation;
5. potentially inappropriate application of simple imputation.
Criteria for the judgement of
‘unclear risk’ of bias
Any one of the following:
1. insufficient reporting of attrition/exclusions to permit judgement of ‘low risk’ or ‘high risk’ (e.g.
number randomised not stated, no reasons for missing data provided);
2. the study did not address this outcome.
Selective reporting
Reporting bias due to selective outcome reporting
Criteria for a judgement of
‘low risk’ of bias
Any of the following:
1. the study protocol is available and all of the study’s prespecified (primary and secondary) out-
comes that are of interest in the review have been reported in the prespecified way;
2. the study protocol is not available but it is clear that the published reports include all expected
outcomes, including those that were prespecified (convincing text of this nature may be uncom-
mon).
Criteria for the judgement of
‘high risk’ of bias
Any one of the following:
1. not all of the study’s prespecified primary outcomes have been reported;
2. one or more primary outcomes is reported using measurements, analysis methods or subsets of
the data (e.g. subscales) that were not prespecified;
3. one or more reported primary outcomes were not prespecified (unless clear justification for their
reporting is provided, such as an unexpected adverse effect);
4. one or more outcomes of interest in the review are reported incompletely so that they cannot be
entered in a meta-analysis;
5. the study report fails to include results for a key outcome that would be expected to have been
reported for such a study.
Criteria for the judgement of
‘unclear risk’ of bias
Insufficient information to permit judgement of ‘low risk’ or ‘high risk’. It is likely that the majority
of studies will fall into this category.
Other bias
Bias due to problems not covered elsewhere in the table
Criteria for a judgement of
‘low risk’ of bias
The study appears to be free of other sources of bias.
Criteria for the judgement of
‘high risk’ of bias
There is at least one important risk of bias. For example, the study:
1. had a potential source of bias related to the specific study design used; or
2. has been claimed to have been fraudulent; or
3. had some other problem.
Criteria for the judgement of
‘unclear risk’ of bias
There may be a risk of bias, but there is either:
1. insufficient information to assess whether an important risk of bias exists; or
2. insufficient rationale or evidence that an identified problem will introduce bias.
  (Continued)
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S O U R C E S   O F   S U P P O R T
Internal sources
• Centre for Public Health, Queens University Belfast, UK
External sources
• Public Health Agency, HSC R & D Division, UK
Provision of funding for the project
D I F F E R E N C E S   B E T W E E N   P R O T O C O L   A N D   R E V I E W
We had planned to report adverse events as a dichotomous outcome. As adverse events were inconsistently measured and reported,
this precluded meta-analysis. We therefore provided a narrative description of adverse events. We did not include overall survival and
recurrence-free survival in our 'Summary of findings' table (as indicated in the protocol) because it was not reported in any of the included
studies. In measures of treatment eJect, we modified the description of our follow-up periods to further clarify our follow-up time
points, e.g. up to 12 weeks follow-up became up to or equal to 12 weeks follow-up. We used the term 'physical activity interventions'
throughout the review to encompass exercise interventions for readers ease. We made reference to this in the description of interventions
section. We made minor changes to the data extraction form that was proposed in the protocol aMer testing the pre developed form on
a random sample of studies. Subgroup analysis were precluded, and we therefore removed any reference to subgroup analysis from the
Assessment of heterogeneity section. We made a minor amendment to the wording under the Types of participants section, as the wording
inferred patients that were not treated surgically would not be included in the review; this was not the case and was an oversight by the
authors during protocol development. We included three studies that had a health education component in addition to a physical activity
intervention, inclusion of these studies was unforeseen and therefore not identified in the protocol. Authors met to discuss inclusion of
these studies and agreed to include studies and investigate the eJect of inclusion in sensitivity analysis, where appropriate. The eJect of
including these studies is discussed in Types of interventions, Quality of the evidence and Potential biases in the review process sections.
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